Attached files

file filename
EX-32.3 - CERTIFICATION OF CHIEF FINANCIAL OFFICER PURSUANT TO 18 U.S.C. SECTION 1350, AS - CION Investment Corpcionex-32_3.htm
EX-32.2 - CERTIFICATION OF CO-CHIEF EXECUTIVE OFFICER PURSUANT TO 18 U.S.C. SECTION 1350, - CION Investment Corpcionex-32_2.htm
EX-32.1 - CERTIFICATION OF CO-CHIEF EXECUTIVE OFFICER PURSUANT TO 18 U.S.C. SECTION 1350, - CION Investment Corpcionex-32_1.htm
EX-31.3 - CERTIFICATION OF CHIEF FINANCIAL OFFICER PURSUANT TO SECTION 302 OF THE SARBANES - CION Investment Corpcionex-31_3.htm
EX-31.2 - CERTIFICATION OF CO-CHIEF EXECUTIVE OFFICER PURSUANT TO SECTION 302 OF THE SARBA - CION Investment Corpcionex-31_2.htm
EX-31.1 - CERTIFICATION OF CO-CHIEF EXECUTIVE OFFICER PURSUANT TO SECTION 302 OF THE SARBA - CION Investment Corpcionex-31_1.htm


UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 10-Q 

[x]
QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the quarterly period ended March 31, 2018
OR
[ ]
TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the transition period from __________ to __________
Commission File Number 000-54755 
 
CĪON Investment Corporation
 
 
(Exact name of registrant as specified in its charter)
 
 
Maryland
 
45-3058280
(State or other jurisdiction of
incorporation or organization)
 
(I.R.S. Employer
Identification No.)
 
 
 
3 Park Avenue, 36th Floor
New York, New York
 
10016
(Address of principal executive offices)
 
(Zip Code)
 
(212) 418-4700
 
 
(Registrant’s telephone number, including area code)
 
 
 
 
 
Not applicable
 
 
(Former name, former address and former fiscal year, if changed since last report)
 
Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.                                                      
Yes [x] No [ ]
Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Website, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files).
Yes [ ] No [ ]
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and "emerging growth company" in Rule 12b-2 of the Exchange Act.
 
Large accelerated filer [ ]
Accelerated filer [ ]
 
Non-accelerated filer [x] (Do not check if a smaller reporting company)
Smaller reporting company [ ]
 
 
Emerging growth company [ ]
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.
[ ]
Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).  
Yes [ ] No [x]
The number of shares of the registrant’s common stock, $0.001 par value, outstanding as of May 10, 2018 was 114,822,990.




CĪON INVESTMENT CORPORATION
FORM 10-Q
TABLE OF CONTENTS
 
 
Page
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 





PART I – FINANCIAL INFORMATION
Item 1. Financial Statements
CĪON Investment Corporation
Consolidated Balance Sheets
(in thousands, except share and per share amounts)
 
 
March 31,
2018
 
December 31,
2017
 
 
(unaudited)
 
 
Assets
Investments, at fair value:
 

 

     Non-controlled, non-affiliated investments (amortized cost of $1,742,041 and $1,692,978, respectively)
 
$
1,746,393

 
$
1,698,662

     Non-controlled, affiliated investments (amortized cost of $19,130 and $19,422, respectively)
 
15,123

 
15,533

          Total investments, at fair value (amortized cost of $1,761,171 and $1,712,400, respectively)
 
1,761,516

 
1,714,195

Cash
 
13,738

 
56,354

Interest receivable on investments
 
12,323

 
12,433

Receivable due on investments sold
 
26,522

 
29,524

Prepaid expenses and other assets
 
3,284

 
3,417

   Total assets
 
$
1,817,383

 
$
1,815,923

Liabilities and Shareholders' Equity
Liabilities
 
 
 
 
Financing arrangements (net of unamortized debt issuance costs of $5,414 and $6,018, respectively)
 
$
706,050

 
$
705,447

Payable for investments purchased
 
38,835

 
36,439

Accounts payable and accrued expenses
 
1,351

 
1,432

Interest payable
 
2,532


2,311

Accrued management fees
 
7,939

 
7,821

Accrued subordinated incentive fee on income
 

 
3,222

Accrued administrative services expense
 
111

 
556

Due to CIG - offering costs
 
12

 
4

Total liabilities
 
756,830

 
757,232

 
 
 
 
 
Commitments and contingencies (Note 4 and Note 11)
 
 
 
 
 
 
 
 
 
Shareholders' Equity
 
 
 
 
Common stock, $0.001 par value; 500,000,000 shares authorized;
 
 
 
 
116,108,932 and 115,781,751 shares issued and outstanding, respectively
 
116

 
116

Capital in excess of par value
 
1,079,262

 
1,076,131

Undistributed net investment income
 
10,549

 
10,368

Accumulated net realized loss from investments
 
(10,385
)
 
(10,385
)
Accumulated net unrealized appreciation on investments
 
345

 
1,795

Accumulated net realized loss from total return swap(1)
 
(19,334
)
 
(19,334
)
Total shareholders' equity
 
1,060,553

 
1,058,691

Total liabilities and shareholders' equity
 
$
1,817,383

 
$
1,815,923

Net asset value per share of common stock at end of period
 
$
9.13

 
$
9.14

(1)  See Note 7 for a discussion of the Company’s total return swap agreement.
See accompanying notes to consolidated financial statements.

1



CĪON Investment Corporation
Consolidated Statements of Operations
(in thousands, except share and per share amounts)
 
 
Three Months Ended
March 31,
 
 
2018

2017
 
 
(unaudited)
 
(unaudited)
Investment income
 
 
 
 
Interest income:
 
 
 
 
     Non-controlled, non-affiliated investments
 
$
38,073

 
$
27,498

     Non-controlled, affiliated investments
 
99

 

          Total interest income
 
38,172

 
27,498

Fee and other income
 
214

 
547

Total investment income
 
38,386

 
28,045

Operating expenses
 
 
 
 
Management fees
 
7,939

 
6,482

Administrative services expense
 
461

 
346

General and administrative(1)
 
1,982

 
1,746

Interest expense
 
8,918

 
2,926

Total operating expenses
 
19,300

 
11,500

Net investment income
 
19,086

 
16,545

Realized and unrealized gains (losses)
 
 
 
 
Net realized gains (losses) on:
 
 
 
 
   Non-controlled, non-affiliated investments
 
2,078

 
740

   Non-controlled, affiliated investments
 
17

 

   Total return swap(2)
 

 
(14,269
)
   Foreign currency
 
2


144

Net realized gains (losses)
 
2,097

 
(13,385
)
Net change in unrealized (depreciation) appreciation on:
 
 
 
 
   Non-controlled, non-affiliated investments
 
(1,333
)
 
(2,817
)
   Non-controlled, affiliated investments
 
(117
)
 

   Total return swap(2)
 

 
15,536

Net change in unrealized (depreciation) appreciation
 
(1,450
)
 
12,719

Net realized and unrealized gains (losses)
 
647

 
(666
)
Net increase in net assets resulting from operations
 
$
19,733

 
$
15,879

Per share information—basic and diluted
 
 
 
 
Net increase in net assets per share resulting from operations
 
$
0.17

 
$
0.14

Weighted average shares of common stock outstanding
 
114,849,958

 
110,083,778

(1)  See Note 10 for details of the Company's general and administrative expenses.
(2)  See Note 7 for a discussion of the Company's total return swap agreement.
See accompanying notes to consolidated financial statements.

2



CĪON Investment Corporation
Consolidated Statements of Changes in Net Assets
(in thousands, except share and per share amounts)
 
 
Three Months Ended
March 31,
 
 
2018
 
2017
 
 
(unaudited)
 
(unaudited)
Changes in net assets from operations:
 
 
 
 
Net investment income
 
$
19,086

 
$
16,545

Net realized gain on investments
 
2,095

 
740

Net realized gain on foreign currency
 
2

 
144

Net change in unrealized depreciation on investments
 
(1,450
)
 
(2,817
)
Net realized loss on total return swap(1)
 

 
(14,269
)
Net change in unrealized appreciation on total return swap(1)
 

 
15,536

Net increase in net assets resulting from operations
 
19,733

 
15,879

Changes in net assets from shareholders' distributions:(2)
 
 
 
 
Net investment income
 
(18,905
)
 
(15,289
)
Net realized gain on total return swap
 
 
 
 
Net interest and other income from TRS portfolio
 

 
(3,316
)
Net gain on TRS loan sales(3)
 

 
(634
)
Net realized gain on investments and foreign currency
 
(2,097
)
 
(884
)
Net decrease in net assets from shareholders' distributions
 
(21,002
)
 
(20,123
)
Changes in net assets from capital share transactions:
 
 
 
 
Issuance of common stock, net of issuance costs of $471 and $448, respectively
 
11,666

 
11,935

Reinvestment of shareholders' distributions
 
9,844

 
9,926

Repurchase of common stock
 
(18,379
)
 
(7,370
)
Net increase in net assets resulting from capital share transactions
 
3,131

 
14,491

 
 
 
 
 
Total increase in net assets
 
1,862

 
10,247

Net assets at beginning of period
 
1,058,691

 
999,763

Net assets at end of period
 
$
1,060,553

 
$
1,010,010

Net asset value per share of common stock at end of period
 
$
9.13

 
$
9.07

Shares of common stock outstanding at end of period
 
116,108,932

 
111,370,686

Undistributed net investment income at end of period
 
$
10,549

 
$
2,684

(1)
See Note 7 for a discussion of the Company’s total return swap agreement.
(2)
This table presents changes in net assets from shareholders' distributions on a GAAP basis. See Note 5 for a discussion of the sources of distributions paid by the Company.
(3)
During the three months ended March 31, 2017, the Company realized losses of $21,146, which were not then deductible on a tax-basis. 
See accompanying notes to consolidated financial statements.

3



CĪON Investment Corporation
Consolidated Statements of Cash Flows
(in thousands)
 
 
Three Months Ended
March 31,
 
 
2018

2017
 
 
(unaudited)
 
(unaudited)
Operating activities:
 
 
 
 
Net increase in net assets resulting from operations
 
$
19,733

 
$
15,879

Adjustments to reconcile net increase in net assets resulting from operations to net cash used in
 
 
 
 
  operating activities:
 
 
 
 
Net accretion of discount on investments
 
(2,318
)
 
(1,817
)
Proceeds from principal repayment of investments
 
192,418

 
109,443

Purchase of investments
 
(322,156
)
 
(508,339
)
Paid-in-kind interest
 
(665
)
 
(729
)
Decrease in short term investments, net
 
25,452

 
198

Proceeds from sale of investments
 
60,369

 
30,903

Net realized gain on investments
 
(2,095
)
 
(740
)
Net unrealized depreciation on investments
 
1,450

 
2,817

Net unrealized appreciation on total return swap(1)
 

 
(15,536
)
Amortization of debt issuance costs
 
737

 
273

(Increase) decrease in due from counterparty(1)
 

 
123,254

(Increase) decrease in interest receivable on investments
 
334

 
1,389

(Increase) decrease in receivable due on investments sold
 
3,002

 
(2,112
)
(Increase) decrease in receivable due on total return swap(1)
 

 
16,874

(Increase) decrease in prepaid expenses and other assets
 
5

 
127

Increase (decrease) in payable for investments purchased
 
2,396

 
11,923

Increase (decrease) in accounts payable and accrued expenses
 
(81
)
 
(395
)
Increase (decrease) in interest payable
 
221

 
109

Increase (decrease) in accrued management fees
 
118

 
701

Increase (decrease) in accrued administrative services expense
 
(445
)
 
(336
)
Increase (decrease) in due to CIG - offering costs
 
8

 

Increase (decrease) in subordinated incentive fee on income payable
 
(3,222
)
 

Net cash used in operating activities
 
(24,739
)
 
(216,114
)
Financing activities:
 
 
 
 
Gross proceeds from issuance of common stock
 
12,137

 
12,383

Commissions and dealer manager fees paid
 
(471
)
 
(450
)
Repurchase of common stock
 
(18,379
)
 
(7,370
)
Shareholders' distributions paid(2)
 
(11,158
)
 
(10,197
)
Borrowings under financing arrangements(3)
 

 
231,698

Debt issuance costs paid
 
(6
)
 
(1,811
)
Net cash (used in) provided by financing activities
 
(17,877
)
 
224,253

Net (decrease) increase in cash and restricted cash
 
(42,616
)
 
8,139

Cash and restricted cash, beginning of period
 
56,354

 
17,046

Cash and restricted cash, end of period
 
$
13,738

 
$
25,185

Supplemental disclosure of cash flow information:
 
 
 
 
Cash paid for interest
 
$
7,976

 
$
2,540

Supplemental non-cash financing activities:
 
 
 
 
Reinvestment of shareholders' distributions(2)
 
$
9,844

 
$
9,926

(1)
See Note 7 for a discussion of the Company’s total return swap agreement.
(2)
See Note 5 for a discussion of the sources of distributions paid by the Company.
(3)
See Note 8 for a discussion of the Company’s financing arrangements.
See accompanying notes to consolidated financial statements.

4



CĪON Investment Corporation
Consolidated Schedule of Investments (unaudited)
March 31, 2018
(in thousands)
Portfolio Company(a)
 
Index Rate(b)
 
Industry
 
Principal/
Par Amount/
Units(e)
 
Cost(d)
 
Fair
Value(c)
Senior Secured First Lien Debt - 109.4%
 
 
 
 
 
 
 
 
 
 
AbelConn, LLC / Atrenne Computing Solutions, LLC / Airco Industries, LLC, L+875, 1.00% LIBOR Floor, 7/17/2019 (p)(r)
 
3 Month LIBOR
 
Aerospace & Defense
 
$
18,506

 
$
18,323

 
$
18,599

Academy, Ltd., L+400, 1.00% LIBOR Floor, 7/1/2022 (q)
 
(y)
 
Retail
 
14,531

 
11,831

 
11,643

Access CIG, LLC, L+375, 0.00% LIBOR Floor, 2/27/2025
 
1 Month LIBOR
 
Services: Business
 
914

 
910

 
927

Access CIG, LLC, 0.00% Unfunded, 8/27/2018
 
None
 
Services: Business
 
191

 

 
3

Adams Publishing Group, LLC, L+700, 1.00% LIBOR Floor, 11/3/2020 (p)
 
3 Month LIBOR
 
Media: Advertising, Printing & Publishing
 
5,074

 
5,034

 
5,074

Advanced Integration Technology LP, L+475, 1.00% LIBOR Floor, 4/3/2023 (q)
 
2 Month LIBOR
 
Aerospace & Defense
 
3,960

 
3,991

 
3,990

Allen Media, LLC, L+925, 1.00% LIBOR Floor, 3/22/2025 (p)(r)
 
1 Month LIBOR
 
Media: Diversified & Production
 
60,000

 
58,504

 
58,650

ALM Media, LLC, L+450, 1.00% LIBOR Floor, 7/31/2020 (k)(q)
 
3 Month LIBOR
 
Media: Advertising, Printing & Publishing
 
13,562

 
12,403

 
11,697

Alvogen Pharma US, Inc., L+500, 1.00% LIBOR Floor, 4/1/2022 (q)
 
1 Month LIBOR
 
Healthcare & Pharmaceuticals
 
8,105

 
8,071

 
8,149

American Clinical Solutions LLC, 12.50%, 6/11/2020 (u)(w)
 
None
 
Healthcare & Pharmaceuticals
 
9,152

 
9,070

 
7,413

American Dental Partners, Inc., L+475, 1.00% LIBOR Floor, 8/29/2021 (q)(s)
 
3 Month LIBOR
 
Healthcare & Pharmaceuticals
 
10,694

 
10,270

 
10,708

American Media, Inc., L+900, 1.00% LIBOR Floor, 8/24/2020 (p)
 
3 Month LIBOR
 
Media: Advertising, Printing & Publishing
 
14,815

 
14,452

 
15,185

American Media, Inc., 0.50% Unfunded, 8/24/2020
 
None
 
Media: Advertising, Printing & Publishing
 
746

 

 
19

American Media, Inc., 9.00% Unfunded, 8/24/2020
 
None
 
Media: Advertising, Printing & Publishing
 
84

 

 
2

American Teleconferencing Services, Ltd., L+650, 1.00% LIBOR Floor, 12/8/2021 (p)(q)(r)(s)
 
2 Month LIBOR
 
Telecommunications
 
21,031

 
19,418

 
21,031

AMPORTS, Inc., L+500, 1.00% LIBOR Floor, 5/19/2020 (l)(p)(r)
 
1 Month LIBOR
 
Automotive
 
18,943

 
18,712

 
18,943

AP Exhaust Acquisition, LLC, L+500, 1.00% LIBOR Floor, 5/10/2024 (q)
 
3 Month LIBOR
 
Automotive
 
5,599

 
5,416

 
5,616

Ascent Resources - Marcellus, LLC, L+650, 1.00% LIBOR Floor, 3/30/2023
 
1 Month LIBOR
 
Energy: Oil & Gas
 
712

 
712

 
712

Associated Asphalt Partners, LLC, L+525, 1.00% LIBOR Floor, 4/5/2024 (q)
 
1 Month LIBOR
 
Construction & Building
 
10,927

 
10,739

 
10,627

Azure Midstream Energy, LLC, L+750, 1.00% LIBOR Floor, 12/31/2019 (q)
 
1 Month LIBOR
 
Energy: Oil & Gas
 
1,964

 
1,928

 
1,934

Cadence Aerospace, LLC, L+650, 1.00% LIBOR Floor, 11/14/2023 (r)(s)
 
3 Month LIBOR
 
Aerospace & Defense
 
19,950

 
19,762

 
19,551

Caraustar Industries, Inc., L+550, 1.00% LIBOR Floor, 3/14/2022 (q)
 
3 Month LIBOR
 
Forest Products & Paper
 
5,563

 
5,620

 
5,566

Cardinal US Holdings, Inc., L+500, 1.00% LIBOR Floor, 7/31/2023 (q)
 
3 Month LIBOR
 
Services: Business
 
8,458

 
7,901

 
8,077

CB URS Holdings Corp., L+525, 1.00% LIBOR Floor, 9/1/2024 (q)(s)
 
1 Month LIBOR
 
Transportation: Cargo
 
14,775

 
14,703

 
15,034

Central Security Group, Inc., L+563, 1.00% LIBOR Floor, 10/6/2021 (q)(s)
 
1 Month LIBOR
 
Services: Consumer
 
17,853

 
17,881

 
17,897

Charming Charlie, LLC, L+100, 1.00% LIBOR Floor, 6/8/2018
 
1 Month LIBOR
 
Retail
 
4,190

 
2,366

 
3,771

Charming Charlie, LLC, L+450, 1.00% LIBOR Floor, 6/8/2018
 
1 Month LIBOR
 
Retail
 
1,885

 
1,885

 
1,678

Charming Charlie, LLC, L+800, 1.00% LIBOR Floor, 12/24/2019 (u)
 
1 Month LIBOR
 
Retail
 
7,936

 
2,417

 

Charming Charlie, LLC, 0.38% Unfunded, 6/8/2018
 
None
 
Retail
 
210

 

 
(23
)
CircusTrix Holdings, LLC, L+550, 1.00% LIBOR Floor, 12/16/2021 (s)
 
3 Month LIBOR
 
Hotel, Gaming & Leisure
 
20,490

 
20,291

 
20,285

CircusTrix Holdings, LLC, 1.00% Unfunded, 12/27/2019
 
None
 
Hotel, Gaming & Leisure
 
4,459

 

 
(45
)
Confie Seguros Holding II Co., L+525, 1.00% LIBOR Floor, 4/16/2022 (q)
 
3 Month LIBOR
 
Banking, Finance, Insurance & Real Estate
 
15,862

 
15,753

 
15,867

Covenant Surgical Partners, Inc., L+475, 0.00% LIBOR Floor, 10/4/2024 (q)
 
3 Month LIBOR
 
Healthcare & Pharmaceuticals
 
1,869

 
1,865

 
1,869

Covenant Surgical Partners, Inc., L+475, 0.00% LIBOR Floor, 10/4/2024 (q)
 
3 Month LIBOR
 
Healthcare & Pharmaceuticals
 
290

 
289

 
290

See accompanying notes to consolidated financial statements.

5



CĪON Investment Corporation
Consolidated Schedule of Investments (unaudited)
March 31, 2018
(in thousands)
Portfolio Company(a)
 
Index Rate(b)
 
Industry
 
Principal/
Par Amount/
Units(e)
 
Cost(d)
 
Fair
Value(c)
Covenant Surgical Partners, Inc., 4.75% Unfunded, 10/4/2018 (q)
 
None
 
Healthcare & Pharmaceuticals
 
271

 

 

CSP Technologies North America, LLC, L+525, 1.00% LIBOR Floor, 1/29/2022 (r)
 
3 Month LIBOR
 
Chemicals, Plastics & Rubber
 
13,483

 
13,263

 
13,517

David's Bridal, Inc., L+400, 1.25% LIBOR Floor, 10/11/2019 (q)
 
3 Month LIBOR
 
Retail
 
3,406

 
3,035

 
2,923

Dayton Superior Corp., L+800, 1.00% LIBOR Floor, 11/15/2021 (q)
 
3 Month LIBOR
 
Construction & Building
 
6,252

 
5,680

 
5,814

DBRS, Inc., L+525, 1.00% LIBOR Floor, 3/4/2022 (i)(q)
 
3 Month LIBOR
 
Services: Business
 
5,892

 
5,714

 
5,943

Deluxe Entertainment Services Group Inc., L+550, 1.00% LIBOR Floor, 2/28/2020 (q)
 
1 Month LIBOR
 
Media: Diversified & Production
 
16,413

 
16,319

 
16,259

DFC Global Facility Borrower II LLC, L+1075, 1.00% LIBOR Floor, 9/27/2022
 
1 Month LIBOR
 
Services: Consumer
 
20,235

 
20,100

 
20,235

DFC Global Facility Borrower II LLC, 0.50% Unfunded, 9/27/2019
 
None
 
Services: Consumer
 
9,765

 

 

Discovery DJ Services LLC, L+725, 1.00% LIBOR Floor, 10/25/2022
 
1 Month LIBOR
 
Energy: Oil & Gas
 
6,078

 
5,893

 
5,987

Discovery DJ Services LLC, 0.50% Unfunded, 4/25/2019
 
None
 
Energy: Oil & Gas
 
392

 

 
(6
)
Discovery DJ Services LLC, 0.50% Unfunded, 10/25/2022
 
None
 
Energy: Oil & Gas
 
3,529

 

 
(53
)
Dodge Data & Analytics, LLC / Skyline Data News and Analytics, LLC, L+875, 1.00% LIBOR Floor, 10/31/2019 (p)
 
3 Month LIBOR
 
Construction & Building
 
9,712

 
9,633

 
9,554

DXP Enterprises, Inc., L+550, 1.00% LIBOR Floor, 8/29/2023 (i)(q)
 
1 Month LIBOR
 
Energy: Oil & Gas
 
9,950

 
9,857

 
10,031

EagleTree-Carbide Acquisition Corp., L+475, 1.00% LIBOR Floor, 8/28/2024 (k)(q)
 
3 Month LIBOR
 
Consumer Goods: Durable
 
19,925

 
19,780

 
20,112

Eastman Kodak Company, L+625, 1.00% LIBOR Floor, 9/3/2019 (i)(q)
 
3 Month LIBOR
 
Consumer Goods: Durable
 
1,965

 
1,961

 
1,856

Elemica, Inc., L+800, 1.00% LIBOR Floor, 7/7/2021 (p)(r)
 
1 Month LIBOR
 
High Tech Industries
 
17,194

 
16,880

 
17,022

Elemica, Inc., 0.50% Unfunded, 7/7/2021
 
None
 
High Tech Industries
 
2,500

 
(41
)
 
(25
)
Emmis Operating Company, L+700, 1.00% LIBOR Floor, 4/18/2019 (q)
 
1 Month LIBOR
 
Media: Broadcasting & Subscription
 
3,384

 
3,229

 
3,300

Entertainment Studios P&A LLC, 11.27%, 5/18/2037
 
None
 
Media: Diversified & Production
 
37,500

 
36,956

 
34,514

Entertainment Studios P&A LLC, 5.00%, 5/18/2037 (m)
 
None
 
Media: Diversified & Production
 
3,410

 
3,343

 
6,862

EnTrans International, LLC, L+750, 1.00% LIBOR Floor, 6/4/2020
 
1 Month LIBOR
 
Capital Equipment
 
12,750

 
10,268

 
12,750

Evergreen Skills Lux S.À.R.L., L+475, 1.00% LIBOR Floor, 4/28/2021 (i)(q)
 
1 Month LIBOR
 
High Tech Industries
 
10,236

 
9,648

 
9,908

F+W Media, Inc., L+1000, 1.50% LIBOR Floor, 5/24/2022 (p)(u)(v)(w)
 
1 Month LIBOR
 
Media: Diversified & Production
 
2,816

 
2,747

 
1,359

F+W Media, Inc., L+650, 1.50% LIBOR Floor, 5/24/2022 (v)(w)
 
1Month LIBOR
 
Media: Diversified & Production
 
1,144

 
1,144

 
1,201

Forbes Media LLC, L+675, 1.00% LIBOR Floor, 9/12/2019 (l)(r)
 
1 Month LIBOR
 
Media: Advertising, Printing & Publishing
 
14,660

 
14,449

 
14,659

Foundation Consumer Healthcare, LLC, L+650, 1.00% LIBOR Floor, 11/2/2023 (p)(r)(s)
 
3 Month LIBOR
 
Healthcare & Pharmaceuticals
 
45,675

 
45,347

 
45,903

Foundation Consumer Healthcare, LLC, 0.50% Unfunded, 11/2/2023
 
None
 
Healthcare & Pharmaceuticals
 
4,211

 
(32
)
 
21

Frontline Technologies Group Holding LLC, 1.00% Unfunded, 9/18/2019
 
None
 
High Tech Industries
 
540

 

 
(6
)
Harland Clarke Holdings Corp., L+475, 1.00% LIBOR Floor, 11/3/2023 (q)(s)
 
3 Month LIBOR
 
Services: Business
 
14,654

 
14,587

 
14,805

Healogics, Inc., L+425, 1.00% LIBOR Floor, 7/1/2021 (q)
 
3 Month LIBOR
 
Healthcare & Pharmaceuticals
 
4,837

 
4,592

 
4,255

Heartland Dental, LLC, L+475, 1.00% LIBOR Floor, 7/31/2023 (q)
 
3 Month LIBOR
 
Healthcare & Pharmaceuticals
 
3,990

 
3,972

 
4,004

Infinity Sales Group, LLC, L+1050, 1.00% LIBOR Floor, 11/21/2018 (p)
 
3 Month LIBOR
 
Services: Business
 
7,480

 
7,254

 
7,106

InfoGroup Inc., L+500, 1.00% LIBOR Floor, 4/3/2023 (k)(q)(r)(s)
 
3 Month LIBOR
 
Media: Advertising, Printing & Publishing
 
16,040

 
16,024

 
15,980

Instant Web, LLC, L+650, 0.00% LIBOR Floor, 12/15/2022 (p)(s)
 
1 Month LIBOR
 
Media: Advertising, Printing & Publishing
 
39,796

 
39,699

 
39,697

Instant Web, LLC, L+650, 0.00% LIBOR Floor, 12/15/2022
 
1 Month LIBOR
 
Media: Advertising, Printing & Publishing
 
649

 
647

 
647

See accompanying notes to consolidated financial statements.

6



CĪON Investment Corporation
Consolidated Schedule of Investments (unaudited)
March 31, 2018
(in thousands)
Portfolio Company(a)
 
Index Rate(b)
 
Industry
 
Principal/
Par Amount/
Units(e)
 
Cost(d)
 
Fair
Value(c)
Instant Web, LLC, 0.50% Unfunded, 12/15/2022
 
None
 
Media: Advertising, Printing & Publishing
 
2,055

 

 
(6
)
International Seaways, Inc., L+550, 1.00% LIBOR Floor, 6/22/2022 (i)(q)
 
1 Month LIBOR
 
Transportation: Cargo
 
9,875

 
9,700

 
9,813

Ipsen International GmbH, L+800, 1.00% LIBOR Floor, 9/30/2019 (i)(l)
 
1 Month LIBOR
 
Capital Equipment
 
1,202

 
1,205

 
1,202

Ipsen, Inc., L+700, 1.00% LIBOR Floor, 9/30/2019 (l)(r)
 
1 Month LIBOR
 
Capital Equipment
 
7,790

 
7,737

 
7,790

Island Medical Management Holdings, LLC, L+550, 1.00% LIBOR Floor, 9/1/2022 (r)
 
3 Month LIBOR
 
Healthcare & Pharmaceuticals
 
13,674

 
13,519

 
12,990

ITC Service Group Acquisition LLC, L+950, 0.50% LIBOR Floor, 5/26/2021 (l)(p)
 
1 Month LIBOR
 
High Tech Industries
 
11,250

 
11,089

 
10,969

KLO Intermediate Holdings, LLC, L+775, 1.25% LIBOR Floor, 4/7/2022 (r)
 
1 Month LIBOR
 
Chemicals, Plastics & Rubber
 
7,525

 
7,446

 
7,375

KLO Intermediate Holdings, LLC, L+775, 1.25% LIBOR Floor, 4/7/2022 (r)
 
1 Month LIBOR
 
Chemicals, Plastics & Rubber
 
4,357

 
4,311

 
4,270

KNB Holdings Corp., L+550, 1.00% LIBOR Floor, 4/26/2024 (q)(s)
 
3 Month LIBOR
 
Consumer Goods: Durable
 
15,800

 
15,514

 
15,721

Labvantage Solutions Inc., L+750, 1.00% LIBOR Floor, 12/29/2020 (r)
 
1 Month LIBOR
 
High Tech Industries
 
4,563

 
4,531

 
4,608

Labvantage Solutions Ltd., E+750, 1.00% EURIBOR Floor, 12/29/2020 (i)
 
1 Month EURIBOR
 
High Tech Industries
 
4,237

 
4,731

 
5,274

Lift Brands, Inc., L+800, 1.00% LIBOR Floor, 12/23/2019 (p)
 
1 Month LIBOR
 
Services: Consumer
 
9,097

 
9,032

 
9,097

Logix Holding Company, LLC, L+575, 1.00% LIBOR Floor, 12/22/2024 (q)
 
1 Month LIBOR
 
Telecommunications
 
5,027

 
4,977

 
4,977

Lonestar Prospects, Ltd., L+950, 1.00% LIBOR Floor, 8/1/2021 (w)
 
3 Month LIBOR
 
Energy: Oil & Gas
 
3,745

 
3,684

 
3,670

LTCG Holdings Corp., L+500, 1.00% LIBOR Floor, 6/6/2020 (q)
 
1 Month LIBOR
 
Services: Business
 
5,911

 
5,638

 
5,919

Mayfield Agency Borrower Inc., L+450, 0.00% LIBOR Floor, 2/28/2025 (q)
 
1 Month LIBOR
 
Banking, Finance, Insurance & Real Estate
 
3,981

 
3,961

 
4,001

MB2 Dental Solutions, LLC, L+475, 1.00% LIBOR Floor, 9/29/2023
 
3 Month LIBOR
 
Healthcare & Pharmaceuticals
 
2,180

 
2,154

 
2,142

Ministry Brands, LLC, L+500, 1.00% LIBOR Floor, 12/2/2022 (p)
 
1 Month LIBOR
 
Services: Business
 
4,935

 
4,768

 
4,934

Ministry Brands, LLC, L+500, 1.00% LIBOR Floor, 12/2/2022 (r)
 
1 Month LIBOR
 
Services: Business
 
3,890

 
3,890

 
3,890

Moss Holding Company, L+675, 1.00% LIBOR Floor, 4/17/2023 (p)(r)
 
3 Month LIBOR
 
Services: Business
 
18,829

 
18,533

 
18,547

Moss Holding Company, 0.75% Unfunded, 5/7/2018
 
None
 
Services: Business
 
1,046

 

 
(16
)
Moss Holding Company, 0.50% Unfunded, 4/17/2023
 
None
 
Services: Business
 
2,232

 

 
(33
)
MRO Holdings, Inc., L+525, 1.00% LIBOR Floor, 10/25/2023 (q)
 
3 Month LIBOR
 
Aerospace & Defense
 
4,479

 
4,437

 
4,535

Murray Energy Corp., L+725, 1.00% LIBOR Floor, 4/16/2020 (q)
 
3 Month LIBOR
 
Metals & Mining
 
3,619

 
3,544

 
3,076

Navex Global, Inc., L+425, 1.00% LIBOR Floor, 11/19/2021 (q)(s)
 
1 Month LIBOR
 
High Tech Industries
 
17,864

 
17,909

 
17,942

NewsCycle Solutions, Inc., L+700, 1.00% LIBOR Floor, 12/29/2022 (s)
 
1 Month LIBOR
 
Media: Advertising, Printing & Publishing
 
20,000

 
19,804

 
19,800

NM GRC Holdco, LLC, L+550, 1.00% LIBOR Floor, 2/9/2024
 
3 Month LIBOR
 
High Tech Industries
 
8,934

 
8,687

 
8,688

NM GRC Holdco, LLC, 1.00% Unfunded, 2/9/2020
 
None
 
High Tech Industries
 
2,654

 

 
(73
)
Ocean Bidco, Inc., L+500, 1.00% LIBOR Floor, 3/21/2025 (k)(q)
 
3 Month LIBOR
 
High Tech Industries
 
4,589

 
4,566

 
4,609

Opal Acquisition, Inc., L+400, 1.00% LIBOR Floor, 11/27/2020 (q)
 
3 Month LIBOR
 
Healthcare & Pharmaceuticals
 
10,182

 
9,663

 
9,749

Orbcomm Inc., 8.00%, 4/1/2024 (p)
 
None
 
Telecommunications
 
9,237

 
9,237

 
9,641

P.F. Chang's China Bistro, Inc., L+500, 1.00% LIBOR Floor, 9/1/2022 (q)
 
3 Month LIBOR
 
Beverage, Food & Tobacco
 
9,950

 
9,677

 
9,452

Paris Presents Inc., L+500, 1.00% LIBOR Floor, 12/31/2020 (r)
 
1 Month LIBOR
 
Consumer Goods: Durable
 
11,910

 
11,849

 
11,969

Pathway Partners Vet Management Company LLC, L+425, 0.00% LIBOR Floor, 10/10/2024
 
1 Month LIBOR
 
Healthcare & Pharmaceuticals
 
563

 
563

 
565

Pathway Partners Vet Management Company LLC, 1.00% Unfunded, 10/10/2019
 
None
 
Healthcare & Pharmaceuticals
 
343

 

 
1

See accompanying notes to consolidated financial statements.

7



CĪON Investment Corporation
Consolidated Schedule of Investments (unaudited)
March 31, 2018
(in thousands)
Portfolio Company(a)
 
Index Rate(b)
 
Industry
 
Principal/
Par Amount/
Units(e)
 
Cost(d)
 
Fair
Value(c)
Patriot Container Corp., L+350, 1.00% LIBOR Floor, 3/20/2025 (q)
 
1 Month LIBOR
 
Capital Equipment
 
5,000

 
4,975

 
5,031

PDI TA Holdings, Inc., L+475, 1.00% LIBOR Floor, 8/25/2023
 
3 Month LIBOR
 
High Tech Industries
 
1,280

 
1,280

 
1,267

Petroflow Energy Corp., L+800, 1.00% LIBOR Floor, 6/29/2019 (p)(u)(v)(w)
 
1 Month LIBOR
 
Energy: Oil & Gas
 
3,488

 
3,247

 
3,243

PFS Holding Corp., L+350, 1.00% LIBOR Floor, 1/31/2021 (k)
 
1 Month LIBOR
 
Retail
 
3,162

 
2,332

 
2,166

Photonis Technologies SAS, L+750, 1.00% LIBOR Floor, 9/18/2019 (i)(q)
 
3 Month LIBOR
 
Aerospace & Defense
 
6,397

 
5,742

 
5,662

Phylogeny, LLC / Conversant Biologics, LLC, L+650, 1.00% LIBOR Floor, 3/30/2024
 
6 Month LIBOR
 
Healthcare & Pharmaceuticals
 
6,493

 
6,331

 
6,331

Phylogeny, LLC / Conversant Biologics, LLC, 1.00% Unfunded, 3/30/2020
 
None
 
Healthcare & Pharmaceuticals
 
1,299

 
(19
)
 
(33
)
Plano Molding Company, LLC, L+800, 1.00% LIBOR Floor, 5/12/2021 (p)
 
1 Month LIBOR
 
Consumer Goods: Non-Durable
 
7,934

 
7,855

 
7,210

Project Leopard Holdings, Inc., L+400, 1.00% LIBOR Floor, 7/7/2023 (q)
 
1 Month LIBOR
 
High Tech Industries
 
3,980

 
3,971

 
4,014

Radio One, Inc., L+400, 1.00% LIBOR Floor, 4/18/2023 (q)
 
1 Month LIBOR
 
Media: Broadcasting & Subscription
 
2,958

 
2,932

 
2,941

Reddy Ice Corp., L+550, 1.25% LIBOR Floor, 5/1/2019 (q)
 
2 Month LIBOR
 
Beverage, Food & Tobacco
 
10,876

 
10,900

 
10,822

Rhino Energy LLC, L+1000, 1.00% LIBOR Floor, 12/27/2020 (s)
 
1 Month LIBOR
 
Metals & Mining
 
8,725

 
8,182

 
8,376

Rimini Street, Inc., 15.00%, 6/24/2020 (p)(w)
 
None
 
High Tech Industries
 
19,756

 
19,564

 
20,984

Sequoia Healthcare Management, LLC, 16.00%, 7/17/2019 (p)(w)
 
None
 
Healthcare & Pharmaceuticals
 
5,223

 
5,179

 
5,223

SG Acquisition, Inc., L+500, 1.00% LIBOR Floor, 3/29/2024 (q)
 
3 Month LIBOR
 
Banking, Finance, Insurance & Real Estate
 
3,853

 
3,821

 
3,868

Shift PPC LLC, L+600, 1.00% LIBOR Floor, 12/22/2021 (r)
 
6 Month LIBOR
 
High Tech Industries
 
4,816

 
4,715

 
4,816

SI Organization, Inc., L+475, 1.00% LIBOR Floor, 11/23/2019 (q)
 
1 Month LIBOR
 
Services: Business
 
7,652

 
7,723

 
7,678

Spinal USA, Inc. / Precision Medical Inc., L+950, 1.00% LIBOR Floor, 1/21/2020 (p)
 
3 Month LIBOR
 
Healthcare & Pharmaceuticals
 
12,696

 
12,644

 
12,633

Spinal USA, Inc. / Precision Medical Inc., L+950, 1.00% LIBOR Floor, 7/21/2020 (w)
 
3 Month LIBOR
 
Healthcare & Pharmaceuticals
 
440

 
438

 
437

Sprint Industrial Holdings, LLC, L+575, 1.25% LIBOR Floor, 5/14/2019 (p)
 
3 Month LIBOR
 
Energy: Oil & Gas
 
8,003

 
7,733

 
7,552

STG-Fairway Acquisitions, Inc., L+525, 1.00% LIBOR Floor, 6/30/2022 (q)
 
1 Month LIBOR
 
Services: Business
 
3,929

 
3,830

 
3,934

Studio Movie Grill Holdings, LLC, L+725, 1.00% LIBOR Floor, 9/30/2020 (f)(p)
 
3 Month LIBOR
 
Hotel, Gaming & Leisure
 
17,378

 
17,282

 
17,378

Teladoc, Inc., 0.50% Unfunded, 7/14/2020 (i)
 
None
 
High Tech Industries
 
1,250

 
(38
)
 

Telestream Holdings Corp., L+643, 1.00% LIBOR Floor, 3/24/2022 (l)(p)
 
3 Month LIBOR
 
High Tech Industries
 
8,618

 
8,448

 
8,360

Tenere Inc., L+1000, 1.00% LIBOR Floor, 12/23/2021 (p)(r)
 
3 Month LIBOR
 
Capital Equipment
 
31,680

 
31,331

 
30,888

Tensar Corp., L+475, 1.00% LIBOR Floor, 7/9/2021 (q)
 
3 Month LIBOR
 
Chemicals, Plastics & Rubber
 
13,236

 
12,523

 
12,988

The Pasha Group, L+750, 1.00% LIBOR Floor, 1/26/2023 (r)
 
1 Month LIBOR
 
Transportation: Cargo
 
7,769

 
7,539

 
7,847

Therapure Biopharma Inc., L+875, 0.50% LIBOR Floor, 12/1/2021 (i)
 
1 Month LIBOR
 
Healthcare & Pharmaceuticals
 
15,000

 
14,941

 
15,675

U.S. Renal Care, Inc., L+425, 1.00% LIBOR Floor, 12/30/2022 (q)
 
3 Month LIBOR
 
Healthcare & Pharmaceuticals
 
7,927

 
7,756

 
7,966

Vero Parent, Inc., L+500, 1.00% LIBOR Floor, 8/16/2024 (q)(s)
 
3 Month LIBOR
 
High Tech Industries
 
14,925

 
14,786

 
14,981

Vince, LLC, L+700, 1.00% LIBOR Floor, 11/27/2019 (i)(q)
 
3 Month LIBOR
 
Retail
 
826

 
800

 
756

Visual Edge Technology, Inc., L+575, 1.00% LIBOR Floor, 8/31/2022
 
1 Month LIBOR
 
Services: Business
 
1,694

 
1,675

 
1,685

Visual Edge Technology, Inc., 0.75% Unfunded, 2/28/2019
 
None
 
Services: Business
 
65

 

 

VLS Recovery Services, LLC, L+600, 1.00% LIBOR Floor, 10/17/2023
 
6 Month LIBOR
 
Services: Business
 
159

 
100

 
157

VLS Recovery Services, LLC, 1.00% Unfunded, 10/17/2019
 
None
 
Services: Business
 
949

 

 
(12
)
See accompanying notes to consolidated financial statements.

8



CĪON Investment Corporation
Consolidated Schedule of Investments (unaudited)
March 31, 2018
(in thousands)
Portfolio Company(a)
 
Index Rate(b)
 
Industry
 
Principal/
Par Amount/
Units(e)
 
Cost(d)
 
Fair
Value(c)
WD Wolverine Holdings, LLC, L+550, 1.00% LIBOR Floor, 8/16/2022 (q)
 
1 Month LIBOR
 
Healthcare & Pharmaceuticals
 
14,138

 
13,865

 
13,961

Total Senior Secured First Lien Debt
 
 
 
 
 
 
 
1,153,204

 
1,160,746

Senior Secured Second Lien Debt - 33.4%
 
 
 
 
 
 
 
 
 
 
1A Smart Start LLC, L+825, 1.00% LIBOR Floor, 8/21/2022 (p)
 
1 Month LIBOR
 
High Tech Industries
 
17,800

 
17,444

 
17,444

ABG Intermediate Holdings 2 LLC, L+775, 1.00% LIBOR Floor, 9/29/2025 (p)
 
3 Month LIBOR
 
Retail
 
6,475

 
6,431

 
6,580

Access CIG, LLC, L+775, 0.00% LIBOR Floor, 2/27/2026 (r)
 
1 Month LIBOR
 
Services: Business
 
13,490

 
13,357

 
13,642

Access CIG, LLC, 0.00% Unfunded, 8/27/2018
 
None
 
Services: Business
 
2,510

 

 
28

Accruent, LLC, L+875, 1.00% LIBOR Floor, 7/28/2024
 
3 Month LIBOR
 
High Tech Industries
 
1,554

 
1,529

 
1,538

Accruent, LLC, 1.50% Unfunded, 7/28/2018
 
None
 
High Tech Industries
 
111

 

 
(1
)
ALM Media, LLC, L+800, 1.00% LIBOR Floor, 7/30/2021 (p)(r)
 
3 Month LIBOR
 
Media: Advertising, Printing & Publishing
 
10,344

 
10,250

 
8,706

American Residential Services LLC, L+800, 1.00% LIBOR Floor, 12/31/2022 (p)
 
1 Month LIBOR
 
Construction & Building
 
4,933

 
4,899

 
4,884

Argon Medical Devices Holdings, Inc., L+800, 0.00% LIBOR Floor, 1/23/2026 (p)
 
3 Month LIBOR
 
Healthcare & Pharmaceuticals
 
14,400

 
14,328

 
14,580

Avalign Technologies, Inc., L+825, 1.00% LIBOR Floor, 7/15/2022 (s)
 
6 Month LIBOR
 
Healthcare & Pharmaceuticals
 
5,500

 
5,451

 
5,483

Barracuda Networks, Inc., L+725, 1.00% LIBOR Floor, 2/12/2026 (i)
 
2 Month LIBOR
 
High Tech Industries
 
500

 
498

 
511

Drew Marine Group, Inc., L+700, 1.00% LIBOR Floor, 5/19/2021 (i)(p)
 
1 Month LIBOR
 
Chemicals, Plastics & Rubber
 
9,500

 
9,468

 
9,559

EagleTree-Carbide Acquisition Corp., L+850, 1.00% LIBOR Floor, 8/28/2025 (r)
 
3 Month LIBOR
 
Consumer Goods: Durable
 
20,000

 
19,713

 
20,300

Elements Behavioral Health, Inc., L+1275, 1.00% LIBOR Floor, 2/11/2020 (u)
 
3 Month LIBOR
 
Healthcare & Pharmaceuticals
 
6,501

 
6,058

 

Emerald 3 Ltd., L+700, 1.00% LIBOR Floor, 5/16/2022 (i)(p)
 
3 Month LIBOR
 
Environmental Industries
 
3,000

 
2,982

 
2,940

Evergreen Skills Lux S.À.R.L., L+825, 1.00% LIBOR Floor, 4/28/2022 (i)(p)
 
1 Month LIBOR
 
High Tech Industries
 
9,999

 
7,362

 
8,799

Flexera Software LLC, L+725, 1.00% LIBOR Floor, 2/26/2026 (r)
 
1 Month LIBOR
 
High Tech Industries
 
3,462

 
3,445

 
3,500

Global Tel*Link Corp., L+825, 1.25% LIBOR Floor, 11/23/2020 (r)
 
3 Month LIBOR
 
Telecommunications
 
11,500

 
11,484

 
11,507

GOBP Holdings, Inc., L+825, 1.00% LIBOR Floor, 10/21/2022 (r)
 
3 Month LIBOR
 
Retail
 
4,000

 
4,019

 
4,040

LSCS Holdings, Inc., L+825, 0.00% LIBOR Floor, 3/16/2026 (p)
 
3 Month LIBOR
 
Services: Business
 
12,273

 
11,997

 
12,211

LSCS Holdings, Inc., 1.00% Unfunded, 9/16/2018 (p)
 
None
 
Services: Business
 
2,727

 
(61
)
 
(14
)
Mayfield Agency Borrower Inc., L+850, 0.00% LIBOR Floor, 3/2/2026 (p)(r)(s)
 
1 Month LIBOR
 
Banking, Finance, Insurance & Real Estate
 
20,000

 
19,704

 
19,988

Medical Solutions Holdings, Inc., L+825, 1.00% LIBOR Floor, 6/16/2025 (p)
 
1 Month LIBOR
 
Healthcare & Pharmaceuticals
 
10,000

 
9,860

 
10,050

Ministry Brands, LLC, L+925, 1.00% LIBOR Floor, 6/2/2023 (p)
 
1 Month LIBOR
 
Services: Business
 
5,488

 
5,396

 
5,488

Ministry Brands, LLC, L+925, 1.00% LIBOR Floor, 6/2/2023
 
1 Month LIBOR
 
Services: Business
 
2,546

 
2,546

 
2,546

Niacet Corp., E+875, 1.00% EURIBOR Floor, 8/1/2024 (i)
 
3 Month EURIBOR
 
Chemicals, Plastics & Rubber
 
7,489

 
7,930

 
9,045

Onex Carestream Finance LP, L+850, 1.00% LIBOR Floor, 12/7/2019 (r)
 
1 Month LIBOR
 
Healthcare & Pharmaceuticals
 
10,557

 
9,847

 
10,539

Onex TSG Holdings II Corp., L+850, 1.00% LIBOR Floor, 7/31/2023 (p)(q)
 
1 Month LIBOR
 
Healthcare & Pharmaceuticals
 
12,249

 
12,147

 
11,605

Paris Presents Inc., L+875, 1.00% LIBOR Floor, 12/31/2021 (p)
 
1 Month LIBOR
 
Consumer Goods: Durable
 
7,000

 
6,958

 
7,088

Patterson Medical Supply, Inc., L+850, 1.00% LIBOR Floor, 8/28/2023 (p)
 
2 Month LIBOR
 
Healthcare & Pharmaceuticals
 
13,500

 
13,391

 
12,960

PDI TA Holdings, Inc., L+875, 1.00% LIBOR Floor, 8/25/2024
 
6 Month LIBOR
 
High Tech Industries
 
550

 
550

 
545

Pelican Products, Inc., L+825, 1.00% LIBOR Floor, 4/11/2021 (r)
 
1 Month LIBOR
 
Chemicals, Plastics & Rubber
 
3,469

 
3,459

 
3,487

See accompanying notes to consolidated financial statements.

9



CĪON Investment Corporation
Consolidated Schedule of Investments (unaudited)
March 31, 2018
(in thousands)
Portfolio Company(a)
 
Index Rate(b)
 
Industry
 
Principal/
Par Amount/
Units(e)
 
Cost(d)
 
Fair
Value(c)
PetroChoice Holdings, Inc., L+875, 1.00% LIBOR Floor, 8/21/2023 (p)
 
2 Month LIBOR
 
Chemicals, Plastics & Rubber
 
15,000

 
14,712

 
14,738

PFS Holding Corp., L+725, 1.00% LIBOR Floor, 1/31/2022 (q)
 
1 Month LIBOR
 
Retail
 
4,998

 
4,711

 
2,399

Premiere Global Services, Inc., L+950, 1.00% LIBOR Floor, 6/6/2022
 
3 Month LIBOR
 
Telecommunications
 
3,000

 
2,903

 
2,895

PT Intermediate Holdings III, LLC, L+800, 1.00% LIBOR Floor, 12/8/2025 (r)
 
3 Month LIBOR
 
Services: Business
 
9,375

 
9,284

 
9,516

Securus Technologies Holdings, Inc., L+825, 1.00% LIBOR Floor, 11/1/2025 (r)
 
1 Month LIBOR
 
Telecommunications
 
2,942

 
2,914

 
2,982

STG-Fairway Acquisitions, Inc., L+925, 1.00% LIBOR Floor, 6/30/2023 (p)(r)
 
3 Month LIBOR
 
Services: Business
 
10,000

 
9,887

 
9,600

TexOak Petro Holdings LLC, 8.00%, 12/29/2019 (u)(v)(w)
 
None
 
Energy: Oil & Gas
 
7,389

 
2,592

 

TMK Hawk Parent, Corp., L+800, 1.00% LIBOR Floor, 8/28/2025 (p)
 
1 Month LIBOR
 
Services: Business
 
13,393

 
13,074

 
13,192

TouchTunes Interactive Networks, Inc., L+825, 1.00% LIBOR Floor, 5/29/2022 (r)
 
1 Month LIBOR
 
Hotel, Gaming & Leisure
 
6,000

 
5,953

 
6,008

U.S. Renal Care, Inc., L+800, 1.00% LIBOR Floor, 12/29/2023 (p)
 
3 Month LIBOR
 
Healthcare & Pharmaceuticals
 
5,000

 
4,922

 
5,025

Wand Intermediate I LP, L+725, 1.00% LIBOR Floor, 9/19/2022 (p)
 
1 Month LIBOR
 
Automotive
 
16,000

 
15,890

 
16,100

Winebow Holdings, Inc., L+750, 1.00% LIBOR Floor, 1/2/2022 (p)
 
1 Month LIBOR
 
Beverage, Food & Tobacco
 
12,823

 
12,600

 
11,990

Zest Acquisition Corp., L+750, 1.00% LIBOR Floor, 3/13/2026 (k)
 
3 Month LIBOR
 
Healthcare & Pharmaceuticals
 
15,000

 
14,850

 
15,038

Zywave Inc., L+900, 1.00% LIBOR Floor, 11/17/2023 (p)
 
1 Month LIBOR
 
High Tech Industries
 
5,000

 
4,937

 
5,000

Total Senior Secured Second Lien Debt
 

 

 

 
361,671

 
354,061

Collateralized Securities and Structured Products - Debt - 2.1%
 

 

 

 

 

Deutsche Bank AG Frankfurt CRAFT 2015-2 Class Credit Linked Note, L+925, 1/16/2022 (i)
 
3 Month LIBOR
 
Diversified Financials
 
14,903

 
14,903

 
14,880

NXT Capital CLO 2014-1, LLC Class E Notes, L+550, 4/23/2026 (h)(i)
 
3 Month LIBOR
 
Diversified Financials
 
7,500

 
7,149

 
7,500

Total Collateralized Securities and Structured Products - Debt
 

 

 

 
22,052

 
22,380

Collateralized Securities and Structured Products - Equity - 1.8%
 

 

 

 

 

Anchorage Capital CLO 2012-1, Ltd. Subordinated Notes, 4.61% Estimated Yield, 1/13/2025 (i)
 
(g)
 
Diversified Financials
 
4,000

 
2,461

 
2,582

APIDOS CLO XVI Subordinated Notes, 4.79% Estimated Yield, 1/19/2025 (i)
 
(g)
 
Diversified Financials
 
9,000

 
3,995

 
3,166

CENT CLO 19 Ltd. Subordinated Notes, 4.57% Estimated Yield, 10/29/2025 (i)
 
(g)
 
Diversified Financials
 
2,000

 
1,283

 
1,085

Galaxy XV CLO Ltd. Class A Subordinated Notes, 12.35% Estimated Yield, 4/15/2025 (i)
 
(g)
 
Diversified Financials
 
4,000

 
2,278

 
2,076

Ivy Hill Middle Market Credit Fund VIII, Ltd. Subordinated Loan, 10.35% Estimated Yield, 2/2/2026 (f)(i)
 
(g)
 
Diversified Financials
 
10,000

 
9,658

 
9,822

Total Collateralized Securities and Structured Products - Equity
 

 

 

 
19,675

 
18,731

Equity - 2.3%
 
 
 
 
 
 
 
 
 
 
Ascent Resources - Marcellus, LLC, Common Shares (t)
 

 
Energy: Oil & Gas
 
511,255 Units

 
1,643

 
1,642

Ascent Resources - Marcellus, LLC, Warrants (t)
 
 
 
Energy: Oil & Gas
 
132,367 Units

 
13

 
13

Avaya Holdings Corp., Common Stock (j)(q)(t)
 
 
 
Telecommunications
 
321,260 Units

 
5,285

 
7,196

Conisus Holdings, Inc., Common Stock (t)(v)
 
 
 
Healthcare & Pharmaceuticals
 
4,914,556 Units

 
200

 
220

Conisus Holdings, Inc., Series B Preferred Stock, 12.00% Dividend (u)(v)(w)
 
 
 
Healthcare & Pharmaceuticals
 
12,677,833 Units

 
9,200

 
9,100

F+W Media, Inc., Common Stock (t)(v)
 
 
 
Media: Diversified & Production
 
31,211 Units

 

 

Mooregate ITC Acquisition, LLC, Class A Units (t)
 
 
 
High Tech Industries
 
500 Units

 
563

 
313

NS NWN Acquisition, LLC, Voting Units (t)
 
 
 
High Tech Industries
 
404 Units

 
393

 
450

NSG Co-Invest (Bermuda) LP, Partnership Interests (i)(t)
 
 
 
Consumer Goods: Durable
 
1,575 Units

 
1,000

 
775

Rhino Energy LLC, Warrants (t)
 
 
 
Metals & Mining
 
170,972 Units

 
280

 
207

See accompanying notes to consolidated financial statements.

10



CĪON Investment Corporation
Consolidated Schedule of Investments (unaudited)
March 31, 2018
(in thousands)
Portfolio Company(a)
 
 
 
Industry
 
Principal/
Par Amount/
Units(e)
 
Cost(d)
 
Fair
Value(c)
Spinal USA, Inc. / Precision Medical Inc., Warrants (t)
 
 
 
Healthcare & Pharmaceuticals
 
9,317,237 Units
 
4,736

 
4,566

Tenere Inc., Warrant (t)
 
 
 
High Tech Industries
 
N/A
 
161

 
21

TexOak Petro Holdings LLC, Membership Interests (t)(v)
 
 
 
Energy: Oil & Gas
 
60,000 Units
 

 

Total Equity
 
 
 
 
 
 
 
23,474

 
24,503

Short Term Investments - 17.1%(n)
 
 
 
 
 
 
 
 
 
 
First American Treasury Obligations Fund, Class Z Shares, 1.52% (o)
 
 
 
 
 
 
 
181,095

 
181,095

Total Short Term Investments
 
 
 
 
 
 
 
181,095

 
181,095

TOTAL INVESTMENTS - 166.1%
 
 
 
 
 
 
 
$
1,761,171

 
1,761,516

LIABILITIES IN EXCESS OF OTHER ASSETS - (66.1%)
 
 
 
 
 
 
 
 
 
(700,963
)
NET ASSETS - 100%
 
 
 
 
 
 
 
 
 
$
1,060,553

a.
All of the Company’s investments are issued by eligible U.S. portfolio companies, as defined in the Investment Company Act of 1940, as amended, or the 1940 Act, except for investments specifically identified as non-qualifying per note i. below. Unless specifically identified in note w. below, investments do not contain a paid-in-kind, or PIK, interest provision.
b.
The 1, 2, 3, and 6 month London Interbank Offered Rate, or LIBOR, rates were 1.88%, 2.00%, 2.31%, and 2.45%, respectively, as of March 31, 2018.  The actual LIBOR rate for each loan listed may not be the applicable LIBOR rate as of March 31, 2018, as the loan may have been priced or repriced based on a LIBOR rate prior to or subsequent to March 31, 2018. The 1 and 3 month Euro Interbank Offered Rate, or EURIBOR, rates were (0.41%) and (0.37%), respectively, as of March 31, 2018.
c.
Fair value determined in good faith by the Company’s board of directors (see Note 9) using significant unobservable inputs unless otherwise noted.
d.
Represents amortized cost for debt securities and cost for equity investments.
e.
Denominated in U.S. dollars unless otherwise noted.
f.
As of March 31, 2018, the Company was committed, upon the satisfaction of certain conditions, to fund additional amounts in connection with this investment. See Note 11 for additional information.
g.
The CLO subordinated notes are considered equity positions in the CLO vehicles and are not rated. Equity investments are entitled to recurring distributions, which are generally equal to the remaining cash flow of the payments made by the underlying vehicle's securities less contractual payments to debt holders and expenses. The estimated yield indicated is based upon a current projection of the amount and timing of these recurring distributions and the estimated amount of repayment of principal upon termination. Such projections are periodically reviewed and adjusted, and the estimated yield may not ultimately be realized.
h.
NXT Capital CLO 2014-1 Class E Notes were rated Ba2 on Moody's credit scale as of March 31, 2018.
i.
The investment or a portion thereof is not a qualifying asset under the 1940 Act. A business development company may not acquire any asset other than qualifying assets, unless, at the time the acquisition is made, qualifying assets represent at least 70% of the company’s total assets as defined under Section 55 of the 1940 Act. As of March 31, 2018, 92.2% of the Company’s total assets represented qualifying assets.
j.
Fair value determined using level 1 inputs.
k.
Position or a portion thereof unsettled as of March 31, 2018.
l.
In addition to the interest earned based on the stated interest rate of this loan, which is the amount reflected in this schedule, the Company may be entitled to receive additional amounts as a result of an arrangement between the Company and other lenders in the syndication in exchange for lower payment priority.
m.
In addition to the interest earned based on the stated interest rate of this loan, which is the amount reflected in this schedule, the Company may be entitled to receive additional residual amounts.
n.
Short term investments represent an investment in a fund that invests in highly liquid investments with average original maturity dates of three months or less.
o.
7-day effective yield as of March 31, 2018.
p.
Investment or a portion thereof held within the Company’s wholly-owned consolidated subsidiary, 34th Street Funding, LLC, or 34th Street, and was pledged as collateral supporting the amounts outstanding under the credit facility with JPMorgan Chase Bank, National Association, or JPM, as of March 31, 2018 (see Note 8).
q.
Investment or a portion thereof held within the Company’s wholly-owned consolidated subsidiary, Flatiron Funding II, LLC, or Flatiron Funding II, and was pledged as collateral supporting the amounts outstanding under the credit facility with Citibank N.A., or Citibank, as of March 31, 2018 (see Note 8).
See accompanying notes to consolidated financial statements.

11



CĪON Investment Corporation
Consolidated Schedule of Investments (unaudited)
March 31, 2018
(in thousands)
r.
Investment or a portion thereof held within the Company’s wholly-owned consolidated subsidiary, Murray Hill Funding II, LLC, or Murray Hill Funding II, and was pledged as collateral supporting the amounts outstanding under the repurchase agreement with UBS AG, or UBS, as of March 31, 2018 (see Note 8).
s.
Investment or a portion thereof held within the Company’s wholly-owned consolidated subsidiary, 33rd Street Funding, LLC, or 33rd Street, and was pledged as collateral supporting the amounts outstanding under the credit facility with Morgan Stanley N.A., or MS, as of March 31, 2018 (see Note 8).
t.
Non-income producing security.
u.
Investment was on non-accrual status as of March 31, 2018.
v.
Investment determined to be an affiliated investment as defined in the 1940 Act as the Company owns between 5% and 25% of the portfolio company’s outstanding voting securities but does not control the company. Fair value as of December 31, 2017 and March 31, 2018, along with transactions during the three months ended March 31, 2018 in these affiliated investments are as follows:
 
 
 
 
Three Months Ended March 31, 2018
 
 
 
Three Months Ended March 31, 2018
Non-Controlled, Affiliated Investments
 
Fair Value at
December 31, 2017
 
Gross
Additions
(Cost)(1)
 
Gross
Reductions
(Cost)(2)
 
Net Unrealized
(Loss) Gain
 
Fair Value at
March 31, 2018
 
Net Realized
Gain (Loss)
 
Interest
Income(3)
  Conisus Holdings, Inc.
 
 
 
 
 
 
 
 
 
 
 
 
 
 
    Series B Preferred Stock
 
$
9,300

 
$

 
$

 
$
(200
)
 
$
9,100

 
$

 
$

    Common Stock
 
175

 

 

 
45

 
220

 

 

  F+W Media, Inc.
 
 
 
 
 
 
 
 
 
 
 
 
 
 
    First Lien Term Loan B-1
 
1,169

 
30

 

 
2

 
1,201

 

 
30

    First Lien Term Loan B-2
 
1,498

 
3

 

 
(142
)
 
1,359

 

 
27

    Common Stock
 

 

 

 

 

 

 

  Petroflow Energy Corp.
 
 
 
 
 
 
 
 
 
 
 
 
 
 
    First Lien Term Loan
 
3,391

 
34

 
(360
)
 
178

 
3,243

 

 
42

  TexOak Petro Holdings LLC
 
 
 
 
 
 
 
 
 
 
 
 
 
 
    Second Lien Term Loan
 

 

 

 

 

 

 

    Membership Interests
 

 

 

 

 

 

 

Totals
 
$
15,533

 
$
67

 
$
(360
)
 
$
(117
)
 
$
15,123

 
$

 
$
99

(1)
Gross additions include increases in the cost basis of investments resulting from new portfolio investments, PIK interest, the amortization of unearned income, the exchange of one or more existing securities for one or more new securities and the movement of an existing portfolio company into this category from a different category.
(2)
Gross reductions include decreases in the cost basis of investments resulting from principal collections related to investment repayments or sales, the exchange of one or more existing securities for one or more new securities and the movement of an existing portfolio company out of this category into a different category.
(3)
Includes PIK interest income.
w.
For the three months ended March 31, 2018, the following investments contain a PIK interest provision whereby the issuer has either the option or the obligation to make interest payments with the issuance of additional securities:
 
 
 
 
Interest Rate
 
Interest Amount
Portfolio Company
 
Investment Type
 
Cash
 
PIK
 
All-in-Rate
 
Cash
 
PIK
 
Total
American Clinical Solutions LLC (x)
 
Senior Secured First Lien Debt
 
10.50%
 
2.00%
 
12.50%
 
$
116

 
$
168

 
$
284

Conisus Holdings, Inc. (x)
 
Preferred Stock
 
 
12.00%
 
12.00%
 
$

 
$

 
$

F+W Media, Inc. (x)
 
Senior Secured First Lien Debt
 
 
11.50%
 
11.50%
 
$
24

 
$

 
$
24

F+W Media, Inc.
 
Senior Secured First Lien Debt
 
 
7.50%
 
7.50%
 
$

 
$
29

 
$
29

Lonestar Prospects, Ltd.
 
Senior Secured First Lien Debt
 
9.50%
 
1.00%
 
10.50%
 
$
146

 
$
29

 
$
175

Petroflow Energy Corp. (x)
 
Senior Secured First Lien Debt
 
3.00%
 
6.00%
 
9.00%
 
$
25

 
$

 
$
25

Rimini Street, Inc.
 
Senior Secured First Lien Debt
 
12.00%
 
3.00%
 
15.00%
 
$
597

 
$
148

 
$
745

Sequoia Healthcare Management, LLC
 
Senior Secured First Lien Debt
 
12.00%
 
4.00%
 
16.00%
 
$
164

 
$
54

 
$
218

Spinal USA, Inc. / Precision Medical Inc.
 
Senior Secured First Lien Debt
 
 
10.50%
 
10.50%
 
$

 
$

 
$

TexOak Petro Holdings LLC (x)
 
Senior Secured Second Lien Debt
 
 
8.00%
 
8.00%
 
$

 
$

 
$

Visual Edge Technology, Inc.
 
Subordinated Note
 
 
12.50%
 
12.50%
 
$

 
$
237

 
$
237

x.
The PIK interest portion of the investment was on non-accrual status as of March 31, 2018.
y.
As of March 31, 2018, the index rate for $9,904 and $4,627 was 1 Month LIBOR and 3 Month LIBOR, respectively.
See accompanying notes to consolidated financial statements.

12



CĪON Investment Corporation
Consolidated Schedule of Investments
December 31, 2017
(in thousands)
Portfolio Company(a)
 
Index Rate(b)
 
Industry
 
Principal/
Par Amount/
Units(d)
 
Cost(m)
 
Fair
Value(c)
Senior Secured First Lien Debt - 103.9%
 
 
 
 
 
 
 
 
 
 
AbelConn, LLC / Atrenne Computing Solutions, LLC / Airco Industries, LLC, L+875, 1.00% LIBOR Floor, 7/17/2019 (n)(p)
 
3 Month LIBOR
 
Aerospace & Defense
 
$
18,724

 
$
18,501

 
$
18,677

Academy, Ltd., L+400, 1.00% LIBOR Floor, 7/1/2022 (o)
 
Various
 
Retail
 
14,572

 
11,714

 
11,557

Access CIG, LLC, L+500, 1.00% LIBOR Floor, 10/18/2021 (e)(o)
 
1 Month LIBOR
 
Services: Business
 
6,729

 
6,769

 
6,796

Adams Publishing Group, LLC, L+700, 1.00% LIBOR Floor, 11/3/2020 (n)
 
3 Month LIBOR
 
Media: Advertising, Printing & Publishing
 
5,303

 
5,258

 
5,303

Advanced Integration Technology LP, L+475, 1.00% LIBOR Floor, 4/3/2023 (o)
 
1 Month LIBOR
 
Aerospace & Defense
 
3,970

 
4,003

 
4,000

ALM Media, LLC, L+450, 1.00% LIBOR Floor, 7/31/2020 (o)
 
3 Month LIBOR
 
Media: Advertising, Printing & Publishing
 
7,529

 
7,254

 
6,588

Alvogen Pharma US, Inc., L+500, 1.00% LIBOR Floor, 4/1/2022 (o)
 
1 Month LIBOR
 
Healthcare & Pharmaceuticals
 
8,224

 
8,188

 
8,168

American Clinical Solutions LLC, 12.50%, 6/11/2020 (u)
 
None
 
Healthcare & Pharmaceuticals
 
8,834

 
8,743

 
8,326

American Dental Partners, Inc., L+475, 1.00% LIBOR Floor, 8/29/2021 (o)
 
3 Month LIBOR
 
Healthcare & Pharmaceuticals
 
10,694

 
10,256

 
10,641

American Energy - Marcellus, LLC, L+425, 1.00% LIBOR Floor, 8/4/2020 (r)
 
1 Month LIBOR
 
Energy: Oil & Gas
 
4,033

 
3,045

 
2,985

American Media, Inc., L+900, 1.00% LIBOR Floor, 8/24/2020 (e)(n)
 
3 Month LIBOR
 
Media: Advertising, Printing & Publishing
 
15,807

 
15,502

 
16,203

American Media, Inc., 9.00% Unfunded, 8/24/2020 (e)
 
None
 
Media: Advertising, Printing & Publishing
 
154

 

 
4

American Media, Inc., 0.50% Unfunded, 8/24/2020 (e)
 
None
 
Media: Advertising, Printing & Publishing
 
83

 

 
2

American Teleconferencing Services, Ltd., L+650, 1.00% LIBOR Floor, 12/8/2021 (n)(o)(p)
 
3 Month LIBOR
 
Telecommunications
 
21,324

 
19,599

 
21,093

AMPORTS, Inc., L+500, 1.00% LIBOR Floor, 5/19/2020 (j)(n)(p)
 
3 Month LIBOR
 
Automotive
 
18,943

 
18,687

 
18,943

AP Exhaust Acquisition, LLC, L+500, 1.00% LIBOR Floor, 5/10/2024 (o)
 
3 Month LIBOR
 
Automotive
 
5,613

 
5,424

 
5,542

ASG Technologies Group, Inc., L+475, 1.00% LIBOR Floor, 7/31/2024 (o)
 
1 Month LIBOR
 
High Tech Industries
 
4,988

 
4,964

 
5,040

Associated Asphalt Partners, LLC, L+525, 1.00% LIBOR Floor, 4/5/2024 (o)
 
1 Month LIBOR
 
Construction & Building
 
10,927

 
10,733

 
9,998

Azure Midstream Energy, LLC, L+650, 1.00% LIBOR Floor, 11/15/2018 (o)
 
1 Month LIBOR
 
Energy: Oil & Gas
 
2,084

 
2,031

 
1,876

Bambino CI Inc., L+600, 0.00% LIBOR Floor, 10/18/2023
 
1 Month LIBOR
 
Healthcare & Pharmaceuticals
 
2,821

 
2,759

 
2,757

Cadence Aerospace, LLC, L+650, 1.00% LIBOR Floor, 11/14/2023 (p)
 
3 Month LIBOR
 
Aerospace & Defense
 
20,000

 
19,802

 
19,500

Caraustar Industries, Inc., L+550, 1.00% LIBOR Floor, 3/14/2022 (o)
 
3 Month LIBOR
 
Forest Products & Paper
 
5,577

 
5,638

 
5,599

Cardinal US Holdings, Inc., L+500, 1.00% LIBOR Floor, 7/31/2023 (o)
 
1 Month LIBOR
 
Services: Business
 
8,479

 
7,897

 
8,140

CB URS Holdings Corp., L+525, 1.00% LIBOR Floor, 9/1/2024 (o)
 
1 Month LIBOR
 
Transportation: Cargo
 
14,888

 
14,814

 
15,046

Central Security Group, Inc., L+563, 1.00% LIBOR Floor, 10/6/2021 (o)
 
1 Month LIBOR
 
Services: Consumer
 
17,899

 
17,929

 
17,966

CF Entertainment Inc., L+850, 1.00% LIBOR Floor, 1/27/2023 (n)(p)
 
6 Month LIBOR
 
Media: Diversified & Production
 
58,900

 
57,853

 
58,900

CF Entertainment Inc., L+850, 1.00% LIBOR Floor, 1/27/2023
 
6 Month LIBOR
 
Media: Diversified & Production
 
3,037

 
2,982

 
3,030

CF Entertainment Inc., L+850, 1.00% LIBOR Floor, 1/27/2023
 
6 Month LIBOR
 
Media: Diversified & Production
 
17,500

 
17,302

 
17,456

Charming Charlie, LLC, L+450, 1.00% LIBOR Floor, 6/8/2018 (e)
 
1 Month LIBOR
 
Retail
 
1,048

 
1,048

 
1,048

Charming Charlie, LLC, 0.38% Unfunded, 6/8/2018 (e)
 
None
 
Retail
 
1,048

 

 

Charming Charlie, LLC, L+800, 1.00% LIBOR Floor, 12/24/2019 (e)(i)(r)
 
3 Month LIBOR
 
Retail
 
12,125

 
4,783

 
3,880

Command Alkon Inc., L+500, 1.00% LIBOR Floor, 9/1/2023
 
3 Month LIBOR
 
High Tech Industries
 
7,541

 
7,504

 
7,390

Confie Seguros Holding II Co., L+525, 1.00% LIBOR Floor, 4/16/2022 (o)
 
3 Month LIBOR
 
Banking, Finance, Insurance & Real Estate
 
15,902

 
15,786

 
15,897

Covenant Surgical Partners, Inc., L+475, 0.00% LIBOR Floor, 10/4/2024 (e)(o)
 
3 Month LIBOR
 
Healthcare & Pharmaceuticals
 
1,874

 
1,869

 
1,888

Covenant Surgical Partners, Inc., L+475, 0.00% LIBOR Floor, 10/4/2024 (e)(o)
 
3 Month LIBOR
 
Healthcare & Pharmaceuticals
 
104

 
102

 
104

See accompanying notes to consolidated financial statements.

13



CĪON Investment Corporation
Consolidated Schedule of Investments
December 31, 2017
(in thousands)
Portfolio Company(a)
 
Index Rate(b)
 
Industry
 
Principal/
Par Amount/
Units(d)
 
Cost(m)
 
Fair
Value(c)
Covenant Surgical Partners, Inc., 4.75% Unfunded, 10/4/2018 (e)(o)
 
None
 
Healthcare & Pharmaceuticals
 
458

 

 
3

CSP Technologies North America, LLC, L+525, 1.00% LIBOR Floor, 1/29/2022 (p)
 
3 Month LIBOR
 
Chemicals, Plastics & Rubber
 
13,518

 
13,283

 
13,552

David's Bridal, Inc., L+400, 1.25% LIBOR Floor, 10/11/2019 (o)
 
3 Month LIBOR
 
Retail
 
3,477

 
3,044

 
3,060

DBRS, Inc., L+525, 1.00% LIBOR Floor, 3/4/2022 (h)(o)
 
3 Month LIBOR
 
Services: Business
 
5,907

 
5,719

 
5,922

Deluxe Entertainment Services Group Inc., L+550, 1.00% LIBOR Floor, 2/28/2020 (o)
 
3 Month LIBOR
 
Media: Diversified & Production
 
9,797

 
9,763

 
9,620

DFC Global Facility Borrower II LLC, L+1075, 1.00% LIBOR Floor, 9/27/2022 (e)
 
1 Month LIBOR
 
Services: Consumer
 
19,575

 
19,433

 
19,575

DFC Global Facility Borrower II LLC, 0.50% Unfunded, 9/27/2019 (e)
 
None
 
Services: Consumer
 
10,425

 

 

Discovery DJ Services LLC, L+725, 1.00% LIBOR Floor, 10/25/2022 (e)
 
3 Month LIBOR
 
Energy: Oil & Gas
 
5,294

 
5,099

 
5,188

Discovery DJ Services LLC, 0.50% Unfunded, 4/25/2019 (e)
 
None
 
Energy: Oil & Gas
 
4,314

 

 
(86
)
Discovery DJ Services LLC, 0.50% Unfunded, 10/25/2022 (e)
 
None
 
Energy: Oil & Gas
 
392

 

 
(8
)
Dodge Data & Analytics, LLC / Skyline Data News and Analytics, LLC, L+875, 1.00% LIBOR Floor, 10/31/2019 (n)
 
3 Month LIBOR
 
Construction & Building
 
9,862

 
9,770

 
9,702

DXP Enterprises, Inc., L+550, 1.00% LIBOR Floor, 8/29/2023 (h)(o)
 
1 Month LIBOR
 
Energy: Oil & Gas
 
9,975

 
9,879

 
9,975

EagleTree-Carbide Acquisition Corp., L+475, 1.00% LIBOR Floor, 8/28/2024 (o)
 
3 Month LIBOR
 
Consumer Goods: Durable
 
9,975

 
9,875

 
10,050

Eastman Kodak Company, L+625, 1.00% LIBOR Floor, 9/3/2019 (h)(o)
 
1 Month LIBOR
 
Consumer Goods: Durable
 
1,965

 
1,961

 
1,695

Elemica, Inc., L+800, 1.00% LIBOR Floor, 7/7/2021 (e)(n)(p)
 
1 Month LIBOR
 
High Tech Industries
 
17,238

 
16,906

 
17,065

Elemica, Inc., 0.50% Unfunded, 7/7/2021 (e)
 
None
 
High Tech Industries
 
2,500

 
(44
)
 
(25
)
Emmis Operating Company, L+700, 1.00% LIBOR Floor, 4/18/2019 (o)
 
1 Month LIBOR
 
Media: Broadcasting & Subscription
 
3,384

 
3,220

 
3,300

Entertainment Studios P&A LLC, 15.00%, 5/18/2037 (w)
 
None
 
Media: Diversified & Production
 
17,500

 
17,353

 
16,887

Entertainment Studios P&A LLC, 5.00%, 5/18/2037 (w)
 
None
 
Media: Diversified & Production
 
3,707

 
3,634

 
9,336

EnTrans International, LLC, L+750, 1.00% LIBOR Floor, 6/4/2020
 
2 Month LIBOR
 
Capital Equipment
 
13,031

 
10,265

 
13,031

Evergreen Skills Lux S.À.R.L., L+475, 1.00% LIBOR Floor, 4/28/2021 (h)(o)
 
1 Month LIBOR
 
High Tech Industries
 
10,236

 
9,607

 
9,887

F+W Media, Inc., L+1000, 1.50% LIBOR Floor, 5/24/2022 (n)(r)(t)(u)
 
1 Month LIBOR
 
Media: Diversified & Production
 
2,736

 
2,743

 
1,498

F+W Media, Inc., L+650, 1.50% LIBOR Floor, 5/24/2022 (t)
 
1 Month LIBOR
 
Media: Diversified & Production
 
1,114

 
1,114

 
1,169

Forbes Media LLC, L+675, 1.00% LIBOR Floor, 9/12/2019 (j)(p)
 
2 Month LIBOR
 
Media: Advertising, Printing & Publishing
 
15,000

 
14,751

 
15,000

Foundation Consumer Healthcare, LLC, 0.50% Unfunded, 11/2/2023 (e)
 
None
 
Healthcare & Pharmaceuticals
 
4,211

 
(32
)
 
(21
)
Foundation Consumer Healthcare, LLC, L+650, 1.00% LIBOR Floor, 11/2/2023 (e)(n)(p)
 
3 Month LIBOR
 
Healthcare & Pharmaceuticals
 
45,789

 
45,451

 
45,561

Frontline Technologies Group Holding LLC, 1.00% Unfunded, 9/18/2019 (e)
 
None
 
High Tech Industries
 
540

 

 
(6
)
Frontline Technologies Group Holding LLC, L+650, 1.00% LIBOR Floor, 9/18/2023 (e)
 
3 Month LIBOR
 
High Tech Industries
 
2,748

 
2,717

 
2,715

Global Franchise Group, LLC, L+575, 1.00% LIBOR Floor, 12/18/2019
 
3 Month LIBOR
 
Beverage, Food & Tobacco
 
2,161

 
2,142

 
2,139

Harland Clarke Holdings Corp., L+475, 1.00% LIBOR Floor, 11/3/2023 (o)
 
3 Month LIBOR
 
Services: Business
 
14,865

 
14,792

 
14,945

Healogics, Inc., L+425, 1.00% LIBOR Floor, 7/1/2021 (o)
 
3 Month LIBOR
 
Healthcare & Pharmaceuticals
 
4,850

 
4,588

 
4,243

Heartland Dental, LLC, L+475, 1.00% LIBOR Floor, 7/31/2023 (o)
 
3 Month LIBOR
 
Healthcare & Pharmaceuticals
 
4,000

 
3,981

 
4,060

Help/Systems Holdings, Inc., L+450, 1.00% LIBOR Floor, 10/8/2021 (o)
 
3 Month LIBOR
 
Services: Business
 
11,909

 
11,897

 
11,987

Infinity Sales Group, LLC, L+1050, 1.00% LIBOR Floor, 11/21/2018 (n)
 
1 Month LIBOR
 
Services: Business
 
7,540

 
7,230

 
7,031

InfoGroup Inc., L+500, 1.00% LIBOR Floor, 4/3/2023 (o)(p)
 
3 Month LIBOR
 
Media: Advertising, Printing & Publishing
 
14,080

 
14,069

 
13,799

See accompanying notes to consolidated financial statements.

14



CĪON Investment Corporation
Consolidated Schedule of Investments
December 31, 2017
(in thousands)
Portfolio Company(a)
 
Index Rate(b)
 
Industry
 
Principal/
Par Amount/
Units(d)
 
Cost(m)
 
Fair
Value(c)
International Seaways, Inc., L+550, 1.00% LIBOR Floor, 6/22/2022 (h)(o)
 
1 Month LIBOR
 
Transportation: Cargo
 
9,938

 
9,753

 
10,012

Ipsen International GmbH, L+800, 1.00% LIBOR Floor, 9/30/2019 (h)(j)
 
1 Month LIBOR
 
Capital Equipment
 
1,253

 
1,256

 
1,253

Ipsen, Inc., L+700, 1.00% LIBOR Floor, 9/30/2019 (j)(p)
 
1 Month LIBOR
 
Capital Equipment
 
8,019

 
7,955

 
7,999

Island Medical Management Holdings, LLC, L+550, 1.00% LIBOR Floor, 9/1/2022 (p)
 
3 Month LIBOR
 
Healthcare & Pharmaceuticals
 
13,709

 
13,543

 
13,411

ITC Service Group Acquisition LLC, L+950, 0.50% LIBOR Floor, 5/26/2021 (j)(n)
 
1 Month LIBOR
 
High Tech Industries
 
11,250

 
11,075

 
11,053

KLO Intermediate Holdings, LLC, L+775, 1.25% LIBOR Floor, 4/7/2022 (p)
 
1 Month LIBOR
 
Chemicals, Plastics & Rubber
 
7,573

 
7,490

 
7,479

KLO Intermediate Holdings, LLC, L+775, 1.25% LIBOR Floor, 4/7/2022 (p)
 
1 Month LIBOR
 
Chemicals, Plastics & Rubber
 
4,384

 
4,336

 
4,330

KNB Holdings Corp., L+550, 1.00% LIBOR Floor, 4/26/2024 (o)
 
3 Month LIBOR
 
Consumer Goods: Durable
 
15,900

 
15,603

 
16,079

Labvantage Solutions Inc., L+800, 1.00% LIBOR Floor, 12/29/2020 (p)
 
1 Month LIBOR
 
High Tech Industries
 
4,625

 
4,590

 
4,671

Labvantage Solutions Ltd., E+800, 1.00% EURIBOR Floor, 12/29/2020 (h)
 
1 Month EURIBOR
 
High Tech Industries
 
4,237

 
4,729

 
5,137

Lift Brands, Inc., L+800, 1.00% LIBOR Floor, 12/23/2019 (n)
 
3 Month LIBOR
 
Services: Consumer
 
9,161

 
9,088

 
9,161

Logix Holding Company, LLC, L+575, 1.00% LIBOR Floor, 12/22/2024 (i)(o)
 
1 Month LIBOR
 
Telecommunications
 
5,040

 
4,990

 
4,990

Lonestar Prospects, Ltd, L+950, 1.00% LIBOR Floor, 8/1/2021
 
3 Month LIBOR
 
Energy: Oil & Gas
 
7,718

 
7,582

 
7,564

LTCG Holdings Corp., L+500, 1.00% LIBOR Floor, 6/6/2020 (o)
 
1 Month LIBOR
 
Services: Business
 
5,911

 
5,610

 
5,897

MB2 Dental Solutions, LLC, L+475, 1.00% LIBOR Floor, 9/29/2023
 
3 Month LIBOR
 
Healthcare & Pharmaceuticals
 
2,185

 
2,159

 
2,158

Ministry Brands, LLC, L+500, 1.00% LIBOR Floor, 12/2/2022 (n)
 
1 Month LIBOR
 
Services: Business
 
4,947

 
4,773

 
4,947

Ministry Brands, LLC, L+500, 1.00% LIBOR Floor, 12/2/2022 (p)
 
1 Month LIBOR
 
Services: Business
 
2,413

 
2,413

 
2,413

Ministry Brands, LLC, L+100, 1.00% LIBOR Floor, Unfunded, 2/22/2019
 
1 Month LIBOR
 
Services: Business
 
1,477

 

 

Moss Holding Company, L+675, 1.00% LIBOR Floor, 4/17/2023 (e)(n)(p)
 
3 Month LIBOR
 
Services: Business
 
18,877

 
18,570

 
18,641

Moss Holding Company, 0.50% Unfunded, 4/17/2023 (e)
 
None
 
Services: Business
 
2,232

 

 
(28
)
Moss Holding Company, 0.75% Unfunded, 5/7/2018 (e)
 
None
 
Services: Business
 
1,046

 

 
(13
)
MRO Holdings, Inc., L+525, 1.00% LIBOR Floor, 10/25/2023 (o)
 
3 Month LIBOR
 
Aerospace & Defense
 
4,490

 
4,446

 
4,529

MSHC, Inc., L+425, 1.00% LIBOR Floor, 7/31/2023
 
3 Month LIBOR
 
Services: Business
 
2,853

 
2,839

 
2,838

Murray Energy Corp., L+725, 1.00% LIBOR Floor, 4/16/2020 (o)
 
3 Month LIBOR
 
Metals & Mining
 
3,629

 
3,546

 
3,185

National Intergovernmental Purchasing Alliance Company, L+500, 1.00% LIBOR Floor, 9/19/2022
 
3 Month LIBOR
 
Services: Business
 
1,826

 
1,791

 
1,790

Navex Global, Inc, L+425, 1.00% LIBOR Floor, 11/19/2021 (o)
 
1 Month LIBOR
 
High Tech Industries
 
17,910

 
17,960

 
17,978

Nextech Systems, LLC, L+725, 1.00% LIBOR Floor, 6/22/2021 (j)(n)
 
1 Month LIBOR
 
High Tech Industries
 
15,142

 
14,673

 
14,991

Opal Acquisition, Inc., L+400, 1.00% LIBOR Floor, 11/27/2020 (o)
 
3 Month LIBOR
 
Healthcare & Pharmaceuticals
 
10,209

 
9,695

 
9,558

Orbcomm Inc., 8.00%, 4/1/2024 (n)
 
None
 
Telecommunications
 
9,237

 
9,237

 
9,843

P.F. Chang's China Bistro, Inc., L+500, 1.00% LIBOR Floor, 9/1/2022 (o)
 
3 Month LIBOR
 
Beverage, Food & Tobacco
 
9,975

 
9,688

 
9,489

Paris Presents Inc., L+500, 1.00% LIBOR Floor, 12/31/2020 (p)
 
1 Month LIBOR
 
Consumer Goods: Durable
 
8,931

 
8,857

 
8,931

Pathway Partners Vet Management Company LLC, 1.00% Unfunded, 10/10/2019 (e)
 
None
 
Healthcare & Pharmaceuticals
 
818

 

 
2

Pathway Partners Vet Management Company LLC, L+425, 0.00% LIBOR Floor, 10/10/2024 (e)
 
1 Month LIBOR
 
Healthcare & Pharmaceuticals
 
2,176

 
2,156

 
2,182

PDI TA Holdings, Inc., L+475, 1.00% LIBOR Floor, 8/25/2023
 
6 Month LIBOR
 
High Tech Industries
 
713

 
713

 
706

PDI TA Holdings, Inc., 0.50% Unfunded, 8/24/2018
 
None
 
High Tech Industries
 
570

 

 
(6
)
Petroflow Energy Corp., L+800, 1.00% LIBOR Floor, 6/29/2019 (n)(r)(t)(u)
 
1 Month LIBOR
 
Energy: Oil & Gas
 
3,789

 
3,573

 
3,391

See accompanying notes to consolidated financial statements.

15



CĪON Investment Corporation
Consolidated Schedule of Investments
December 31, 2017
(in thousands)
Portfolio Company(a)
 
Index Rate(b)
 
Industry
 
Principal/
Par Amount/
Units(d)
 
Cost(m)
 
Fair
Value(c)
Photonis Technologies SAS, L+750, 1.00% LIBOR Floor, 9/18/2019 (h)(o)
 
3 Month LIBOR
 
Aerospace & Defense
 
6,397

 
5,646

 
5,606

Plano Molding Company, LLC, L+750, 1.00% LIBOR Floor, 5/12/2021 (n)
 
1 Month LIBOR
 
Consumer Goods: Non-Durable
 
7,954

 
7,880

 
7,055

Project Leopard Holdings, Inc., L+550, 1.00% LIBOR Floor, 7/7/2023 (o)
 
3 Month LIBOR
 
High Tech Industries
 
3,990

 
3,981

 
4,020

Radio One, Inc., L+400, 1.00% LIBOR Floor, 4/18/2023 (o)
 
3 Month LIBOR
 
Media: Broadcasting & Subscription
 
2,965

 
2,938

 
2,924

Reddy Ice Corp., L+550, 1.25% LIBOR Floor, 5/1/2019 (o)
 
3 Month LIBOR
 
Beverage, Food & Tobacco
 
1,905

 
1,889

 
1,885

Rhino Energy LLC, L+1000, 1.00% LIBOR Floor, 12/27/2020
 
3 Month LIBOR
 
Metals & Mining
 
10,000

 
9,601

 
9,600

Rimini Street, Inc., 15.00%, 6/24/2020 (n)(u)
 
None
 
High Tech Industries
 
20,087

 
19,866

 
20,589

Robertshaw US Holding Corp., L+450, 0.00% LIBOR Floor, 8/10/2024 (o)
 
1 Month LIBOR
 
Chemicals, Plastics & Rubber
 
3,147

 
3,124

 
3,178

Sequoia Healthcare Management, LLC, 16.00%, 7/17/2019 (n)(t)
 
None
 
Healthcare & Pharmaceuticals
 
5,407

 
5,351

 
5,407

SG Acquisition, Inc., L+500, 1.00% LIBOR Floor, 3/29/2024 (o)
 
3 Month LIBOR
 
Banking, Finance, Insurance & Real Estate
 
3,985

 
3,950

 
3,960

Shift PPC LLC, L+600, 1.00% LIBOR Floor, 12/22/2021 (p)
 
3 Month LIBOR
 
High Tech Industries
 
4,847

 
4,739

 
4,847

SI Organization, Inc., L+475, 1.00% LIBOR Floor, 11/23/2019 (o)
 
3 Month LIBOR
 
Services: Business
 
7,672

 
7,754

 
7,782

Spinal USA, Inc. / Precision Medical Inc., L+950, 1.00% LIBOR Floor, 1/21/2020 (n)
 
3 Month LIBOR
 
Healthcare & Pharmaceuticals
 
12,728

 
12,668

 
12,632

Spinal USA, Inc. / Precision Medical Inc., L+950, 1.00% LIBOR Floor, 7/21/2020 (n)(s)
 
3 Month LIBOR
 
Healthcare & Pharmaceuticals
 
428

 
426

 
425

Sprint Industrial Holdings, LLC, L+575, 1.25% LIBOR Floor, 5/14/2019 (n)
 
3 Month LIBOR
 
Energy: Oil & Gas
 
8,024

 
7,695

 
7,512

STG-Fairway Acquisitions, Inc., L+525, 1.00% LIBOR Floor, 6/30/2022 (o)
 
3 Month LIBOR
 
Services: Business
 
3,929

 
3,825

 
3,889

Studio Movie Grill Holdings, LLC, L+725, 1.00% LIBOR Floor, 9/30/2020 (e)(n)
 
3 Month LIBOR
 
Hotel, Gaming & Leisure
 
17,378

 
17,273

 
17,378

Teladoc, Inc., 0.50% Unfunded, 7/14/2020 (e)(h)
 
None
 
High Tech Industries
 
1,250

 
(43
)
 

Telestream Holdings Corp., L+643, 1.00% LIBOR Floor, 3/24/2022 (j)(n)
 
3 Month LIBOR
 
High Tech Industries
 
8,640

 
8,460

 
8,381

Tenere Inc., L+1000, 1.00% LIBOR Floor, 12/23/2021 (n)(p)
 
3 Month LIBOR
 
Capital Equipment
 
31,760

 
31,288

 
30,966

Tensar Corp., L+475, 1.00% LIBOR Floor, 7/9/2021 (o)
 
3 Month LIBOR
 
Chemicals, Plastics & Rubber
 
13,236

 
12,476

 
12,938

The Pasha Group, L+750, 1.00% LIBOR Floor, 1/26/2023 (i)(p)
 
1 Month LIBOR
 
Transportation: Cargo
 
8,020

 
7,779

 
7,819

Therapure Biopharma Inc., L+875, 0.50% LIBOR Floor, 12/1/2021 (h)
 
1 Month LIBOR
 
Healthcare & Pharmaceuticals
 
15,000

 
14,938

 
15,713

U.S. Renal Care, Inc., L+425, 1.00% LIBOR Floor, 12/30/2022 (o)
 
3 Month LIBOR
 
Healthcare & Pharmaceuticals
 
7,947

 
7,768

 
7,844

Vero Parent, Inc., L+500, 1.00% LIBOR Floor, 8/16/2024 (o)
 
3 Month LIBOR
 
High Tech Industries
 
14,963

 
14,819

 
14,645

Vince, LLC, L+700, 1.00% LIBOR Floor, 11/27/2019 (h)(o)
 
3 Month LIBOR
 
Retail
 
901

 
868

 
789

Visual Edge Technology, Inc., L+575, 1.00% LIBOR Floor, 8/31/2022 (e)
 
1 Month LIBOR
 
Services: Business
 
9,446

 
9,267

 
9,304

Visual Edge Technology, Inc., L+575, 1.00% LIBOR Floor, 8/31/2022 (e)
 
1 Month LIBOR
 
Services: Business
 
4,796

 
4,751

 
4,724

VLS Recovery Services, LLC, L+600, 1.00% LIBOR Floor, 10/17/2023 (e)
 
2 Month LIBOR
 
Services: Business
 
3,900

 
3,853

 
3,801

VLS Recovery Services, LLC, 1.00% Unfunded, 10/17/2019 (e)
 
None
 
Services: Business
 
1,108

 
(62
)
 
(28
)
WD Wolverine Holdings, LLC, L+550, 1.00% LIBOR Floor, 8/16/2022 (o)
 
1 Month LIBOR
 
Healthcare & Pharmaceuticals
 
14,228

 
13,941

 
13,801

Western Dental Services, Inc., L+525, 1.00% LIBOR Floor, 6/30/2023 (o)
 
1 Month LIBOR
 
Healthcare & Pharmaceuticals
 
2,186

 
2,165

 
2,197

Total Senior Secured First Lien Debt
 
 
 
 
 
 

 
1,088,512

 
1,100,336

Senior Secured Second Lien Debt - 31.5%
 
 
 
 
 
 
 
 
 
 
1A Smart Start LLC, L+850, 1.00% LIBOR Floor, 8/21/2022 (n)
 
3 Month LIBOR
 
High Tech Industries
 
17,800

 
17,455

 
17,444

See accompanying notes to consolidated financial statements.

16



CĪON Investment Corporation
Consolidated Schedule of Investments
December 31, 2017
(in thousands)
Portfolio Company(a)
 
Index Rate(b)
 
Industry
 
Principal/
Par Amount/
Units(d)
 
Cost(m)
 
Fair
Value(c)
ABG Intermediate Holdings 2 LLC, L+775, 1.00% LIBOR Floor, 9/29/2025 (n)
 
3 Month LIBOR
 
Retail
 
6,475

 
6,428

 
6,572

Access CIG, LLC, L+875, 1.00% LIBOR Floor, 10/17/2022 (e)(p)
 
1 Month LIBOR
 
Services: Business
 
16,030

 
15,533

 
15,709

Accruent, LLC, L+875, 1.00% LIBOR Floor, 7/28/2024
 
3 Month LIBOR
 
High Tech Industries
 
1,554

 
1,529

 
1,530

Accruent, LLC, 0.75% Unfunded, 7/28/2018 (e)
 
None
 
High Tech Industries
 
111

 

 
(2
)
ALM Media, LLC, L+800, 1.00% LIBOR Floor, 7/30/2021 (n)(p)
 
3 Month LIBOR
 
Media: Advertising, Printing & Publishing
 
10,344

 
10,241

 
8,896

American Residential Services LLC, L+800, 1.00% LIBOR Floor, 12/31/2021 (n)
 
1 Month LIBOR
 
Construction & Building
 
4,933

 
4,898

 
4,933

Argon Medical Devices Holdings, Inc., L+800, 0.00% LIBOR Floor, 10/27/2025 (i)(n)
 
1 Month LIBOR
 
Healthcare & Pharmaceuticals
 
14,400

 
14,328

 
14,472

Avalign Technologies, Inc., L+825, 1.00% LIBOR Floor, 7/15/2022
 
3 Month LIBOR
 
Healthcare & Pharmaceuticals
 
5,500

 
5,449

 
5,514

Command Alkon Inc., L+900, 1.00% LIBOR Floor, 3/1/2024
 
3 Month LIBOR
 
High Tech Industries
 
2,440

 
2,405

 
2,404

Drew Marine Group, Inc., L+700, 1.00% LIBOR Floor, 5/19/2021 (h)(n)
 
1 Month LIBOR
 
Chemicals, Plastics & Rubber
 
9,500

 
9,467

 
9,506

EagleTree-Carbide Acquisition Corp., L+850, 1.00% LIBOR Floor, 8/28/2025 (p)
 
3 Month LIBOR
 
Consumer Goods: Durable
 
20,000

 
19,707

 
19,800

Elements Behavioral Health, Inc., L+1200, 1.00% LIBOR Floor, 2/11/2020 (r)(u)
 
3 Month LIBOR
 
Healthcare & Pharmaceuticals
 
6,501

 
6,056

 
455

Emerald 3 Ltd., L+700, 1.00% LIBOR Floor, 5/16/2022 (h)(n)
 
3 Month LIBOR
 
Environmental Industries
 
3,000

 
2,981

 
2,865

Evergreen Skills Lux S.À.R.L., L+825, 1.00% LIBOR Floor, 4/28/2022 (h)(n)
 
1 Month LIBOR
 
High Tech Industries
 
9,999

 
7,260

 
8,949

Flexera Software LLC, L+700, 1.00% LIBOR Floor, 4/2/2021 (p)
 
2 Month LIBOR
 
High Tech Industries
 
9,385

 
9,180

 
9,385

Genex Holdings, Inc., L+775, 1.00% LIBOR Floor, 5/30/2022 (n)(p)
 
1 Month LIBOR
 
Services: Business
 
11,410

 
11,331

 
11,282

Global Tel*Link Corp., L+825, 1.25% LIBOR Floor, 11/23/2020 (p)
 
3 Month LIBOR
 
Telecommunications
 
11,500

 
11,481

 
11,507

GOBP Holdings, Inc., L+825, 1.00% LIBOR Floor, 10/21/2022 (p)
 
3 Month LIBOR
 
Retail
 
4,000

 
4,019

 
4,020

Medical Solutions Holdings, Inc., L+825, 1.00% LIBOR Floor, 6/16/2025 (n)
 
1 Month LIBOR
 
Healthcare & Pharmaceuticals
 
10,000

 
9,859

 
9,950

Ministry Brands, LLC, L+925, 1.00% LIBOR Floor, 6/2/2023 (n)
 
1 Month LIBOR
 
Services: Business
 
5,488

 
5,393

 
5,488

Ministry Brands, LLC, L+925, 1.00% LIBOR Floor, 6/2/2023
 
1 Month LIBOR
 
Services: Business
 
2,158

 
2,158

 
2,158

Ministry Brands, LLC, L+100, 1.00% LIBOR Floor, Unfunded, 2/22/2019
 
1 Month LIBOR
 
Services: Business
 
388

 

 

Niacet Corp., E+875, 1.00% EURIBOR Floor, 8/1/2024 (h)
 
3 Month EURIBOR
 
Chemicals, Plastics & Rubber
 
7,489

 
7,944

 
8,811

Onex Carestream Finance LP, L+850, 1.00% LIBOR Floor, 12/7/2019 (p)
 
3 Month LIBOR
 
Healthcare & Pharmaceuticals
 
10,557

 
9,755

 
10,398

Onex TSG Holdings II Corp., L+850, 1.00% LIBOR Floor, 7/31/2023 (n)(o)
 
1 Month LIBOR
 
Healthcare & Pharmaceuticals
 
12,249

 
12,146

 
11,759

Paris Presents Inc., L+875, 1.00% LIBOR Floor, 12/31/2021 (n)
 
1 Month LIBOR
 
Consumer Goods: Durable
 
3,500

 
3,438

 
3,483

Patterson Medical Supply, Inc., L+850, 1.00% LIBOR Floor, 8/28/2023 (n)
 
3 Month LIBOR
 
Healthcare & Pharmaceuticals
 
13,500

 
13,386

 
12,488

PDI TA Holdings, Inc., L+875, 1.00% LIBOR Floor, 8/25/2024
 
3 Month LIBOR
 
High Tech Industries
 
306

 
306

 
303

PDI TA Holdings, Inc., 0.50% Unfunded, 8/24/2018
 
None
 
High Tech Industries
 
244

 

 
(2
)
Pelican Products, Inc., L+825, 1.00% LIBOR Floor, 4/11/2021 (p)
 
3 Month LIBOR
 
Chemicals, Plastics & Rubber
 
3,469

 
3,458

 
3,469

PetroChoice Holdings, Inc., L+875, 1.00% LIBOR Floor, 8/21/2023 (n)
 
1 Month LIBOR
 
Chemicals, Plastics & Rubber
 
15,000

 
14,707

 
14,737

PFS Holding Corp., L+725, 1.00% LIBOR Floor, 1/31/2022 (o)
 
1 Month LIBOR
 
Retail
 
4,998

 
4,694

 
2,393

Premiere Global Services, Inc., L+950, 1.00% LIBOR Floor, 6/6/2022 (n)
 
1 Month LIBOR
 
Telecommunications
 
3,000

 
2,897

 
2,839

PT Intermediate Holdings III, LLC, L+800, 1.00% LIBOR Floor, 12/8/2025 (i)(p)
 
3 Month LIBOR
 
Services: Business
 
9,375

 
9,281

 
9,422

Robertshaw US Holding Corp., L+900, 0.00% LIBOR Floor, 2/10/2025
 
1 Month LIBOR
 
Chemicals, Plastics & Rubber
 
5,000

 
4,863

 
4,981

See accompanying notes to consolidated financial statements.

17



CĪON Investment Corporation
Consolidated Schedule of Investments
December 31, 2017
(in thousands)
Portfolio Company(a)
 
Index Rate(b)
 
Industry
 
Principal/
Par Amount/
Units(d)
 
Cost(m)
 
Fair
Value(c)
Securus Technologies Holdings, Inc., L+825, 1.00% LIBOR Floor, 11/1/2025 (p)
 
2 Month LIBOR
 
Telecommunications
 
2,942

 
2,913

 
2,981

SMG, L+825, 1.00% LIBOR Floor, 2/27/2021 (n)
 
1 Month LIBOR
 
Hotel, Gaming & Leisure
 
6,142

 
6,142

 
6,165

STG-Fairway Acquisitions, Inc., L+925, 1.00% LIBOR Floor, 6/30/2023 (n)(p)
 
3 Month LIBOR
 
Services: Business
 
10,000

 
9,883

 
9,600

TexOak Petro Holdings LLC, 8.00%, 12/29/2019 (r)(t)(u)
 
None
 
Energy: Oil & Gas
 
7,343

 
2,592

 

TMK Hawk Parent, Corp., L+800, 1.00% LIBOR Floor, 8/28/2025 (n)
 
3 Month LIBOR
 
Services: Business
 
13,393

 
13,069

 
13,175

TouchTunes Interactive Networks, Inc, L+825, 1.00% LIBOR Floor, 5/29/2022 (p)
 
3 Month LIBOR
 
Hotel, Gaming & Leisure
 
6,000

 
5,951

 
6,007

U.S. Renal Care, Inc., L+800, 1.00% LIBOR Floor, 12/29/2023 (n)
 
3 Month LIBOR
 
Healthcare & Pharmaceuticals
 
5,000

 
4,920

 
4,912

Wand Intermediate I LP, L+725, 1.00% LIBOR Floor, 9/19/2022 (n)
 
3 Month LIBOR
 
Automotive
 
16,000

 
15,881

 
16,080

Winebow Holdings, Inc., L+750, 1.00% LIBOR Floor, 1/2/2022 (n)
 
1 Month LIBOR
 
Beverage, Food & Tobacco
 
12,823

 
12,588

 
12,118

Zywave Inc., L+900, 1.00% LIBOR Floor, 11/17/2023 (n)
 
3 Month LIBOR
 
High Tech Industries
 
5,000

 
4,934

 
4,988

Total Senior Secured Second Lien Debt
 
 
 
 
 
 
 
342,906

 
333,944

Collateralized Securities and Structured Products - Debt - 2.4%
 
 
 
 
 
 
 
 
 
 
Deutsche Bank AG Frankfurt CRAFT 2014-1 Class Credit Linked Note, L+965, 5/15/2019 (h)
 
3 Month LIBOR
 
Diversified Financials
 
3,447

 
3,447

 
3,447

Deutsche Bank AG Frankfurt CRAFT 2015-2 Class Credit Linked Note, L+925, 1/16/2022 (h)
 
3 Month LIBOR
 
Diversified Financials
 
14,826

 
14,826

 
14,531

NXT Capital CLO 2014-1, LLC Class E Notes, L+550, 4/23/2026 (g)(h)
 
3 Month LIBOR
 
Diversified Financials
 
7,500

 
7,138

 
7,311

Total Collateralized Securities and Structured Products - Debt
 
 
 
 
 
 

 
25,411

 
25,289

Collateralized Securities and Structured Products - Equity - 1.8%
 
 
 
 
 
 
 
 
 
 
Anchorage Capital CLO 2012-1, Ltd. Subordinated Notes, 2.82% Estimated Yield, 1/13/2025 (h)
 
(f)
 
Diversified Financials
 
4,000

 
2,530

 
2,102

APIDOS CLO XVI Subordinated Notes, 11.84% Estimated Yield, 1/19/2025 (h)
 
(f)
 
Diversified Financials
 
9,000

 
4,035

 
3,387

CENT CLO 19 Ltd. Subordinated Notes, 6.47% Estimated Yield, 10/29/2025 (h)
 
(f)
 
Diversified Financials
 
2,000

 
1,305

 
1,060

Galaxy XV CLO Ltd. Class A Subordinated Notes, 4.60% Estimated Yield, 4/15/2025 (h)
 
(f)
 
Diversified Financials
 
4,000

 
2,282

 
2,362

Ivy Hill Middle Market Credit Fund VIII, Ltd. Subordinated Loan, 10.35% Estimated Yield, 2/2/2026 (e)(h)
 
(f)
 
Diversified Financials
 
10,000

 
9,681

 
9,614

Total Collateralized Securities and Structured Products - Equity
 
 
 
 
 
 

 
19,833

 
18,525

Unsecured Debt - 0.7%
 
 
 
 
 
 
 
 
 
 
Visual Edge Technology, Inc., 12.50%, 8/31/2024 (t)(u)
 
None
 
Services: Business
 
7,835

 
7,653

 
7,639

Total Unsecured Debt
 
 
 
 
 
 

 
7,653

 
7,639

Equity - 2.1%
 
 
 
 
 
 
 
 
 
 
Avaya Holdings Corp., Common Stock (o)(q)(s)
 
 
 
Telecommunications
 
321,260 Units

 
5,285

 
5,638

Conisus Holdings, Inc, Series B Preferred Stock, 12.00% Dividend (r)(t)(u)
 
 
 
Healthcare & Pharmaceuticals
 
12,677,833 Units

 
9,200

 
9,300

Conisus Holdings, Inc, Common Stock (q)(t)
 
 
 
Healthcare & Pharmaceuticals
 
4,914,556 Units

 
200

 
175

F+W Media, Inc., Common Stock (q)
 
 
 
Media: Diversified & Production
 
31,211 Units

 

 

Mooregate ITC Acquisition, LLC, Class A Units (q)
 
 
 
High Tech Industries
 
500 Units

 
563

 
375

NS NWN Acquisition, LLC, Voting Units (q)
 
 
 
High Tech Industries
 
404 Units

 
393

 
450

NSG Co-Invest (Bermuda) LP, Partnership Interests (h)(q)
 
 
 
Consumer Goods: Durable
 
1,575 Units

 
1,000

 
825

Spinal USA, Inc. / Precision Medical Inc., Warrants (n)(q)
 
 
 
Healthcare & Pharmaceuticals
 
9,317,237 Units

 
4,736

 
5,125

See accompanying notes to consolidated financial statements.

18



CĪON Investment Corporation
Consolidated Schedule of Investments
December 31, 2017
(in thousands)
Portfolio Company(a)
 
 
 
Industry
 
Principal/
Par Amount/
Units(d)
 
Cost(m)
 
Fair
Value(c)
Tenere Inc., Warrant (q)
 
 
 
Capital Equipment
 
N/A
 
161

 
27

Texoak Petro Holdings LLC, Membership Interests (q)(t)
 
 
 
Energy: Oil & Gas
 
60,000 Units
 

 

Total Equity
 
 
 
 
 
 
 
21,538

 
21,915

Short Term Investments - 19.5%(k)
 
 
 
 
 
 
 
 
 
 
First American Treasury Obligations Fund, Class Z Shares, 1.18% (l)(s)
 
 
 
 
 
 
 
206,547

 
206,547

Total Short Term Investments
 
 
 
 
 
 
 
206,547

 
206,547

TOTAL INVESTMENTS - 161.9%
 
 
 
 
 
 
 
$
1,712,400

 
1,714,195

LIABILITIES IN EXCESS OF OTHER ASSETS - (61.9%)
 
 
 
 
 
 
 
 
 
(655,504
)
NET ASSETS - 100%
 
 
 
 
 
 
 
 
 
$
1,058,691

a.
All of the Company’s investments are issued by eligible U.S. portfolio companies, as defined in the 1940 Act, except for investments specifically identified as non-qualifying per note h. below. Unless specifically identified in note u. below, investments do not contain a PIK interest provision.
b.
The 1, 2, 3 and 6 month LIBOR rates were 1.57%, 1.62%, 1.69% and 1.84%, respectively, as of December 31, 2017.  The actual LIBOR rate for each loan listed may not be the applicable LIBOR rate as of December 31, 2017, as the loan may have been priced or repriced based on a LIBOR rate prior to or subsequent to December 31, 2017. The 1 and 3 month EURIBOR rates were (0.41%) and (0.38%), respectively, as of December 31, 2017.
c.
Fair value determined in good faith by the Company’s board of directors (see Note 9) using significant unobservable inputs unless otherwise noted.
d.
Denominated in U.S. dollars unless otherwise noted.
e.
As discussed in Note 11, on December 31, 2017, the Company was committed, upon the satisfaction of certain conditions, to fund an additional $1,608 and $1,111 to Studio Movie Grill Holdings, LLC and Ivy Hill Middle Market Credit Fund VIII, Ltd., respectively. As of March 8, 2018, the Company was committed, upon the satisfaction of certain conditions, to fund an additional $2,701, $111, $830, $210, $271, $9,765, $4,510, $2,500, $4,211, $540, $1,111, $3,278, $433, $1,608, $1,250, $64 and $949 to Access CIG, LLC, Accruent, LLC, American Media, Inc., Charming Charlie, LLC, Covenant Surgical Partners, Inc., DFC Global Facility Borrower II LLC, Discovery DJ Services LLC, Elemica Holdings, Inc., Foundation Consumer Healthcare, LLC, Frontline Technologies Group Holding LLC, Ivy Hill Middle Market Credit Fund VIII, Ltd., Moss Holding Company, Pathway Partners Vet Management Company LLC, Studio Movie Grill Holdings, LLC, Teladoc, Inc., Visual Edge Technology Inc. and VLS Recovery Services, LLC, respectively.
f.
The CLO subordinated notes are considered equity positions in the CLO vehicles and are not rated. Equity investments are entitled to recurring distributions, which are generally equal to the remaining cash flow of the payments made by the underlying vehicle's securities less contractual payments to debt holders and expenses. The estimated yield indicated is based upon a current projection of the amount and timing of these recurring distributions and the estimated amount of repayment of principal upon termination. Such projections are periodically reviewed and adjusted, and the estimated yield may not ultimately be realized.
g.
NXT Capital CLO 2014-1 Class E Notes were rated Ba2 on Moody's credit scale as of December 31, 2017.
h.
The investment or a portion thereof is not a qualifying asset under the 1940 Act. A business development company may not acquire any asset other than qualifying assets, unless, at the time the acquisition is made, qualifying assets represent at least 70% of the company’s total assets as defined under Section 55 of the 1940 Act. As of December 31, 2017, 92.0% of the Company’s total assets represented qualifying assets.
i.
Position or a portion thereof unsettled as of December 31, 2017.
j.
In addition to the interest earned based on the stated interest rate of this loan, which is the amount reflected in this schedule, the Company may be entitled to receive additional amounts as a result of an arrangement between the Company and other lenders in the syndication in exchange for lower payment priority.
k.
Short term investments represent an investment in a fund that invests in highly liquid investments with average original maturity dates of three months or less.
l.
7-day effective yield as of December 31, 2017.
m.
Represents amortized cost for debt securities and cost for equity investments.
n.
Investment or a portion thereof held within the Company’s wholly-owned consolidated subsidiary, 34th Street, and was pledged as collateral supporting the amounts outstanding under the credit facility with JPM as of December 31, 2017 (see Note 8).
o.
Investment or a portion thereof held within the Company’s wholly-owned consolidated subsidiary, Flatiron Funding II, and was pledged as collateral supporting the amounts outstanding under the credit facility with Citibank as of December 31, 2017 (see Note 8).
See accompanying notes to consolidated financial statements.

19



CĪON Investment Corporation
Consolidated Schedule of Investments
December 31, 2017
(in thousands)
p.
Investment or a portion thereof held within the Company’s wholly-owned consolidated subsidiary, Murray Hill Funding II, and was pledged as collateral supporting the amounts outstanding under the repurchase agreement with UBS as of December 31, 2017 (see Note 8).
q.
Non-income producing security.
r.
Investment or a portion thereof was on non-accrual status as of December 31, 2017.
s.
Value determined using level 1 inputs.
t.
Investment determined to be an affiliated investment as defined in the 1940 Act as the Company owns between 5% and 25% of the portfolio company’s outstanding voting securities but does not control the company. Fair value as of December 31, 2016 and 2017, along with transactions during the year ended December 31, 2017 in these affiliated investments are as follows:
 
 
 
 
Year Ended December 31, 2017
 
 
 
Year Ended December 31, 2017
Non-Controlled, Affiliated Investments
 
Fair Value at
December 31, 2016
 
Gross
Additions
(Cost)(1)
 
Gross
Reductions
(Cost)(2)
 
Net Unrealized
Gain (Loss)
 
Fair Value at
December 31, 2017
 
Net Realized
Gain (Loss)
 
Interest
Income(3)
    Conisus Holdings, Inc.
 
 
 
 
 
 
 
 
 
 
 
 
 
 
        Series B Preferred Stock
 
$

 
$
9,200

 
$

 
$
100

 
$
9,300

 
$

 
$

        Common Stock
 

 
200

 

 
(25
)
 
175

 

 

    F+W Media, Inc.
 
 
 
 
 
 
 
 
 
 
 
 
 
 
        First Lien Term Loan B-1
 

 
1,114

 

 
55

 
1,169

 

 
69

        First Lien Term Loan B-2
 

 
2,743

 

 
(1,245
)
 
1,498

 

 
226

        Common Stock
 

 

 

 

 

 

 

    Petroflow Energy Corp.
 
 
 
 
 
 
 
 
 
 
 
 
 
 
        First Lien Term Loan
 
4,601

 
395

 
(1,440
)
 
(165
)
 
3,391

 
65

 
283

    TexOak Petro Holdings LLC
 
 
 
 
 
 
 
 
 
 
 
 
 
 
        Second Lien Term Loan
 
2,590

 
1,042

 

 
(3,632
)
 

 

 
1,035

        Membership Interests
 

 

 

 

 

 

 

    Totals
 
$
7,191

 
$
14,694

 
$
(1,440
)
 
$
(4,912
)
 
$
15,533

 
$
65

 
$
1,613

(1)
Gross additions include increases in the cost basis of investments resulting from new portfolio investments, PIK interest, the amortization of unearned income, the exchange of one or more existing securities for one or more new securities and the movement of an existing portfolio company into this category from a different category.
(2)
Gross reductions include decreases in the cost basis of investments resulting from principal collections related to investment repayments or sales, the exchange of one or more existing securities for one or more new securities and the movement of an existing portfolio company out of this category into a different category.
(3)
Includes PIK interest income.
u.
For the year ended December 31, 2017, the following investments contain a PIK interest provision whereby the issuer has either the option or the obligation to make interest payments with the issuance of additional securities:
 
 
 
 
Interest Rate
 
Interest Amount
Portfolio Company
 
Investment Type
 
Cash
 
PIK
 
All-in-Rate
 
Cash
 
PIK
 
Total
American Clinical Solutions LLC
 
Senior Secured First Lien Debt
 
10.50%
 
2.00%
 
12.50%
 
$
962

 
$

 
$
962

Conisus Holdings, Inc. (v)
 
Preferred Stock
 
 
12.00%
 
12.00%
 
$

 
$

 
$

Elements Behavioral Health, Inc. (v)
 
Senior Secured Second Lien Debt
 
 
13.00%
 
13.00%
 
$

 
$
370

 
$
370

F+W Media, Inc. (v)
 
Senior Secured First Lien Debt
 
1.50%
 
10.00%
 
11.50%
 
$
33

 
$
176

 
$
209

Petroflow Energy Corp. (v)
 
Senior Secured First Lien Debt
 
3.00%
 
6.00%
 
9.00%
 
$
41

 
$
242

 
$
283

Rimini Street, Inc.
 
Senior Secured First Lien Debt
 
12.00%
 
3.00%
 
15.00%
 
$
2,185

 
$
552

 
$
2,737

Sequoia Healthcare Management, LLC
 
Senior Secured First Lien Debt
 
12.00%
 
4.00%
 
16.00%
 
$
765

 
$
248

 
$
1,013

Southcross Holdings Borrower LP
 
Senior Secured First Lien Debt
 
3.50%
 
5.50%
 
9.00%
 
$
9

 
$
7

 
$
16

Spinal USA, Inc. / Precision Medical Inc.
 
Senior Secured First Lien Debt
 
 
10.50%
 
10.50%
 
$

 
$
313

 
$
313

TexOak Petro Holdings LLC (v)
 
Senior Secured Second Lien Debt
 
 
8.00%
 
8.00%
 
$

 
$
313

 
$
313

Visual Edge Technology, Inc.
 
Subordinated Note
 
 
12.50%
 
12.50%
 
$

 
$
324

 
$
324

v.
The PIK interest portion of the investment was on non-accrual status as of December 31, 2017.
w.
In addition to the interest earned based on the stated interest rate of this loan, which is the amount reflected in this schedule, the Company may be entitled to receive additional residual amounts.
See accompanying notes to consolidated financial statements.

20

CĪON Investment Corporation
Notes to Consolidated Financial Statements (unaudited)
March 31, 2018
(in thousands, except share and per share amounts)


Note 1. Organization and Principal Business
CĪON Investment Corporation, or the Company, was incorporated under the general corporation laws of the State of Maryland on August 9, 2011. On December 17, 2012, the Company successfully raised gross proceeds from unaffiliated outside investors of at least $2,500, or the minimum offering requirement, and commenced operations. The Company is an externally managed, non-diversified closed-end management investment company that has elected to be regulated as a business development company, or BDC, under the 1940 Act. The Company elected to be treated for federal income tax purposes as a regulated investment company, or RIC, as defined under Subchapter M of the Internal Revenue Code of 1986, as amended, or the Code.
The Company’s investment objective is to generate current income and, to a lesser extent, capital appreciation for investors. The Company’s portfolio is comprised primarily of investments in senior secured debt, including first lien loans, second lien loans and unitranche loans, and, to a lesser extent, collateralized securities, structured products and other similar securities, unsecured debt, including corporate bonds and long-term subordinated loans, referred to as mezzanine loans, and equity, of private and thinly-traded U.S. middle-market companies.
The Company is managed by CION Investment Management, LLC, or CIM, a registered investment adviser and an affiliate of the Company. Pursuant to an investment advisory agreement with the Company, CIM oversees the management of the Company’s activities and is responsible for making investment decisions for the Company’s investment portfolio. On November 1, 2017, the board of directors of the Company, including a majority of the board of directors who are not interested persons, approved the renewal of the investment advisory agreement with CIM for a period of twelve months commencing December 17, 2017. The Company and CIM previously engaged Apollo Investment Management, L.P., or AIM, a subsidiary of Apollo Global Management, LLC, or, together with its subsidiaries, Apollo, a leading global alternative investment manager, to act as the Company’s investment sub-adviser.
On July 11, 2017, the members of CIM entered into a third amended and restated limited liability company agreement of CIM, or the Third CIM LLC Agreement, for the purpose of creating a joint venture between AIM and CION Investment Group, LLC, or CIG. Under the Third CIM LLC Agreement, AIM became a member of CIM and was issued a newly-created class of membership interests in CIM pursuant to which AIM will, among other things, share in the profits, losses, distributions and expenses of CIM with the other members in accordance with the terms of the Third CIM LLC Agreement, which will ultimately result in CIG and AIM each owning a 50% economic interest in CIM.
On July 10, 2017, the Company’s independent directors unanimously approved the termination of the investment sub-advisory agreement with AIM, effective as of July 11, 2017. Although the investment sub-advisory agreement and AIM's engagement as the Company’s investment sub-adviser were terminated, AIM continues to perform certain non-advisory services for CIM and the Company, including, without limitation, identifying investment opportunities for approval by CIM's investment committee. AIM is not paid a separate fee in exchange for such services, but is entitled to receive distributions as a member of CIM as described above.
On December 4, 2017, the members of CIM entered into a fourth amended and restated limited liability company agreement of CIM, or the Fourth CIM LLC Agreement. Under the Fourth CIM LLC Agreement, AIM performs sourcing services for CIM, which include, among other services, (i) identifying and providing information about potential investment opportunities for approval by CIM’s investment committee; (ii) providing (a) trade and settlement support; (b) portfolio and cash reconciliation; (c) market pipeline information regarding syndicated deals, in each case, as reasonably requested by CIM; and (d) monthly valuation reports and support for all broker-quoted investments. AIM has a limited role as a member of CIM and does not provide advice, evaluation, or recommendation with respect to the Company's investments. All of the Company's investment decisions are the sole responsibility of, and are made at the sole discretion of, CIM.
Note 2. Summary of Significant Accounting Policies
Basis of Presentation and Consolidation
The accompanying unaudited consolidated financial statements of the Company have been prepared in accordance with U.S. generally accepted accounting principles, or GAAP, for interim financial information and pursuant to the instructions for Form 10-Q and Article 10 of Regulation S-X. Accordingly, they do not include all of the information and footnotes required by GAAP for complete financial statements. In the opinion of management, all adjustments (consisting of normal recurring adjustments) considered necessary for a fair presentation have been included. For a more complete discussion of significant accounting policies and certain other information, the Company’s interim unaudited consolidated financial statements should be read in conjunction with its audited consolidated financial statements as of December 31, 2017 and for the year then ended included in the Company’s Annual Report on Form 10-K. Operating results for interim periods are not necessarily indicative of the results that may be expected for the full year ending December 31, 2018. The consolidated balance sheet and the consolidated schedule of investments as of December 31, 2017 are derived from the 2017 audited consolidated financial statements and include the accounts of the Company’s wholly-owned subsidiaries.
The Company evaluates subsequent events through the date that the consolidated financial statements are issued.

21

CĪON Investment Corporation
Notes to Consolidated Financial Statements (unaudited)
March 31, 2018
(in thousands, except share and per share amounts)

Recently Adopted Accounting Standards
In May 2014, the Financial Accounting Standards Board, or the FASB, issued ASU 2014-09, Revenue from Contracts with Customers, or ASU 2014-09, which establishes a comprehensive and converged standard on revenue recognition to enable financial statement users to better understand and consistently analyze an entity’s revenue across industries, transactions and geographies. The core principle of ASU 2014-09 is that an entity should recognize revenue to depict the transfer of promised goods or services to customers in an amount that reflects the consideration to which the entity expects to be entitled in exchange for those goods or services. As such, ASU 2014-09 could impact the timing of revenue recognition. ASU 2014-09 also requires improved disclosures to help users of financial statements better understand the nature, amount, timing and uncertainty of revenue that is recognized. ASU 2014-09 applies to all entities. In August 2015, the FASB issued ASU 2015-14, Revenue from Contracts with Customers: Deferral of the Effective Date, or ASU 2015-14, which amended the effective date of ASU 2014-09. ASU 2015-14 deferred the effective date of ASU 2014-09 to interim reporting periods within annual reporting periods beginning after December 15, 2017. This guidance was adopted by the Company during the three months ended March 31, 2018 and did not have a material impact on the Company’s consolidated financial statements.
In August 2016, the FASB issued ASU 2016-15, Statement of Cash Flows: Classification of Certain Cash Receipts and Cash Payments (a consensus of the Emerging Issues Task Force), or ASU 2016-15, which intends to reduce diversity in practice in how certain cash receipts and payments are classified in the statement of cash flows, including debt prepayment or extinguishment costs, the settlement of contingent liabilities arising from a business combination, proceeds from insurance settlements and distributions from certain equity method investments. ASU 2016-15 is effective for interim and annual periods beginning after December 15, 2017. This guidance was adopted by the Company during the three months ended March 31, 2018 and did not have a material impact on the Company’s consolidated financial statements.
In November 2016, the FASB issued ASU 2016-18, Statement of Cash Flows (Topic 230): Restricted Cash (a consensus of the FASB Emerging Issues Task Force), or ASU 2016-18, which requires an entity to include in its cash and cash-equivalent balances in the statement of cash flows those amounts that are deemed to be restricted cash and restricted cash equivalents. ASU 2016-18 is effective for interim and annual periods beginning after December 15, 2017. This guidance was adopted by the Company during the three months ended March 31, 2018 and did not have a material impact on the Company’s consolidated financial statements.
In January 2017, the FASB issued ASU 2017-01, Business Combinations: Clarifying the Definition of a Business, or ASU 2017-01, which clarifies the definition of a business with the objective of adding guidance to assist companies with evaluating whether transactions should be accounted for as acquisitions (or disposals) of assets or businesses. ASU 2017-01 is expected to reduce the number of transactions that need to be further evaluated as businesses. ASU 2017-01 is effective for interim and annual periods beginning after December 15, 2017. This guidance was adopted by the Company during the three months ended March 31, 2018 and did not have a material impact on the Company’s consolidated financial statements.
Recently Announced Accounting Standards
In March 2017, the FASB issued ASU 2017-08, Premium Amortization on Purchased Callable Debt Securities, or ASU 2017-08, which shortens the amortization period for the premium on certain purchased callable debt securities to the earliest call date. ASU 2017-08 is effective for fiscal years beginning after December 15, 2019, and interim periods within fiscal years beginning after December 15, 2020. Early adoption is permitted, including adoption during an interim period. If the Company early adopts the amendments during an interim period, any adjustments will be reflected as of the beginning of the fiscal year that includes such interim period. The Company is in the process of evaluating the impact that this guidance will have on its consolidated financial statements.
Cash and Cash Equivalents
Cash and cash equivalents include cash in banks and highly liquid investments with original maturity dates of three months or less. The Company’s cash and cash equivalents are held principally at one financial institution and at times may exceed insured limits. The Company periodically evaluates the creditworthiness of this institution and has not experienced any losses on such deposits.
Foreign Currency Translations
The accounting records of the Company are maintained in U.S. dollars. All assets and liabilities denominated in foreign currencies are translated into U.S. dollars based on the foreign exchange rate on the date of valuation. The Company does not isolate that portion of the results of operations resulting from changes in foreign exchange rates on investments from the fluctuations arising from changes in market prices of securities held. Changes in the relationship of foreign currencies to the U.S. dollar can significantly affect the value of these investments and therefore the earnings of the Company.

22

CĪON Investment Corporation
Notes to Consolidated Financial Statements (unaudited)
March 31, 2018
(in thousands, except share and per share amounts)

Short Term Investments
Short term investments include an investment in a U.S. Treasury obligations fund, which seeks to provide current income and daily liquidity by purchasing U.S. Treasury securities and repurchase agreements that are collateralized by such securities. The Company had $181,095 and $206,547 of such investments at March 31, 2018 and December 31, 2017, respectively, which are included in investments, at fair value on the accompanying consolidated balance sheets and on the consolidated schedules of investments.
Offering and Organizational Costs
Offering costs include, among other things, legal fees and other costs pertaining to the preparation of the Company’s registration statements in connection with the continuous public offerings of the Company’s shares. Certain initial offering costs that were funded by CIG on behalf of the Company were submitted by CIG for reimbursement upon meeting the minimum offering requirement on December 17, 2012. These costs were capitalized and amortized over a twelve month period as an adjustment to capital in excess of par value. All other offering costs are expensed as incurred by the Company.
Organizational costs include, among other things, the cost of organizing the Company as a Maryland corporation, including the cost of legal services and other fees pertaining to the organization of the Company. All organizational costs were funded by CIG and its affiliates and there was no liability for these organizational costs to the Company until CIG and its affiliates submitted such costs for reimbursement.
Income Taxes
The Company elected to be treated for federal income tax purposes as a RIC under Subchapter M of the Code. To qualify and maintain qualification as a RIC, the Company must, among other things, meet certain source of income and asset diversification requirements and distribute to shareholders, for each taxable year, at least 90% of the Company’s “investment company taxable income”, which is generally equal to the sum of the Company’s net ordinary income plus the excess, if any, of realized net short-term capital gains over realized net long-term capital losses. If the Company continues to qualify as a RIC and continues to satisfy the annual distribution requirement, the Company will not be subject to corporate level federal income taxes on any income that the Company distributes to its shareholders. The Company intends to make distributions in an amount sufficient to maintain RIC status each year and to avoid any federal income taxes on income. The Company will also be subject to nondeductible federal excise taxes if the Company does not distribute at least 98.0% of net ordinary income, 98.2% of capital gains, if any, and any recognized and undistributed income from prior years for which it paid no federal income taxes. 
Two of the Company’s wholly-owned consolidated subsidiaries, View ITC, LLC and View Rise, LLC, or collectively the Taxable Subsidiaries, have elected to be treated as taxable entities for U.S. federal income tax purposes. The Taxable Subsidiaries are not consolidated with the Company for income tax purposes and may generate income tax expense or benefit, and the related tax assets and liabilities, as a result of its ownership of certain portfolio investments. The income tax expense or benefit, if any, and related tax assets and liabilities, where material, are reflected in the Company’s consolidated financial statements. There were no deferred tax assets or liabilities as of March 31, 2018.
Book/tax differences relating to permanent differences are reclassified among the Company’s capital accounts, as appropriate. Additionally, the tax character of distributions is determined in accordance with income tax regulations that may differ from GAAP (see Note 5).
Uncertainty in Income Taxes
The Company evaluates its tax positions to determine if the tax positions taken meet the minimum recognition threshold for the purposes of measuring and recognizing tax liabilities in the consolidated financial statements. Recognition of a tax benefit or liability with respect to an uncertain tax position is required only when the position is “more likely than not” to be sustained assuming examination by the taxing authorities. The Company recognizes interest and penalties, if any, related to unrecognized tax benefits as income tax expense in the consolidated statements of operations. The Company did not have any uncertain tax positions during the periods presented herein. 
The Company is subject to examination by U.S. federal, New York State, New York City and Maryland income tax jurisdictions for 2014, 2015, and 2016.
Use of Estimates
The preparation of the consolidated financial statements in conformity with GAAP requires the Company to make estimates and assumptions that affect the reported amounts of assets and liabilities at the date of the consolidated financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results may materially differ from those estimates.

23

CĪON Investment Corporation
Notes to Consolidated Financial Statements (unaudited)
March 31, 2018
(in thousands, except share and per share amounts)

Valuation of Portfolio Investments
The fair value of the Company’s investments is determined quarterly in good faith by the Company’s board of directors pursuant to its consistently applied valuation procedures and valuation process in accordance with Accounting Standards Codification Topic 820, Fair Value Measurements and Disclosure, or ASC 820. ASC 820 defines fair value as the price that would be received from the sale of an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. ASC 820 also establishes a three-tier fair value hierarchy that prioritizes and ranks the level of market price observability of inputs used in measuring investments at fair value. Inputs used to measure these fair values are classified into the following hierarchy:
Level 1 -
Quoted prices in active markets for identical assets or liabilities, accessible by the Company at the measurement date.
Level 2 -
Quoted prices for similar assets or liabilities in active markets, or quoted prices for identical or similar assets or liabilities in markets that are not active, or other observable inputs other than quoted prices.
Level 3 -
Unobservable inputs for the asset or liability. The inputs used in the determination of fair value may require significant management judgment or estimation. Such information may be the result of consensus pricing information or broker quotes that include a disclaimer that the broker would not be held to such a price in an actual transaction. The non-binding nature of consensus pricing and/or quotes accompanied by the disclaimer would result in classification as a Level 3 asset, assuming no additional corroborating evidence.
Market price observability is affected by a number of factors, including the type of investment and the characteristics specific to the investment. Investments with readily available active quoted prices or for which fair value can be measured from actively quoted prices generally will have a higher degree of market price observability and a lesser degree of judgment used in measuring fair value.
Based on the observability of the inputs used in the valuation techniques, the Company is required to provide disclosures on fair value measurements according to the fair value hierarchy. The level in the fair value hierarchy for each fair value measurement has been determined based on the lowest level of input that is significant to the fair value measurement. Our assessment of the significance of a particular input to the fair value measurement in its entirety requires judgment and considers factors specific to each investment. The level assigned to the investment valuations may not be indicative of the risk or liquidity associated with investing in such investments. Because of the inherent uncertainties of valuation, the values reflected in the financial statements may differ materially from the value that would be received upon an actual sale of such investments. In addition, changes in the market environment and other events that may occur over the life of the investments may cause the gains or losses that the Company ultimately realizes on these investments to materially differ from the valuations currently assigned.
The Company’s investments, excluding short term investments, consist primarily of debt securities that are traded on a private over-the-counter market for institutional investments. CIM attempts to obtain market quotations from at least two brokers or dealers for each investment (if available, otherwise from a principal market maker or a primary market dealer or other independent pricing service). CIM utilizes mid-market pricing to determine fair value unless a different point within the range is more representative. Because of the private nature of this marketplace (meaning actual transactions are not publicly reported) and the non-binding nature of consensus pricing and/or quotes, the Company believes that these valuation inputs result in Level 3 classification within the fair value hierarchy.
Notwithstanding the foregoing, if in the reasonable judgment of CIM, the price of any investment held by the Company and determined in the manner described above does not accurately reflect the fair value of such investment, CIM will value such investment at a price that reflects such investment’s fair value and report such change in the valuation to the board of directors or its designee as soon as practicable. Investments that carry certain restrictions on sale will typically be valued at a discount from the public market value of the investment.
Any investments that are not publicly traded or for which a market price is not otherwise readily available are valued at a price that reflects its fair value. With respect to such investments, if CIM is unable to obtain market quotations, the investments are reviewed and valued using one or more of the following types of analyses:
i.
Market comparable statistics and public trading multiples discounted for illiquidity, minority ownership and other factors for companies with similar characteristics.
ii.
Valuations implied by third-party investments in the applicable portfolio companies.
iii.
Discounted cash flow analysis, including a terminal value or exit multiple.

24

CĪON Investment Corporation
Notes to Consolidated Financial Statements (unaudited)
March 31, 2018
(in thousands, except share and per share amounts)

Determination of fair value involves subjective judgments and estimates. Accordingly, these notes to the Company’s consolidated financial statements refer to the uncertainty with respect to the possible effect of such valuations, and any change in such valuations, on the Company’s consolidated financial statements. Below is a description of factors that the Company’s board of directors may consider when valuing the Company’s equity and debt investments where a market price is not readily available:
the size and scope of a portfolio company and its specific strengths and weaknesses;
prevailing interest rates for like securities;
expected volatility in future interest rates;
leverage; 
call features, put features and other relevant terms of the debt;
the borrower’s ability to adequately service its debt;
the fair market value of the portfolio company in relation to the face amount of its outstanding debt;
the quality of collateral securing the Company’s debt investments;
multiples of earnings before interest, taxes, depreciation and amortization, or EBITDA, cash flows, net income, revenues or, in some cases, book value or liquidation value; and
other factors deemed applicable.
All of these factors may be subject to adjustment based upon the particular circumstances of a portfolio company or the Company’s actual investment position. For example, adjustments to EBITDA may take into account compensation to previous owners, or acquisition, recapitalization, and restructuring expenses or other related or non-recurring items. The choice of analyses and the weight assigned to such factors may vary across investments and may change within an investment if events occur that warrant such a change.
The discounted cash flow model deemed appropriate by CIM is prepared for the applicable investments and reviewed by the Company’s valuation committee consisting of senior management. Such models are prepared at least quarterly or on an as needed basis. The model uses the estimated cash flow projections for the underlying investments and an appropriate discount rate is determined based on the latest financial information available for the borrower, prevailing market trends, comparable analysis and other inputs. The model, key assumptions, inputs, and results are reviewed by the Company’s valuation committee with final approval from the board of directors.
Consistent with the Company’s valuation policy, the Company evaluates the source of inputs, including any markets in which the Company’s investments are trading, in determining fair value.
The Company periodically benchmarks the broker quotes from the brokers or dealers against the actual prices at which the Company purchases and sells its investments. Based on the results of the benchmark analysis and the experience of the Company’s management in purchasing and selling these investments, the Company believes that these quotes are reliable indicators of fair value. The Company may also use other methods to determine fair value for securities for which it cannot obtain market quotations through brokers or dealers, including the use of an independent valuation firm. The Company’s valuation committee and board of directors review and approve the valuation determinations made with respect to these investments in a manner consistent with the Company’s valuation process.
The value of the total return swap, or TRS, was primarily based on the increase or decrease in the value of the loans underlying the TRS, as determined by the Company. The loans underlying the TRS were valued in the same manner as loans owned by the Company. As in all cases, the level in the fair value hierarchy for each instrument is determined based on the lowest level of inputs that are significant to the fair value measurement. The Company classified the TRS as Level 3 within the fair value hierarchy based on the lowest level of significant inputs. For additional information on the TRS, see Note 7.
Revenue Recognition
Securities transactions are accounted for on the trade date. The Company records interest and dividend income on an accrual basis beginning on the trade settlement date or the ex-dividend date, respectively, to the extent that the Company expects to collect such amounts.  For investments in equity tranches of collateralized loan obligations, the Company records income based on the effective interest rate determined using the amortized cost and estimated cash flows, which is updated periodically. Loan origination fees, original issue discounts, and market discounts/premiums are recorded and such amounts are amortized as adjustments to interest income over the respective term of the loan using the effective interest method. The Company records prepayments on loans and debt securities as interest income when it receives such amounts. In addition, the Company may generate revenue in the form of commitment, amendment, structuring or diligence fees, monitoring fees, fees for providing managerial assistance and possibly consulting fees and performance-based fees. Any such fees generated in connection with investments are recognized when earned.

25

CĪON Investment Corporation
Notes to Consolidated Financial Statements (unaudited)
March 31, 2018
(in thousands, except share and per share amounts)

The Company may have investments in its investment portfolio that contain a PIK interest provision. PIK interest is accrued as interest income if the portfolio company valuation indicates that such PIK interest is collectible and recorded as interest receivable up to the interest payment date. On the interest payment dates, the Company will capitalize the accrued interest receivable attributable to PIK as additional principal due from the borrower. Additional PIK securities typically have the same terms, including maturity dates and interest rates, as the original securities. In order to maintain RIC status, substantially all of this income must be paid out to shareholders in the form of distributions, even if the Company has not collected any cash. For additional information on investments that contain a PIK interest provision, see the consolidated schedules of investments as of March 31, 2018 and December 31, 2017.
Loans and debt securities, including those that are individually identified as being impaired under Accounting Standards Codification 310, Receivables, or ASC 310, are generally placed on non-accrual status immediately if, in the opinion of management, principal or interest is not likely to be paid in accordance with the terms of the debt agreement, or when principal or interest is past due 90 days or more. Interest accrued but not collected at the date a loan or security is placed on non-accrual status is reversed against interest income. Interest income is recognized on non-accrual loans or debt securities only to the extent received in cash. However, where there is doubt regarding the ultimate collectibility of principal, cash receipts, whether designated as principal or interest, are thereafter applied to reduce the carrying value of the loan or debt security. Loans or securities are restored to accrual status only when interest and principal payments are brought current and future payments are reasonably assured.
Net Realized Gains or Losses and Net Change in Unrealized Appreciation or Depreciation
Gains or losses on the sale and repayment of investments are calculated by using the weighted-average method. The Company measures realized gains or losses by the difference between the net proceeds from the repayment or sale and the weighted-average amortized cost of the investment, without regard to unrealized appreciation or depreciation previously recognized, but considering unamortized upfront fees. Net change in unrealized appreciation or depreciation reflects the change in portfolio investment values during the reporting period, including any reversal of previously recorded unrealized appreciation or depreciation when gains or losses are realized.
Derivative Instrument
The Company recognizes all derivative instruments as assets or liabilities at fair value in its consolidated financial statements. Derivative contracts entered into by the Company are not designated as hedging instruments, and as a result, the Company presents changes in fair value through current period earnings.
Derivative instruments are measured in terms of the notional contract amount and derive their value based upon one or more underlying instruments. Derivative instruments are subject to various risks similar to non-derivative instruments including market, credit, liquidity and operational risks. For additional information on the Company's derivative instruments, see Note 7.
Capital Gains Incentive Fee
Pursuant to the terms of the investment advisory agreement the Company entered into with CIM, the incentive fee on capital gains earned on liquidated investments of the Company’s investment portfolio during operations is determined and payable in arrears as of the end of each calendar year. Such fee equals 20% of the Company’s incentive fee capital gains (i.e., the Company’s realized capital gains on a cumulative basis from inception, calculated as of the end of each calendar year, computed net of all realized capital losses and unrealized capital depreciation on a cumulative basis), less the aggregate amount of any previously paid capital gains incentive fees. On a cumulative basis and to the extent that all realized capital losses and unrealized capital depreciation exceed realized capital gains as well as the aggregate realized net capital gains for which a fee has previously been paid, the Company would not be required to pay CIM a capital gains incentive fee. On a quarterly basis, the Company accrues for the capital gains incentive fee by calculating such fee as if it were due and payable as of the end of such period.
CIM did not take any incentive fees with respect to the Company’s TRS. For purposes of computing the capital gains incentive fee, CIM became entitled to a capital gains incentive fee upon the termination of the TRS, at which point all gains and losses of the underlying loans constituting the reference assets of the TRS were realized. However, realized losses exceeded realized gains on the underlying loans, resulting in no capital gains incentive fees on the TRS. Any net unrealized gains on the TRS were reflected in total assets on the Company’s consolidated balance sheets and included in the computation of the base management fee. Any net unrealized losses on the TRS were reflected in total liabilities on the Company’s consolidated balance sheets and excluded in the computation of the base management fee.
While the investment advisory agreement with CIM neither includes nor contemplates the inclusion of unrealized gains in the calculation of the capital gains incentive fee, pursuant to an interpretation of the American Institute for Certified Public Accountants, or AICPA, Technical Practice Aid for investment companies, the Company accrues capital gains incentive fees on unrealized gains. This accrual reflects the incentive fees that would be payable to CIM if the Company’s entire investment portfolio was liquidated at its fair value as of the balance sheet date even though CIM is not entitled to an incentive fee with respect to unrealized gains unless and until such gains are actually realized.

26

CĪON Investment Corporation
Notes to Consolidated Financial Statements (unaudited)
March 31, 2018
(in thousands, except share and per share amounts)

Net Increase in Net Assets per Share
Net increase in net assets per share is calculated based upon the daily weighted average number of shares of common stock outstanding during the reporting period.
Distributions
Distributions to shareholders are recorded as of the record date. The amount paid as a distribution is declared by the Company's co-chief executive officers and ratified by the board of directors on a quarterly basis. Net realized capital gains, if any, are distributed at least annually.
Note 3. Share Transactions
The Company’s initial continuous public offering commenced on July 2, 2012 and ended on December 31, 2015. The Company’s follow-on continuous public offering commenced on January 25, 2016 and will continue until no later than January 25, 2019.
The following table summarizes transactions with respect to shares of the Company’s common stock during the three months ended March 31, 2018 and 2017:
 
Three Months Ended
March 31,
 
2018
 
2017
 
Shares
 
Amount
 
Shares
 
Amount
Gross shares/proceeds from the offering
1,265,970

 
$
12,137

 
1,308,726

 
$
12,383

Reinvestment of distributions
1,075,747

 
9,844

 
1,088,626

 
9,926

Total gross shares/proceeds
2,341,717

 
21,981

 
2,397,352

 
22,309

Sales commissions and dealer manager fees

 
(471
)
 

 
(448
)
    Net shares/proceeds
2,341,717

 
21,510

 
2,397,352

 
21,861

Share repurchase program
(2,014,536
)
 
(18,379
)
 
(814,223
)
 
(7,370
)
    Net shares/proceeds from share transactions
327,181

 
$
3,131

 
1,583,129

 
$
14,491

During the three months ended March 31, 2018 and 2017, the Company sold 2,341,717 and 2,397,352 shares, respectively, at an average price per share of $9.39 and $9.31, respectively.
Since commencing its initial continuous public offering on July 2, 2012 and through March 31, 2018, the Company sold 116,108,932 shares of common stock for net proceeds of $1,178,452 at an average price per share of $10.15. The net proceeds include gross proceeds received from reinvested shareholder distributions of $133,976, for which the Company issued 14,699,524 shares of common stock, and gross proceeds paid for shares of common stock tendered for repurchase of $84,200, for which the Company repurchased 9,276,383 shares of common stock.
During the period from April 1, 2018 to May 10, 2018, the Company sold 737,563 shares of common stock pursuant to its follow-on continuous public offering for gross proceeds of $7,033 at an average price per share of $9.54. The Company also received gross proceeds of $3,008 from reinvested shareholder distributions, for which the Company issued 329,075 shares of common stock, and gross proceeds paid for shares of common stock tendered for repurchase of $21,525, for which the Company repurchased 2,352,580 shares of common stock.

The Company has temporarily suspended the sale of shares of its common stock while it engages with the SEC to have declared effective a post-effective amendment to the Company’s registration statement. The Company is currently working with the SEC to have its registration statement declared effective as promptly as practicable.
Since commencing its initial continuous public offering on July 2, 2012 and through May 10, 2018, the Company sold 114,822,990 shares of common stock for net proceeds of $1,166,968 at an average price per share of $10.16. The net proceeds include gross proceeds received from reinvested shareholder distributions of $136,984, for which the Company issued 15,028,599 shares of common stock, and gross proceeds paid for shares of common stock tendered for repurchase of $105,725, for which the Company repurchased 11,628,963 shares of common stock.
To ensure that the offering price per share, net of sales commissions and dealer manager fees, equaled or exceeded the net asset value per share on each subscription closing date and distribution reinvestment date, certain of the Company’s directors increased the offering price per share of common stock on certain dates. Due to a decline in the Company’s net asset value per share to an amount more than 2.5% below the Company’s then-current net offering price, certain of the Company’s directors decreased the offering price per share of common stock on certain dates.  

27

CĪON Investment Corporation
Notes to Consolidated Financial Statements (unaudited)
March 31, 2018
(in thousands, except share and per share amounts)

The changes to our offering price per share since the commencement of our initial continuous public offering and the associated approval and effective dates of such changes were as follows:
Approval Date
 
Effective Date
 
New Offering Price Per Share
December 28, 2012
 
January 2, 2013
 
$10.04
January 31, 2013
 
February 1, 2013
 
$10.13
March 14, 2013
 
March 18, 2013
 
$10.19
May 15, 2013
 
May 16, 2013
 
$10.24
August 15, 2013
 
August 16, 2013
 
$10.32
February 4, 2014
 
February 5, 2014
 
$10.45
October 6, 2015
 
October 7, 2015
 
$10.20
November 24, 2015
 
November 25, 2015
 
$10.05
December 22, 2015
 
December 23, 2015
 
$9.95
March 8, 2016
 
March 9, 2016
 
$9.40
March 15, 2016
 
March 16, 2016
 
$9.45
March 22, 2016
 
March 23, 2016
 
$9.50
March 29, 2016
 
March 30, 2016
 
$9.55
April 5, 2016
 
April 6, 2016
 
$9.60
April 26, 2016
 
April 27, 2016
 
$9.65
May 3, 2016
 
May 4, 2016
 
$9.70
May 10, 2016
 
May 11, 2016
 
$9.75
May 31, 2016
 
June 1, 2016
 
$9.80
July 19, 2016
 
July 20, 2016
 
$9.85
July 26, 2016
 
July 27, 2016
 
$9.90
August 9, 2016
 
August 10, 2016
 
$9.95
August 23, 2016
 
August 24, 2016
 
$10.00
October 4, 2016
 
October 5, 2016
 
$10.05
October 11, 2016
 
October 12, 2016
 
$10.10
January 3, 2017
 
January 4, 2017
 
$9.57(1)
January 24, 2017
 
January 25, 2017
 
$9.60
March 7, 2017
 
March 8, 2017
 
$9.65
August 22, 2017
 
August 23, 2017
 
$9.70
(1)
On December 28, 2016, the Company entered into an amended and restated follow-on dealer manager agreement pursuant to which, among other things, the dealer manager fee was reduced to up to 2% and selling commissions were reduced to up to 3%. As a result, the Company adjusted its public offering price from $10.10 per share to $9.57 per share in order to maintain its net offering price of $9.09 per share (net of selling commissions and dealer manager fees).
Share Repurchase Program
On a quarterly basis, the Company offers, and intends to continue offering, to repurchase shares on such terms as may be determined by the Company’s board of directors in its complete and absolute discretion unless, in the judgment of the independent directors of the Company’s board of directors, such repurchases would not be in the best interests of the Company’s shareholders or would violate applicable law.

28

CĪON Investment Corporation
Notes to Consolidated Financial Statements (unaudited)
March 31, 2018
(in thousands, except share and per share amounts)

The Company limits the number of shares to be repurchased during any calendar year to the number of shares it can repurchase with the proceeds it receives from the issuance of shares pursuant to its fifth amended and restated distribution reinvestment plan. At the discretion of the Company’s board of directors, it may also use cash on hand, cash available from borrowings and cash from liquidation of investments as of the end of the applicable period to repurchase shares. In addition, the Company limits the number of shares to be repurchased in any calendar year to 15% of the weighted average number of shares outstanding in the prior calendar year, or 3.75% in each quarter, though the actual number of shares that it offers to repurchase may be less in light of the limitations noted above. The Company currently offers to repurchase such shares at a price equal to the estimated net asset value per share on each date of repurchase.

On January 22, 2016, the Company further amended the terms of the quarterly share repurchase program, effective as of the Company’s quarterly repurchase offer for the first quarter of 2016, which commenced in February 2016 and was completed in April 2016. Under the further amended share repurchase program, the Company offered to repurchase shares of common stock at a price equal to 90% of the public offering price in effect on each date of repurchase.
On December 8, 2016, the Company further amended the terms of the quarterly share repurchase program, effective as of the Company's quarterly repurchase offer for the fourth quarter of 2016, which commenced in November 2016 and was completed in January 2017. Under the further amended share repurchase program, the Company will offer to repurchase shares of common stock at a price equal to the estimated net asset value per share determined on each date of repurchase.
Any periodic repurchase offers are subject in part to the Company’s available cash and compliance with the BDC and RIC qualification and diversification rules promulgated under the 1940 Act and the Code, respectively. While the Company conducts quarterly tender offers as described above, it is not required to do so and may suspend or terminate the share repurchase program at any time, upon 30 days’ notice.
The following table summarizes the share repurchases completed during the three months ended March 31, 2018:
Three Months Ended
 
Repurchase Date
 
Shares Repurchased
 
Percentage of Shares Tendered That Were Repurchased
 
Repurchase Price Per Share
 
Aggregate Consideration for Repurchased Shares
March 31, 2018
 
January 3, 2018
 
2,014,536

 
100
%
 
9.12

 
$
18,379

   Total
 
 
 
2,014,536

 
 
 
 
 
$
18,379

Note 4. Transactions with Related Parties
For the three months ended March 31, 2018 and 2017, fees and other expenses incurred by the Company related to CIM and its affiliates were as follows:
 
 
 
 
 
 
Three Months Ended
March 31,
Entity
 
Capacity
 
Description
 
2018
 
2017
CION Securities, LLC
 
Dealer manager
 
Dealer manager fees(1)
 
$
218

 
$
210

CIM
 
Investment adviser
 
Management fees(2)
 
7,939

 
6,482

ICON Capital, LLC
 
Administrative services provider
 
Administrative services expense(2)
 
461

 
346

 
 
 
 
 
 
$
8,618

 
$
7,038

(1)
Amounts charged directly to equity.
(2)
Amounts charged directly to operations.
On December 28, 2016, the Company entered into an amended and restated follow-on dealer manager agreement with CIM and CION Securities, LLC (formerly, ICON Securities, LLC), or CION Securities, in connection with the Company's follow-on continuous public offering. Under the amended and restated dealer manager agreement, the dealer manager fee was reduced from up to 3% to up to 2% of gross offering proceeds and selling commissions to the selling dealers were reduced from up to 7% to up to 3% of gross offering proceeds. Such costs are charged against capital in excess of par value when incurred. Since commencing its initial continuous public offering on July 2, 2012 and through May 10, 2018, the Company paid or accrued sales commissions of $64,845 to the selling dealers and dealer manager fees of $32,305 to CION Securities. 

29

CĪON Investment Corporation
Notes to Consolidated Financial Statements (unaudited)
March 31, 2018
(in thousands, except share and per share amounts)

The Company has entered into an investment advisory agreement with CIM. On November 1, 2017, the board of directors of the Company, including a majority of the board of directors who are not interested persons, approved the renewal of the investment advisory agreement for a period of twelve months commencing December 17, 2017.  Pursuant to the investment advisory agreement, CIM is paid an annual base management fee equal to 2.0% of the average value of the Company’s gross assets, less cash and cash equivalents, and an incentive fee based on the Company’s performance, as described below. The base management fee is payable quarterly in arrears and is calculated based on the two most recently completed calendar quarters. The incentive fee consists of two parts. The first part, which is referred to as the subordinated incentive fee on income, is calculated and payable quarterly in arrears based on “pre-incentive fee net investment income” for the immediately preceding quarter and is subject to a hurdle rate, measured quarterly and expressed as a rate of return on adjusted capital, as defined in the investment advisory agreement, equal to 1.875% per quarter, or an annualized rate of 7.5%. For the three months ended March 31, 2018 and 2017, the Company had no liability for and did not record any subordinated incentive fees on income. The second part of the incentive fee, which is referred to as the incentive fee on capital gains, is described in Note 2. 

The Company accrues the capital gains incentive fee based on net realized gains and net unrealized appreciation; however, under the terms of the investment advisory agreement, the fee payable to CIM is based on net realized gains and unrealized depreciation and no such fee is payable with respect to unrealized appreciation unless and until such appreciation is actually realized. For the three months ended March 31, 2018 and 2017, the Company had no liability for and did not record any capital gains incentive fees.

With respect to the TRS, CIM became entitled to receive a capital gains incentive fee upon the termination of the TRS, at which point all net gains and losses of the underlying loans constituting the reference assets of the TRS were realized. However, CIM did not take any incentive fees with respect to the Company’s TRS as realized losses exceeded realized gains on the underlying loans upon termination. See Note 2 for an additional discussion of CIM's entitlement to receive payment of incentive fees.

The Company entered into an administration agreement with CIM’s affiliate, ICON Capital, LLC, or ICON Capital, pursuant to which ICON Capital furnishes the Company with administrative services including accounting, investor relations and other administrative services necessary to conduct its day-to-day operations. ICON Capital is reimbursed for administrative expenses it incurs on the Company’s behalf in performing its obligations, provided that such reimbursement will be for the lower of ICON Capital’s actual costs or the amount that the Company would be required to pay for comparable administrative services in the same geographic location. Such costs will be reasonably allocated to the Company on the basis of assets, revenues, time records or other reasonable methods. The Company will not reimburse ICON Capital for any services for which it receives a separate fee or for rent, depreciation, utilities, capital equipment or other administrative items allocated to a person with a controlling interest in ICON Capital. On November 1, 2017, the board of directors of the Company, including a majority of the board of directors who are not interested persons, approved the renewal of the administration agreement for a period of twelve months commencing December 17, 2017.

On April 1, 2018, the Company entered into an administration agreement with CIM for the purpose of replacing ICON Capital with CIM as the Company's administrator pursuant to the terms of the administration agreement. No other material terms of the administration agreement with ICON Capital were amended in connection with the administration agreement with CIM.

Under the terms of the investment advisory agreement, CIM and certain of its affiliates, which includes CIG, are entitled to receive reimbursement of up to 1.5% of the gross proceeds raised until all offering and organizational costs have been reimbursed. The Company’s payment of offering and organizational costs will not exceed 1.5% of the actual gross proceeds raised from the offerings (without giving effect to any potential expense support from CIG and its affiliates, which includes CIM). If the Company sells the maximum number of shares at its latest public offering price of $9.70 per share, the Company estimates that it may incur up to approximately $29,888 of expenses. With respect to any reimbursements for offering and organizational costs, the Company will interpret the 1.5% limit based on actual gross proceeds raised at the time of such reimbursement.  In addition, the Company will not issue any of its shares or other securities for services or for property other than cash or securities except as a dividend or distribution to its security holders or in connection with a reorganization. 
From inception through December 31, 2012, CIG and its affiliates incurred offering, organizational and other pre-effective costs of $2,012. Of these costs, $1,812 represented offering and organizational costs, all of which were submitted to the Company for reimbursement. The Company paid $450 in October 2013, $550 in March 2014, $592 in May 2014 and $420 in March 2015.  No additional material offering, organizational or other pre-effective costs have been incurred by CIG or its affiliates subsequent to December 31, 2012.
Reinvestment of shareholder distributions and share repurchases are excluded from the gross proceeds from the Company’s offerings for purposes of determining the total amount of offering and organizational costs that can be paid by the Company. As of March 31, 2018, the Company raised gross offering proceeds of $1,128,676, of which it can pay up to $16,930 in offering and organizational costs (which represents 1.5% of the actual gross offering proceeds raised). Through March 31, 2018, the Company paid $10,147 of such costs, leaving an additional $6,783 that can be paid. As of May 10, 2018, the Company raised gross offering proceeds of $1,135,709, of which it can pay up to $17,036 in offering and organizational costs (which represents 1.5% of the actual gross offering proceeds raised). Through May 10, 2018, the Company paid $10,217 of such costs, leaving an additional $6,819 that can be paid.

30

CĪON Investment Corporation
Notes to Consolidated Financial Statements (unaudited)
March 31, 2018
(in thousands, except share and per share amounts)

On January 30, 2013, the Company entered into the expense support and conditional reimbursement agreement with CIG, whereby CIG agreed to provide expense support to the Company in an amount that is sufficient to: (1) ensure that no portion of the Company’s distributions to shareholders will be paid from its offering proceeds or borrowings, and/or (2) reduce the Company’s operating expenses until it has achieved economies of scale sufficient to ensure that it bears a reasonable level of expense in relation to its investment income. On December 13, 2013 and January 16, 2015, the Company and CIG amended the expense support and conditional reimbursement agreement to extend the termination date of such agreement from January 30, 2014 to January 30, 2015 and from January 30, 2015 to December 31, 2015, respectively. On December 16, 2015 and December 14, 2016, the Company further amended and restated the expense support and conditional reimbursement agreement for purposes of including AIM as a party to the agreement and extending the termination date from December 31, 2016 to December 31, 2017, respectively. On January 2, 2018, the Company entered into an expense support and conditional reimbursement agreement with CIM for purposes of (i) replacing CIG and AIM with CIM as the expense support provider pursuant to the terms of the expense support and conditional reimbursement agreement; and (ii) extending the termination date to December 31, 2018.

For the three months ended March 31, 2018, the Company did not receive any expense support from CIM. For the three months ended March 31, 2017, the Company did not receive any expense support from CIG or AIM. See Note 5 for additional information on the sources of the Company’s distributions.
Pursuant to the expense support and conditional reimbursement agreement, the Company will have a conditional obligation to reimburse CIM for any amounts funded by CIM under such agreement (i) if expense support amounts funded by CIM exceed operating expenses incurred during any fiscal quarter, (ii) if the sum of the Company’s net investment income for tax purposes, net capital gains and the amount of any dividends and other distributions paid to the Company on account of investments in portfolio companies (to the extent not included in net investment income or net capital gains for tax purposes) exceeds the distributions paid by the Company to shareholders, and (iii) during any fiscal quarter occurring within three years of the date on which CIM funded such amount. The obligation to reimburse CIM for any expense support provided by CIM under such agreement is further conditioned by the following: (i) in the period in which reimbursement is sought, the ratio of operating expenses to average net assets, when considering the reimbursement, cannot exceed the ratio of operating expenses to average net assets, as defined, for the period when the expense support was provided; (ii) in the period when reimbursement is sought, the annualized distribution rate cannot fall below the annualized distribution rate for the period when the expense support was provided; and (iii) the expense support can only be reimbursed within three years from the date the expense support was provided.
Expense support, if any, will be determined as appropriate to meet the objectives of the expense support and conditional reimbursement agreement. The Company did not record any obligation to repay expense support from CIG or CIM during the three months ended March 31, 2017 or 2018, respectively. The Company did not repay any expense support to CIG or CIM during the three months ended March 31, 2017 or 2018. The Company may or may not be requested to reimburse any expense support provided in the future.
The Company or CIM may terminate the expense support and conditional reimbursement agreement at any time. CIM has indicated that it expects to continue such expense support until it believes that the Company has achieved economies of scale sufficient to ensure that it bears a reasonable level of expenses in relation to its income. If the Company terminates the investment advisory agreement with CIM, the Company may be required to repay all unreimbursed expense support funded by CIM within three years of the date of termination. There will be no acceleration or increase of such repayment obligation at termination of the investment advisory agreement with CIM. The specific amount of expense support provided by CIM, if any, will be determined at the end of each quarter. There can be no assurance that the expense support and conditional reimbursement agreement will remain in effect or that CIM will support any portion of the Company’s expenses in future quarters.
As of March 31, 2018 and December 31, 2017, the total liability payable to CIM and its affiliates was $8,062 and $11,603, respectively, which primarily related to fees earned by CIM during the three months ended March 31, 2018 and December 31, 2017, respectively.
Because CIM’s senior management team is comprised of substantially the same personnel as the senior management team of the Company’s affiliate, ICON Capital, which is the investment manager to certain equipment finance funds, or equipment funds, such members of senior management provide investment advisory and management services to the equipment funds in addition to the Company. In the event that CIM undertakes to provide investment advisory services to other clients in the future, it will strive to allocate investment opportunities in a fair and equitable manner consistent with the Company’s investment objective and strategies so that the Company will not be disadvantaged in relation to any other client of the investment adviser or its senior management team. However, it is currently possible that some investment opportunities will be provided to the equipment funds or other clients of CIM rather than to the Company.
Indemnifications
The investment advisory agreement, the administration agreement and the dealer manager agreement each provide certain indemnifications from the Company to the other relevant parties to such agreements. The Company’s maximum exposure under these agreements is unknown. However, the Company has not experienced claims or losses pursuant to these agreements and believes the risk of loss related to such indemnifications to be remote. 

31

CĪON Investment Corporation
Notes to Consolidated Financial Statements (unaudited)
March 31, 2018
(in thousands, except share and per share amounts)

Note 5. Distributions
From February 1, 2014 through July 17, 2017, the Company’s board of directors authorized and declared on a monthly basis a weekly distribution amount per share of common stock. On July 18, 2017, the Company's board of directors authorized and declared on a quarterly basis a weekly distribution amount per share of common stock. Effective September 28, 2017, the Company's board of directors delegated to management the authority to determine the amount, record dates, payment dates and other terms of distributions to shareholders, which will be ratified by the board of directors, each on a quarterly basis. Declared distributions are paid monthly.
    
The Company’s board of directors declared or ratified distributions for 52 and 13 record dates during the year ended December 31, 2017 and the three months ended March 31, 2018, respectively.
The following table presents cash distributions per share that were declared during the year ended December 31, 2017 and the three months ended March 31, 2018:
 
 
Distributions
Three Months Ended
 
Per Share
 
Amount
2017
 
 
 
 
March 31, 2017 (thirteen record dates)
 
$
0.1829

 
$
20,123

June 30, 2017 (thirteen record dates)
 
0.1829

 
20,371

September 30, 2017 (thirteen record dates)
 
0.1829

 
20,644

December 31, 2017 (thirteen record dates)
 
0.1829

 
20,923

Total distributions for the year ended December 31, 2017
 
$
0.7316

 
$
82,061

 
 
 
 
 
2018
 
 
 
 
March 31, 2018 (thirteen record dates)
 
$
0.1829

 
$
21,002

Total distributions for the three months ended March 31, 2018
 
$
0.1829

 
$
21,002

    
On March 29, 2018, the Company's co-chief executive officers declared regular weekly cash distributions of $0.014067 per share for April 2018 through June 2018. On May 3, 2018, the Company's board of directors ratified the distributions declared for March 2018 and April 2018. Each distribution was or will be paid monthly to shareholders of record as of the weekly record dates set forth below.
Record Date
 
Payment Date
 
Distribution Amount Per Share
April 3, 2018
 
April 25, 2018
 
$0.014067
April 10, 2018
 
April 25, 2018
 
$0.014067
April 17, 2018
 
April 25, 2018
 
$0.014067
April 24, 2018
 
April 25, 2018
 
$0.014067
May 1, 2018
 
May 30, 2018
 
$0.014067
May 8, 2018
 
May 30, 2018
 
$0.014067
May 15, 2018
 
May 30, 2018
 
$0.014067
May 22, 2018
 
May 30, 2018
 
$0.014067
May 29, 2018
 
May 30, 2018
 
$0.014067
June 5, 2018
 
June 27, 2018
 
$0.014067
June 12, 2018
 
June 27, 2018
 
$0.014067
June 19, 2018
 
June 27, 2018
 
$0.014067
June 26, 2018
 
June 27, 2018
 
$0.014067

The Company has adopted an “opt in” distribution reinvestment plan for shareholders. As a result, if the Company makes a distribution, shareholders will receive distributions in cash unless they specifically “opt in” to the fifth amended and restated distribution reinvestment plan so as to have their cash distributions reinvested in additional shares of the Company’s common stock.

32

CĪON Investment Corporation
Notes to Consolidated Financial Statements (unaudited)
March 31, 2018
(in thousands, except share and per share amounts)

On January 22, 2016, the Company further amended and restated its distribution reinvestment plan pursuant to the fourth amended and restated distribution reinvestment plan, or the Fourth Amended DRIP.  The Fourth Amended DRIP became effective as of, and first applied to the reinvestment of cash distributions paid on, March 30, 2016. Under the Fourth Amended DRIP, cash distributions to participating shareholders were reinvested in additional shares of common stock at a purchase price equal to 90% of the public offering price per share in effect as of the date of issuance.

On December 8, 2016, the Company further amended and restated its distribution reinvestment plan pursuant to the fifth amended and restated distribution reinvestment plan, or the Fifth Amended DRIP. The Fifth Amended DRIP became effective as of, and first applied to the reinvestment of cash distributions paid on, February 1, 2017.  Under the Fifth Amended DRIP, cash distributions to participating shareholders will be reinvested in additional shares of common stock at a purchase price equal to the estimated net asset value per share of common stock as of the date of issuance.

The Company may fund its cash distributions to shareholders from any sources of funds available to the Company, including offering proceeds, borrowings, net investment income from operations, capital gains proceeds from the sale of assets, non-capital gains proceeds from the sale of assets, dividends or other distributions paid to it on account of preferred and common equity investments in portfolio companies and expense support from CIM, which is subject to repayment by the Company within three years. The Company has not established limits on the amount of funds it may use from available sources to make distributions. For the three months ended March 31, 2018, none of the Company's distributions resulted from expense support from CIM. For the years ended December 31, 2015, 2016 and 2017, none of the Company's distributions resulted from expense support from CIG or AIM. The purpose of this arrangement is to avoid such distributions being characterized as a return of capital. Shareholders should understand that any such distributions are not based on the Company’s investment performance, and can only be sustained if the Company achieves positive investment performance in future periods and/or CIM provides such expense support. Shareholders should also understand that the Company’s future repayments of expense support will reduce the distributions that they would otherwise receive. There can be no assurance that the Company will achieve such performance in order to sustain these distributions, or be able to pay distributions at all. CIM has no obligation to provide expense support to the Company in future periods.
The following table reflects the sources of cash distributions on a GAAP basis that the Company has declared on its shares of common stock during the three months ended March 31, 2018 and 2017:
 
 
Three Months Ended
March 31,
 
 
2018
 
2017
Source of Distribution
 
Per Share
 
Amount
 
Percentage
 
Per Share
 
Amount
 
Percentage
Net investment income
 
$
0.1646

 
$
18,905

 
90.0
%
 
$
0.1390

 
$
15,289

 
76.0
%
Net realized gain on total return swap
 
 
 
 
 
 
 
 
 
 
 
 
   Net interest and other income from TRS portfolio
 

 

 

 
0.0301

 
3,316

 
16.5
%
   Net gain on TRS loan sales(1)
 

 

 

 
0.0058

 
634

 
3.1
%
Net realized gain on investments and foreign currency
 
0.0183

 
2,097

 
10.0
%
 
0.0080

 
884

 
4.4
%
Total distributions
 
$
0.1829

 
$
21,002

 
100.0
%
 
$
0.1829

 
$
20,123

 
100.0
%
(1)
During the three months ended March 31, 2017, the Company realized losses of $21,146 primarily due to the purchase of loans by Flatiron Funding II that were previously held in the TRS and were not deductible on a tax-basis during the period. See Note 8 for an additional discussion regarding this purchase.
It is the Company's policy to comply with all requirements of the Code applicable to RICs and to distribute substantially all of its taxable income to its shareholders. In addition, by distributing during each calendar year substantially all of its net investment income, net realized capital gains and certain other amounts, if any, the Company intends not to be subject to corporate level federal income tax or federal excise taxes. Accordingly, no federal income tax provision was required for the year ended December 31, 2017.
Income and capital gain distributions are determined in accordance with the Code and federal tax regulations, which may differ from amounts determined in accordance with GAAP. These book/tax differences, which could be material, are primarily due to differing treatments of income and gains on various investments held by the Company. Permanent book/tax differences result in reclassifications to capital in excess of par value, accumulated undistributed net investment income and accumulated undistributed realized gain on investments. During 2017, book/tax differences were primarily due to differing treatments of income and gains on various investments held by the Company. Permanent book/tax differences result in reclassifications to capital in excess of par value, accumulated undistributed net investment income and accumulated undistributed realized gain on investments.

33

CĪON Investment Corporation
Notes to Consolidated Financial Statements (unaudited)
March 31, 2018
(in thousands, except share and per share amounts)

The determination of the tax attributes of the Company’s distributions is made annually as of the end of the Company’s fiscal year based upon the Company’s taxable income for the full year and distributions paid for the full year. The tax characteristics of distributions to shareholders are reported to shareholders annually on Form 1099-DIV. Except for long term capital gains of $927, all distributions for 2017 were characterized as ordinary income distributions for federal income tax purposes.

The tax components of accumulated earnings for the current year will be determined at year end. As of December 31, 2017, the components of accumulated earnings on a tax basis were as follows:
 
December 31, 2017
Undistributed ordinary income
$
10,508

Accumulated losses
(3,354
)
Undistributed long term capital gains

Net unrealized depreciation on investments and total return swap
(24,568
)
Total accumulated earnings
$
(17,414
)
As of March 31, 2018, the aggregate gross unrealized appreciation for all securities in which there was an excess of value over tax cost was $25,301; the aggregate gross unrealized depreciation for all securities in which there was an excess of tax cost over value was $52,338; the net unrealized depreciation was $27,037; and the aggregate cost of securities for Federal income tax purposes was $1,788,553.
As of December 31, 2017, the aggregate gross unrealized appreciation for all securities in which there was an excess of value over tax cost was $23,910; the aggregate gross unrealized depreciation for all securities in which there was an excess of tax cost over value was $48,478; the net unrealized depreciation was $24,568; and the aggregate cost of securities for Federal income tax purposes was $1,738,763.
Note 6. Investments
The composition of the Company’s investment portfolio as of March 31, 2018 and December 31, 2017 at amortized cost and fair value was as follows:
 
 
March 31, 2018
 
December 31, 2017
 
 
Cost(1)
 
Fair
Value
 
Percentage of
Investment
Portfolio
 
Cost(1)
 
Fair
Value
 
Percentage of
Investment
Portfolio
Senior secured first lien debt
 
$
1,153,204

 
$
1,160,746

 
73.4
%
 
$
1,088,512

 
$
1,100,336

 
73.0
%
Senior secured second lien debt
 
361,671

 
354,061

 
22.4
%
 
342,906

 
333,944

 
22.1
%
Collateralized securities and structured products - debt
 
22,052

 
22,380

 
1.4
%
 
25,411

 
25,289

 
1.7
%
Collateralized securities and structured products - equity
 
19,675

 
18,731

 
1.2
%
 
19,833

 
18,525

 
1.2
%
Unsecured debt
 

 

 

 
7,653

 
7,639

 
0.5
%
Equity
 
23,474

 
24,503

 
1.6
%
 
21,538

 
21,915

 
1.5
%
Subtotal/total percentage
 
1,580,076

 
1,580,421

 
100.0
%
 
1,505,853

 
1,507,648

 
100.0
%
Short term investments(2)
 
181,095

 
181,095

 
 
 
206,547

 
206,547

 
 
Total investments
 
$
1,761,171

 
$
1,761,516

 
 
 
$
1,712,400

 
$
1,714,195

 
 
(1)
Cost represents the original cost adjusted for the amortization of premiums and/or accretion of discounts, as applicable, for debt investments and cost for equity investments.
(2)
Short term investments represent an investment in a fund that invests in highly liquid investments with average original maturity dates of three months or less.

34

CĪON Investment Corporation
Notes to Consolidated Financial Statements (unaudited)
March 31, 2018
(in thousands, except share and per share amounts)

The following tables show the composition of the Company’s investment portfolio by industry classification and geographic dispersion, and the percentage, by fair value, of the total investment portfolio assets in such industries and geographies as of March 31, 2018 and December 31, 2017:
 
 
March 31, 2018
 
December 31, 2017
Industry Classification
 
Investments at
Fair Value
 
Percentage of
Investment Portfolio
 
Investments at
Fair Value
 
Percentage of
Investment Portfolio
Healthcare & Pharmaceuticals
 
$
269,418

 
17.0
%
 
$
255,608

 
17.0
%
High Tech Industries
 
171,458

 
10.8
%
 
194,902

 
12.9
%
Services: Business
 
149,753

 
9.5
%
 
195,251

 
13.0
%
Media: Advertising, Printing & Publishing
 
131,460

 
8.3
%
 
65,795

 
4.4
%
Media: Diversified & Production
 
118,845

 
7.5
%
 
117,896

 
7.8
%
Consumer Goods: Durable
 
77,821

 
4.9
%
 
60,863

 
4.0
%
Chemicals, Plastics & Rubber
 
74,979

 
4.7
%
 
82,981

 
5.5
%
Telecommunications
 
60,229

 
3.8
%
 
58,891

 
3.9
%
Capital Equipment
 
57,661

 
3.6
%
 
53,276

 
3.5
%
Aerospace & Defense
 
52,337

 
3.3
%
 
52,312

 
3.5
%
Services: Consumer
 
47,229

 
3.0
%
 
46,702

 
3.1
%
Banking, Finance, Insurance & Real Estate
 
43,724

 
2.8
%
 
19,857

 
1.3
%
Hotel, Gaming & Leisure
 
43,626

 
2.8
%
 
29,550

 
2.0
%
Diversified Financials
 
41,111

 
2.6
%
 
43,814

 
2.9
%
Automotive
 
40,659

 
2.6
%
 
40,565

 
2.7
%
Retail
 
35,933

 
2.3
%
 
33,319

 
2.2
%
Energy: Oil & Gas
 
34,725

 
2.2
%
 
38,397

 
2.5
%
Transportation: Cargo
 
32,694

 
2.1
%
 
32,877

 
2.2
%
Beverage, Food & Tobacco
 
32,264

 
2.0
%
 
25,631

 
1.7
%
Construction & Building
 
30,879

 
2.0
%
 
24,633

 
1.6
%
Metals & Mining
 
11,659

 
0.7
%
 
12,785

 
0.8
%
Consumer Goods: Non-Durable
 
7,210

 
0.5
%
 
7,055

 
0.5
%
Media: Broadcasting & Subscription
 
6,241

 
0.4
%
 
6,224

 
0.4
%
Forest Products & Paper
 
5,566

 
0.4
%
 
5,599

 
0.4
%
Environmental Industries
 
2,940

 
0.2
%
 
2,865

 
0.2
%
Subtotal/total percentage
 
1,580,421

 
100.0
%
 
1,507,648

 
100.0
%
Short term investments
 
181,095

 
 
 
206,547

 
 
Total investments
 
$
1,761,516

 
 
 
$
1,714,195

 
 
 
 
March 31, 2018
 
December 31, 2017
Geographic Dispersion(1)
 
Investments at
Fair Value
 
Percentage of
Investment Portfolio
 
Investments at
Fair Value
 
Percentage of
Investment Portfolio
United States
 
$
1,454,840

 
92.1
%
 
$
1,379,180

 
91.5
%
Canada
 
28,993

 
1.8
%
 
29,114

 
1.9
%
Cayman Islands
 
18,731

 
1.2
%
 
18,525

 
1.2
%
Luxembourg
 
18,707

 
1.2
%
 
18,836

 
1.2
%
Netherlands
 
18,604

 
1.2
%
 
18,317

 
1.2
%
Germany
 
16,082

 
1.0
%
 
19,231

 
1.3
%
Marshall Islands
 
9,813

 
0.6
%
 
10,012

 
0.7
%
France
 
5,662

 
0.4
%
 
5,606

 
0.4
%
Cyprus
 
5,274

 
0.3
%
 
5,137

 
0.3
%
United Kingdom
 
2,940

 
0.2
%
 
2,865

 
0.2
%
Bermuda
 
775

 
0.0
%
 
825

 
0.1
%
Subtotal/total percentage
 
1,580,421

 
100.0
%
 
1,507,648

 
100.0
%
Short term investments
 
181,095

 
 
 
206,547

 
 
Total investments
 
$
1,761,516

 
 
 
$
1,714,195

 
 
(1)
The geographic dispersion is determined by the portfolio company's country of domicile.

35

CĪON Investment Corporation
Notes to Consolidated Financial Statements (unaudited)
March 31, 2018
(in thousands, except share and per share amounts)

As of March 31, 2018 and December 31, 2017, investments on non-accrual status represented 1.3% and 1.4%, respectively, of the Company's investment portfolio on a fair value basis.
The Company’s investment portfolio may contain senior secured investments that are in the form of lines of credit, delayed draw term loans, revolving credit facilities, or unfunded commitments, which may require the Company to provide funding when requested in accordance with the terms of the underlying agreements. As of March 31, 2018 and December 31, 2017, the Company’s unfunded commitments amounted to $110,181 and $48,259, respectively. As of May 10, 2018, the Company’s unfunded commitments amounted to $173,081. Since these commitments may expire without being drawn upon, unfunded commitments do not necessarily represent future cash requirements or future earning assets for the Company.  Refer to Note 11 for further details on the Company’s unfunded commitments.
Note 7. Derivative Instruments
    
In the normal course of business and subject to the requirements of the 1940 Act, the Company enters into derivative instruments as part of its investment strategy.

Credit Default Swap

On October 14, 2016, the Company entered into a credit default swap with JPMorgan Chase Bank N.A. with a base notional amount of €22,000, to purchase protection with respect to Deutsche Bank AG exposure. As of December 31, 2016, the fair value of the credit default swap was $46. The swap terminated on March 20, 2017.

Total Return Swap

On December 17, 2012, the Company, through its wholly-owned consolidated subsidiary, Flatiron Funding, LLC, or Flatiron, entered into a TRS with Citibank, N.A., or Citibank.  Flatiron and Citibank amended the TRS on several occasions, most recently on February 18, 2017 to extend the termination or call date from February 18, 2017 to April 18, 2017. Prior to the call date, the maximum aggregate market value of the portfolio of loans subject to the TRS (determined at the time each such loan became subject to the TRS) was $800,000 and the interest rate payable by Flatiron to Citibank with respect to each loan included in the TRS was a spread of 1.40% per year over the floating rate index specified for each such loan, which would not be less than zero.  On April 18, 2017, the TRS expired in accordance with its terms. The agreements between Flatiron and Citibank, which collectively established the TRS, are referred to herein as the TRS Agreement. 

The value of the TRS was based on the increase or decrease in the value of the loans underlying the TRS, as determined by the Company. The loans underlying the TRS were valued in the same manner as loans owned by the Company.  As of December 31, 2017, Citibank returned all cash collateral to Flatiron.
Realized gains and losses on the TRS are composed of any gains or losses on loans underlying the TRS as well as net interest and fees earned during the period. For the three months ended March 31, 2018 and 2017, the net realized loss on the TRS consisted of the following:
 
 
Three Months Ended
March 31,
 
 
2018
 
2017
Interest and other income from TRS portfolio
 
$

 
$
6,082

Interest and other expense from TRS portfolio
 

 
(2,767
)
Net loss on TRS loan sales
 

 
(17,584
)
Net realized loss (1)
 
$

 
$
(14,269
)
(1)
Net realized loss is reflected in net realized loss on total return swap on the Company's consolidated statements of operations.
On March 29, 2017, Flatiron Funding II purchased certain loans underlying the TRS with a notional value of $363,860 in connection with the TRS refinancing. See Note 8 for additional information on Flatiron Funding II.

36

CĪON Investment Corporation
Notes to Consolidated Financial Statements (unaudited)
March 31, 2018
(in thousands, except share and per share amounts)

Note 8. Financing Arrangements

The following table presents summary information with respect to the Company’s outstanding financing arrangements as of March 31, 2018
Arrangement
 
Type of Arrangement
 
Rate
 
Amount Outstanding
 
Amount Available
 
Maturity Date
Citibank Credit Facility
 
Revolving Credit Facility
 
L+2.00%
 
$
324,542

 
$
458

 
March 30, 2020
JPM Credit Facility
 
Term Loan Credit Facility
 
L+3.50%
 
224,423

 
577

 
August 23, 2020
UBS Facility
 
Repurchase Agreement
 
L+3.50%
 
162,500

 
37,500

 
May 19, 2020
MS Credit Facility
 
Revolving Credit Facility
 
L+3.00%
 

 
200,000

 
December 19, 2022

Citibank Credit Facility
    
On March 29, 2017, Flatiron Funding II entered into a senior secured credit facility with Citibank. The senior secured credit facility with Citibank, or the Citibank Credit Facility, provides for a revolving credit facility in an aggregate principal amount of $325,000, subject to compliance with a borrowing base. On March 29, 2017, September 26, 2017 and November 17, 2017, Flatiron Funding II drew down $231,698, $50,000 and $42,844 of borrowings under the Citibank Credit Facility, respectively.

On July 11, 2017, Flatiron Funding II amended the Citibank Credit Facility, or the Amended Citibank Credit Facility, with Citibank to make certain immaterial administrative amendments as a result of the termination of AIM as the Company's investment sub-adviser as discussed in Note 1.

Advances under the Amended Citibank Credit Facility bear interest at a floating rate equal to (1) the higher of (a) the Citibank prime rate, (b) the federal funds rate plus 1.5% or (c) the three-month LIBOR plus 1.0%, plus (2) a spread of (a) 2% per year during the period from and including March 29, 2017 and the earlier of March 29, 2019 and the date the Amended Citibank Credit Facility matures, or (b) 3% per year during the period from the date the Amended Citibank Credit Facility matures until all obligations under the Amended Citibank Credit Facility have been paid in full. Interest is payable quarterly in arrears. All advances under the Amended Citibank Credit Facility will mature, and all accrued and unpaid interest thereunder will be due and payable, by no later than March 30, 2020. Flatiron Funding II may prepay advances pursuant to the terms and conditions of the credit and security agreement, subject to a 0.50% premium if the amount of the Amended Citibank Credit Facility is reduced or terminated on or prior to March 29, 2019. In addition, Flatiron Funding II will be subject to a non-usage fee of 0.75% per year (subject to an increase to 2% in certain circumstances) on the amount, if any, of the aggregate principal amount available under the Amended Citibank Credit Facility that has not been borrowed. The non-usage fees, if any, are payable quarterly in arrears. Flatiron Funding II incurred certain customary costs and expenses in connection with obtaining the Citibank Credit Facility.

The Company incurred debt issuance costs of $1,945 in connection with obtaining the Citibank Credit Facility, which were recorded as a direct reduction to the outstanding balance of the Amended Citibank Credit Facility, which is included in the Company’s consolidated balance sheets and will amortize to interest expense over the term of the Amended Citibank Credit Facility. At March 31, 2018, the unamortized portion of the debt issuance costs was $1,293.

Flatiron Funding II purchased loans and other corporate debt securities with a fair value of $354,967 on the closing date pursuant to master participation and assignment agreements between Flatiron Funding II and each of 15th Street Loan Funding LLC and 15th Street Loan Funding 2 LLC, each a special purpose subsidiary of Citibank. 15th Street Loan Funding LLC and 15th Street Loan Funding 2 LLC held loans and other corporate debt securities in connection with the TRS Agreement between Citibank and Flatiron. Flatiron Funding II’s obligations to Citibank under the Amended Citibank Credit Facility are secured by a first priority security interest in all of the assets of Flatiron Funding II. The obligations of Flatiron Funding II under the Amended Citibank Credit Facility are non-recourse to the Company, and the Company’s exposure under the Amended Citibank Credit Facility is limited to the value of the Company’s investment in Flatiron Funding II. 

In connection with the Amended Citibank Credit Facility, Flatiron Funding II has made certain representations and warranties and is required to comply with various covenants, reporting requirements and other customary requirements for similar facilities. As of and for the three months ended March 31, 2018, Flatiron Funding II was in compliance with all covenants and reporting requirements.

37

CĪON Investment Corporation
Notes to Consolidated Financial Statements (unaudited)
March 31, 2018
(in thousands, except share and per share amounts)

For the three months ended March 31, 2018 and the period from March 29, 2017 through March 31, 2017, the components of interest expense, average borrowings, and weighted average interest rate for the Amended Citibank Credit Facility were as follows:
 
 
Three Months Ended March 31, 2018
 
For the Period from March 29, 2017 through March 31, 2017
Stated interest expense
 
$
2,907

 
$
61

Amortization of deferred financing costs
 
160

 
5

Non-usage fee
 
1

 
6

Total interest expense
 
$
3,068

 
$
72

Weighted average interest rate(1)
 
3.58
%
 
3.45
%
Average borrowings
 
$
324,542

 
$
231,698

(1)
Includes the stated interest expense and non-usage fee on the unused portion of the Amended Citibank Credit Facility and is annualized for periods covering less than one year.

JPM Credit Facility

On August 26, 2016, 34th Street entered into a senior secured credit facility with JPM. The senior secured credit facility with JPM, or the JPM Credit Facility, provided for borrowings in an aggregate principal amount of $150,000, of which $25,000 may be funded as a revolving credit facility, each subject to conditions described in the JPM Credit Facility. On August 26, 2016, 34th Street drew down $57,000 of borrowings under the JPM Credit Facility.

On September 30, 2016, July 11, 2017 and November 28, 2017, 34th Street amended and restated the JPM Credit Facility, or the Amended JPM Credit Facility, with JPM. Under the Amended JPM Credit Facility entered into on September 30, 2016, the aggregate principal amount available for borrowings was increased from $150,000 to $225,000, of which $25,000 may be funded as a revolving credit facility, subject to conditions described in the Amended JPM Credit Facility. On September 30, 2016, 34th Street drew down $167,423 of additional borrowings under the Amended JPM Credit Facility, a portion of which was used to purchase the portfolio of loans from Credit Suisse Park View BDC, Inc. Under the Amended JPM Credit Facility entered into on July 11, 2017 and November 28, 2017, certain immaterial administrative amendments were made as a result of the termination of AIM as the Company's investment sub-adviser as discussed in Note 1. No other material terms of the JPM Credit Facility were revised in connection with the Amended JPM Credit Facility.

 Advances under the Amended JPM Credit Facility bear interest at a floating rate equal to the three-month LIBOR, plus a spread of 3.50% per year. Interest is payable quarterly in arrears. All advances under the Amended JPM Credit Facility will mature, and all accrued and unpaid interest thereunder will be due and payable, by no later than August 23, 2020. 34th Street may prepay advances pursuant to the terms and conditions of the Amended JPM Credit Facility, subject to a 1% premium in certain circumstances. In addition, 34th Street will be subject to a non-usage fee of 0.5% and 1.0% per year on the amount, if any, of the aggregate principal amount available under the Amended JPM Credit Facility that has not been borrowed during the period from the closing date and ending on, but excluding, May 23, 2017, or the Ramp-Up Period, and from the termination of the Ramp-Up Period and ending on, but excluding, August 23, 2019, respectively. The non-usage fees, if any, are payable quarterly in arrears.  

The Company contributed loans and other corporate debt securities to 34th Street in exchange for 100% of the membership interests of 34th Street, and may contribute additional loans and other corporate debt securities to 34th Street in the future. 34th Street’s obligations to JPM under the Amended JPM Credit Facility are secured by a first priority security interest in all of the assets of 34th Street. The obligations of 34th Street under the Amended JPM Credit Facility are non-recourse to the Company, and the Company’s exposure under the Amended JPM Credit Facility is limited to the value of the Company’s investment in 34th Street.  

In connection with the Amended JPM Credit Facility, 34th Street has made certain representations and warranties and is required to comply with various covenants, reporting requirements and other customary requirements for similar facilities. As of and for the three months ended March 31, 2018, 34th Street was in compliance with all covenants and reporting requirements.

The Company incurred debt issuance costs of $3,515 in connection with obtaining and amending the JPM Credit Facility, which were recorded as a direct reduction to the outstanding balance of the Amended JPM Credit Facility, which is included in the Company’s consolidated balance sheet as of March 31, 2018 and will amortize to interest expense over the term of the Amended JPM Credit Facility. At March 31, 2018, the unamortized portion of the debt issuance costs was $2,114.

38

CĪON Investment Corporation
Notes to Consolidated Financial Statements (unaudited)
March 31, 2018
(in thousands, except share and per share amounts)

For the three months ended March 31, 2018 and 2017, the components of interest expense, average borrowings, and weighted average interest rate for the Amended JPM Credit Facility were as follows:
 
 
Three Months Ended March 31,
 
 
2018
 
2017
Stated interest expense
 
$
2,838

 
$
2,535

Amortization of deferred financing costs
 
217

 
218

Non-usage fee
 
1

 
1

Total interest expense
 
$
3,056

 
$
2,754

Weighted average interest rate(1)
 
4.98
%
 
4.48
%
Average borrowings
 
$
224,423

 
$
224,423

(1)
Includes the stated interest expense and non-usage fee on the unused portion of the Amended JPM Credit Facility and is annualized for periods covering less than one year.

UBS Facility

On May 19, 2017, the Company, through two newly-formed, wholly-owned, special-purpose financing subsidiaries, entered into a financing arrangement with UBS pursuant to which up to $125,000 was made available to the Company.
Pursuant to the financing arrangement, assets in the Company's portfolio may be contributed from time to time to Murray Hill Funding II through Murray Hill Funding, LLC, or Murray Hill Funding, each a newly-formed, wholly-owned, special-purpose financing subsidiary of the Company. On May 19, 2017, the Company contributed assets to Murray Hill Funding II. The assets held by Murray Hill Funding II secure the obligations of Murray Hill Funding II under Class A Notes, or the Notes, issued by Murray Hill Funding II. Pursuant to an Indenture, dated May 19, 2017, between Murray Hill Funding II and U.S. Bank National Association, or U.S. Bank, as trustee, or the Indenture, the aggregate principal amount of Notes that may be issued by Murray Hill Funding II from time to time was $192,308. Murray Hill Funding purchased the Notes issued by Murray Hill Funding II at a purchase price equal to their par value. Murray Hill Funding makes capital contributions to Murray Hill Funding II to, among other things, maintain the value of the portfolio of assets held by Murray Hill Funding II.

Principal on the Notes will be due and payable on the stated maturity date of May 19, 2027. Pursuant to the Indenture, Murray Hill Funding II has made certain representations and warranties and is required to comply with various covenants, reporting requirements and other customary requirements for similar transactions. The Indenture contains events of default customary for similar transactions, including, without limitation: (a) the failure to make principal payments on the Notes at their stated maturity or any earlier redemption date or to make interest payments on the Notes and such failure is not cured within three business days; (b) the failure to disburse amounts in accordance with the priority of payments and such failure is not cured within three business days; and (c) the occurrence of certain bankruptcy and insolvency events with respect to Murray Hill Funding II or Murray Hill Funding.

Murray Hill Funding, in turn, entered into a repurchase transaction with UBS, pursuant to the terms of a Global Master Repurchase Agreement and the related Annex and Master Confirmation thereto, each dated May 19, 2017, or collectively, the UBS Facility. Pursuant to the UBS Facility, on May 19, 2017 and June 19, 2017, UBS purchased Notes held by Murray Hill Funding for an aggregate purchase price equal to 65% of the principal amount of Notes purchased. Subject to certain conditions, the maximum principal amount of Notes that may be purchased under the UBS Facility was $192,308. Accordingly, the aggregate maximum amount payable to Murray Hill Funding under the UBS Facility would not exceed $125,000. Murray Hill Funding will repurchase the Notes sold to UBS under the UBS Facility by no later than May 19, 2020. The repurchase price paid by Murray Hill Funding to UBS will be equal to the purchase price paid by UBS for the repurchased Notes (giving effect to any reductions resulting from voluntary partial prepayment(s)). If the UBS Facility is accelerated prior to May 19, 2020 due to an event of default or a mandatory or voluntary full payment by Murray Hill Funding, then Murray Hill Funding must pay to UBS a fee equal to the present value of the spread portion of the financing fees that would have been payable to UBS from the date of acceleration through May 19, 2020 had the acceleration not occurred. The financing fee under the UBS Facility is equal to the three-month LIBOR plus a spread of up to 3.50% per year for the relevant period.

On December 1, 2017, Murray Hill Funding II amended and restated the Indenture, or the Amended Indenture, pursuant to which the aggregate principal amount of Notes that may be issued by Murray Hill Funding II was increased from $192,308 to $266,667. Murray Hill Funding will purchase the Notes to be issued by Murray Hill Funding II from time to time. On December 1, 2017, Murray Hill Funding entered into a First Amended and Restated Master Confirmation to the Global Master Repurchase Agreement, or the Amended Master Confirmation, which sets forth the terms of the repurchase transaction between Murray Hill Funding and UBS under the UBS Facility. As part of the Amended Master Confirmation, on December 15, 2017 and April 2, 2018, UBS purchased the increased aggregate principal amount of Notes held by Murray Hill Funding for an aggregate purchase price equal to 75% of the principal amount of Notes issued. As a result of the Amended Master Confirmation, the aggregate maximum amount payable to Murray Hill Funding and made available to the Company under the UBS Facility was increased from $125,000 to $200,000. No other material terms of the UBS Facility were revised in connection with the amended UBS Facility.

39

CĪON Investment Corporation
Notes to Consolidated Financial Statements (unaudited)
March 31, 2018
(in thousands, except share and per share amounts)

UBS may require Murray Hill Funding to post cash collateral if, without limitation, the sum of the market value of the portfolio of assets and the cash and eligible investments held by Murray Hill Funding II, together with any posted cash collateral, is less than the required margin amount under the UBS Facility; provided, however, that Murray Hill Funding will not be required to post cash collateral with UBS until such market value has declined at least 10% from the initial market value of the portfolio assets.

The Company has no contractual obligation to post any such cash collateral or to make any payments to UBS on behalf of Murray Hill Funding. The Company may, but is not obligated to, increase its investment in Murray Hill Funding for the purpose of funding any cash collateral or payment obligations for which Murray Hill Funding becomes obligated in connection with the amended UBS Facility. The Company’s exposure under the amended UBS Facility is limited to the value of the Company’s investment in Murray Hill Funding.  

Pursuant to the amended UBS Facility, Murray Hill Funding has made certain representations and warranties and is required to comply with various covenants, reporting requirements and other customary requirements for similar transactions. The amended UBS Facility contains events of default customary for similar financing transactions, including, without limitation: (a) failure to transfer the Notes to UBS on the applicable purchase date or repurchase the Notes from UBS on the applicable repurchase date; (b) failure to pay certain fees and make-whole amounts when due; (c) failure to post cash collateral as required; (d) the occurrence of insolvency events with respect to Murray Hill Funding; and (e) the admission by Murray Hill Funding of its inability to, or its intention not to, perform any of its obligations under the amended UBS Facility.

Murray Hill Funding paid an upfront fee and incurred certain other customary costs and expenses totaling $2,637 in connection with obtaining the amended UBS Facility, which were recorded as a direct reduction to the outstanding balance of the amended UBS Facility, which is included in the Company’s consolidated balance sheets and will amortize to interest expense over the term of the amended UBS Facility. At March 31, 2018, the unamortized portion of the upfront fee and other expenses was $2,007.

As of March 31, 2018, Notes in the aggregate principal amount of $216,667 had been purchased by Murray Hill Funding from Murray Hill Funding II and subsequently sold to UBS under the amended UBS Facility for aggregate proceeds of $162,500. The carrying amount outstanding under the amended UBS Facility approximates its fair value. The Company funded each purchase of Notes by Murray Hill Funding through a capital contribution to Murray Hill Funding. As of March 31, 2018, the amount due at maturity under the amended UBS Facility was $162,500. On April 2, 2018, additional Notes in the aggregate principal amount of $50,000 that had been purchased by Murray Hill Funding from Murray Hill Funding II were sold to UBS under the amended UBS Facility for aggregate proceeds of $37,500. The Notes issued by Murray Hill Funding II and purchased by Murray Hill Funding eliminate in consolidation on the Company’s consolidated financial statements.

As of March 31, 2018, the fair value of assets held by Murray Hill Funding II was $363,298.

For the three months ended March 31, 2018, the components of interest expense, average borrowings, and weighted average interest rate for the amended UBS Facility were as follows:
 
 
Three Months Ended March 31, 2018
Stated interest expense
 
$
2,005

Amortization of deferred financing costs
 
232

Total interest expense
 
$
2,237

Weighted average interest rate(1)
 
4.94
%
Average borrowings
 
$
162,500

(1)
Includes the stated interest expense and non-usage fee, if any, on the unused portion of the amended UBS Facility and is annualized for periods covering less than one year.

MS Credit Facility

On December 19, 2017, 33rd Street Funding entered into a senior secured credit facility, or the MS Credit Facility, with MS. The MS Credit Facility provides for a revolving credit facility in an aggregate principal amount of up to $200,000, subject to compliance with a borrowing base. 33rd Street Funding has not drawn down on any borrowings under the MS Credit Facility.

40

CĪON Investment Corporation
Notes to Consolidated Financial Statements (unaudited)
March 31, 2018
(in thousands, except share and per share amounts)

Advances under the MS Credit Facility will be available through December 19, 2020 and will bear interest at a floating rate equal to the three-month LIBOR, plus a spread of (i) 3.0% per year through December 19, 2020 and (i) 3.5% per year thereafter through December 19, 2022. Interest is payable quarterly in arrears. All advances under the MS Credit Facility will mature, and all accrued and unpaid interest thereunder will be due and payable, by no later than December 19, 2022. 33rd Street Funding may prepay advances pursuant to the terms and conditions of the loan and servicing agreement, subject to a 3% premium if the amount of the MS Credit Facility is reduced below $100,000 or terminated on or prior to December 19, 2018, and subject to a 2% or 1% premium if the amount of the MS Credit Facility is reduced or terminated on or prior to December 19, 2019 or December 19, 2020, respectively. In addition, 33rd Street Funding will be subject to a non-usage fee of 0.75% per year that accrues for each day of an accrual period on the amount by which $200,000 exceeds the greater of (x) the aggregate principal amount, if any, of the advances outstanding on such day and (y) prior to June 20, 2018, zero, and during the period from June 20, 2018 through December 19, 2020, 75% of $200,000 (or such smaller amount if the committed facility amount is reduced pursuant to the terms and conditions of the loan and servicing agreement). The non-usage fees, if any, are payable quarterly in arrears. 33rd Street Funding incurred certain customary costs and expenses in connection with obtaining the MS Credit Facility.

The Company contributed loans and other corporate debt securities to 33rd Street Funding in exchange for 100% of the membership interests of 33rd Street Funding, and may contribute additional loans and other corporate debt securities to 33rd Street Funding in the future. 33rd Street Funding’s obligations to MS under the MS Credit Facility are secured by a first priority security interest in all of the assets of 33rd Street Funding. The obligations of 33rd Street Funding under the MS Credit Facility are non-recourse to the Company, and the Company's exposure under the MS Credit Facility is limited to the value of the Company's investment in 33rd Street Funding. 33rd Street Funding has appointed CIM to manage its portfolio.
 
In connection with the MS Credit Facility, 33rd Street Funding has made certain representations and warranties and is required to comply with various covenants, reporting requirements and other customary requirements for similar facilities. The MS Credit Facility contains customary events of default for similar financing transactions, including, without limitation: (a) the failure to make any payment when due and thereafter (other than with respect to payments of principal and interest), within one business day following the earlier of (i) 33rd Street Funding becoming aware of such failure; or (ii) notice of such default is provided by MS; (b) the insolvency or bankruptcy of 33rd Street Funding, the Company or CIM; (c) a change of control of 33rd Street Funding shall have occurred or CIM ceases to be the investment advisor of the Company; (d) the failure by 33rd Street Funding to make any payment when due in connection with any of its other indebtedness having an aggregate value of at least $500, or any other default by 33rd Street Funding of any agreement related to such indebtedness; (e) any representation, warranty, condition or agreement of 33rd Street Funding, the Company or CIM under the loan and servicing agreement is incorrect or not performed, which if capable of being cured, is not cured within 30 days; and (f) the failure to satisfy certain financial covenants, which if capable of being cured, is not cured within the time period specified in the loan and servicing agreement. Upon the occurrence and during the continuation of an event of default, MS may declare the outstanding advances and all other obligations under the MS Credit Facility immediately due and payable.

33rd Street Funding paid an upfront fee and incurred certain other customary costs and expenses totaling $2,591 in connection with obtaining the MS Credit Facility, which the Company initially recorded as prepaid expenses and other assets on the Company’s consolidated balance sheets and will amortize to interest expense over the term of the MS Credit Facility. Upon funding of the MS Credit Facility, any unamortized upfront fees will be recorded as a direct reduction to the outstanding balance of the MS Credit Facility, which will be included in the Company’s consolidated balance sheets. At March 31, 2018, the unamortized portion of the upfront fee and other expenses was $2,447.

For the three months ended March 31, 2018, the components of interest expense, average borrowings, and weighted average interest rate for the MS Credit Facility were as follows:
 
 
Three Months Ended March 31, 2018
Non-usage fee
 
$
429

Amortization of deferred financing costs
 
128

Total interest expense
 
$
557


East West Bank Credit Facility
 
On April 30, 2015, the Company entered into a revolving credit facility, or the EWB Credit Facility, with East West Bank, or EWB. The EWB Credit Facility provided for borrowings in an aggregate principal amount of up to $40,000, subject to certain conditions, and the Company was required to maintain $2,000 in a demand deposit account with EWB at all times. On April 27, 2017, the EWB Credit Facility expired in accordance with its terms. Through the expiration date, the Company was in compliance with all covenants and reporting requirements under the EWB Credit Facility.

41

CĪON Investment Corporation
Notes to Consolidated Financial Statements (unaudited)
March 31, 2018
(in thousands, except share and per share amounts)

For the three months ended March 31, 2018 and 2017, the components of interest expense, average borrowings, and weighted average interest rate for the EWB Credit Facility were as follows:
 
 
Three Months Ended March 31,
 
 
2018
 
2017
Non-usage fee
 
$

 
$
50

Amortization of deferred financing costs
 

 
50

Total interest expense
 
$

 
$
100


Note 9. Fair Value of Financial Instruments
 
The following table presents fair value measurements of the Company’s portfolio investments as of March 31, 2018 and December 31, 2017, according to the fair value hierarchy: 
 
March 31, 2018
 
December 31, 2017
 
Level 1
 
Level 2
 
Level 3
 
Total
 
Level 1
 
Level 2
 
Level 3
 
Total
Senior secured first lien debt
$

 
$

 
$
1,160,746

 
$
1,160,746

 
$

 
$

 
$
1,100,336

 
$
1,100,336

Senior secured second lien debt

 

 
354,061

 
354,061

 

 

 
333,944

 
333,944

Collateralized securities and structured products - debt

 

 
22,380

 
22,380

 

 

 
25,289

 
25,289

Collateralized securities and structured products - equity

 

 
18,731

 
18,731

 

 

 
18,525

 
18,525

Unsecured debt

 

 

 

 

 

 
7,639

 
7,639

Equity
7,196

 

 
17,307

 
24,503

 
5,638

 

 
16,277

 
21,915

Short term investments
181,095

 

 

 
181,095

 
206,547

 

 

 
206,547

Total Investments
$
188,291

 
$

 
$
1,573,225

 
$
1,761,516

 
$
212,185

 
$

 
$
1,502,010

 
$
1,714,195

 
The following tables provide a reconciliation of the beginning and ending balances for investments that use Level 3 inputs for the three months ended March 31, 2018 and 2017:
 
Three Months Ended
March 31, 2018
 
Senior Secured First Lien Debt
 
Senior Secured Second Lien Debt
 
Collateralized Securities and Structured Products - Debt
 
Collateralized Securities and Structured Products - Equity
 
Unsecured Debt
 
Equity
 
Total
Beginning balance, December 31, 2017
$
1,100,336

 
$
333,944

 
$
25,289

 
$
18,525

 
$
7,639

 
$
16,277

 
$
1,502,010

Investments purchased
245,653

 
75,008

 

 

 

 
1,936

 
322,597

Net realized gain
1,159

 
915

 

 

 
21

 

 
2,095

Net change in unrealized (depreciation) appreciation
(4,282
)
 
1,352

 
451

 
363

 
14

 
(906
)
 
(3,008
)
Accretion of discount
1,993

 
311

 
10

 

 
4

 

 
2,318

Sales and principal repayments
(184,113
)
 
(57,469
)
 
(3,370
)
 
(157
)
 
(7,678
)
 

 
(252,787
)
Ending balance, March 31, 2018
$
1,160,746

 
$
354,061

 
$
22,380

 
$
18,731

 
$

 
$
17,307

 
$
1,573,225

Change in net unrealized (depreciation) appreciation on investments still held as of March 31, 2018(1)
$
(2,606
)
 
$
1,825

 
$
451

 
$
363

 
$

 
$
653

 
$
686

(1)
Included in net change in unrealized (depreciation) appreciation on investments in the consolidated statements of operations.

42

CĪON Investment Corporation
Notes to Consolidated Financial Statements (unaudited)
March 31, 2018
(in thousands, except share and per share amounts)

 
Three Months Ended
March 31, 2017
 
Senior Secured First Lien Debt
 
Senior Secured Second Lien Debt
 
Collateralized Securities and Structured Products - Debt
 
Collateralized Securities and Structured Products - Equity
 
Unsecured Debt
 
Equity
 
Total Return
Swap
 
Total
Beginning balance, December 31, 2016
$
489,913

 
$
434,347

 
$
38,114

 
$
34,648

 
$
16,851

 
$
5,107

 
$
(15,402
)
 
$
1,003,578

Investments purchased
445,482

 
62,497

 

 

 
1,089

 

 

 
509,068

Net realized gain (loss)
217

 
637

 

 

 
115

 

 
(14,269
)
 
(13,300
)
Net change in unrealized (depreciation) appreciation
(5,873
)
 
2,742

 
445

 
564

 
493

 
(1,371
)
 
15,536

 
12,536

Accretion of discount
1,194

 
567

 
27

 

 
29

 

 

 
1,817

Sales and principal repayments
(64,453
)
 
(57,153
)
 

 
(4,053
)
 
(14,687
)
 

 
14,269

 
(126,077
)
Ending balance, March 31, 2017
$
866,480

 
$
443,637

 
$
38,586

 
$
31,159

 
$
3,890

 
$
3,736

 
$
134

 
$
1,387,622

Change in net unrealized (depreciation) appreciation on investments still held as of March 31, 2017(1)
$
(5,439
)
 
$
2,871

 
$
445

 
$
564

 
$
446

 
$
(1,371
)
 
$
(200
)
 
$
(2,684
)
(1)
Included in net change in unrealized (depreciation) appreciation on investments in the consolidated statements of operations except where related to the total return swap, which is included in net change in unrealized (depreciation) appreciation on total return swap.
Significant Unobservable Inputs
The valuation techniques and significant unobservable inputs used in recurring Level 3 fair value measurements of investments as of March 31, 2018 and December 31, 2017 were as follows:
 
 
March 31, 2018
 
 
Fair Value
 
Valuation Techniques/
Methodologies
 
Unobservable
Inputs
 
Range
 
Weighted Average(1)
Senior secured first lien debt
 
$
726,325

 
Discounted Cash Flow
 
Discount Rates
 
5.0%
 
 
25.0%
 
10.6%
 
 
423,191

 
Broker Quotes
 
Broker Quotes
 
N/A
 
N/A
 
 
11,230

 
Market Comparable Approach
 
EBITDA Multiple
 
3.00x
 
 
6.00x
 
4.03x
 
 
 
 
 
Revenue Multiple
 
0.20x
 
 
0.35x
 
0.29x
Senior secured second lien debt
 
219,744

 
Broker Quotes
 
Broker Quotes
 
N/A
 
N/A
 
 
134,317

 
Discounted Cash Flow
 
Discount Rates
 
10.0%
 
 
13.0%
 
11.1%
Collateralized securities and structured products - debt
 
22,380

 
Discounted Cash Flow
 
Discount Rates
 
6.3%
 
 
11.0%
 
9.4%
Collateralized securities and structured products - equity
 
18,731

 
Discounted Cash Flow
 
Discount Rates
 
9.7%
 
 
14.0%
 
11.7%
Equity
 
9,100

 
Discounted Cash Flow
 
Discount Rates
 
18.5%
 
 
23.5%
 
21.8%
 
 
6,323

 
Market Comparable Approach
 
EBITDA Multiple
 
5.50x
 
 
11.00x
 
7.73x
 
 
1,643

 
Broker Quotes
 
Broker Quotes
 
N/A
 
N/A
 
 
241

 
Options Pricing Model
 
Expected Volatility
 
19.8%
 
 
107.4%
 
51.7%
Total
 
$
1,573,225

 
 
 
 
 
 
 
 
 
 
 
 
(1)
Weighted average amounts are based on the estimated fair values.

43

CĪON Investment Corporation
Notes to Consolidated Financial Statements (unaudited)
March 31, 2018
(in thousands, except share and per share amounts)

 
 
December 31, 2017
 
 
Fair Value
 
Valuation Techniques/
Methodologies
 
Unobservable
Inputs
 
Range
 
Weighted Average(1)
Senior secured first lien debt
 
$
701,362

 
Discounted Cash Flow
 
Discount Rates
 
5.0%
 
-
 
375.0%
 
12.0%
 
 
377,869

 
Broker Quotes
 
Broker Quotes
 
N/A
 
N/A
 
 
21,105

 
Market Comparable Approach
 
EBITDA Multiple
 
3.75x
 
-
 
10.50x
 
7.65x
 
 
 
 
 
Revenue Multiple
 
0.75x
 
-
 
1.00x
 
0.88x
Senior secured second lien debt
 
175,847

 
Discounted Cash Flow
 
Discount Rates
 
8.7%
 
-
 
246.3%
 
11.1%
 
 
158,097

 
Broker Quotes
 
Broker Quotes
 
N/A
 
N/A
Collateralized securities and structured products - debt
 
25,289

 
Discounted Cash Flow
 
Discount Rates
 
6.3%
 
-
 
11.0%
 
9.6%
Collateralized securities and structured products - equity
 
18,525

 
Discounted Cash Flow
 
Discount Rates
 
14.0%
 
-
 
15.0%
 
14.5%
Unsecured debt
 
7,639

 
Discounted Cash Flow
 
Discount Rates
 
N/A
 
13.1%
Equity
 
16,250

 
Market Comparable Approach
 
EBITDA Multiple
 
4.50x
 
-
 
11.00x
 
9.34x
 
 
27

 
Options Pricing Model
 
Expected Volatility
 
29.0%
 
-
 
30.0
%
 
29.5%
Total
 
$
1,502,010

 
 
 
 
 
 
 
 
 
 
 
 
(1)
Weighted average amounts are based on the estimated fair values.
The significant unobservable inputs used in the fair value measurement of the Company’s senior secured first lien debt, senior secured second lien debt, collateralized securities and structured products, unsecured debt and equity are discount rates, EBITDA multiples, revenue multiples, broker quotes and expected volatility. A significant increase or decrease in discount rates would result in a significantly lower or higher fair value measurement, respectively. A significant increase or decrease in the EBITDA multiples, revenue multiples, broker quotes and expected volatility would result in a significantly higher or lower fair value measurement, respectively.
Note 10. General and Administrative Expense
General and administrative expense consisted of the following items for the three months ended March 31, 2018 and 2017:
 
Three Months Ended
March 31,
 
2018
 
2017
Professional fees
$
629

 
$
568

Transfer agent expense
329

 
314

Dues and subscriptions
244

 
170

Valuation expense
164

 
199

Director fees and expenses
121

 
86

Insurance expense
100

 
103

Due diligence fees
82

 
55

Accounting costs
77

 
55

Printing and marketing expense
72

 
106

Other expenses
164

 
90

Total general and administrative expense
$
1,982

 
$
1,746


44

CĪON Investment Corporation
Notes to Consolidated Financial Statements (unaudited)
March 31, 2018
(in thousands, except share and per share amounts)

Note 11. Commitments and Contingencies
The Company entered into certain contracts with other parties that contain a variety of indemnifications. The Company’s maximum exposure under these arrangements is unknown. However, the Company has not experienced claims or losses pursuant to these contracts and believes the risk of loss related to such indemnifications to be remote.
As of March 31, 2018 and December 31, 2017, the Company’s unfunded commitments were as follows:
Unfunded Commitments
 
March 31, 2018(1)
 
December 31, 2017(1)
SS&C Technologies, Inc.(3)
 
$
35,979

 
$

Centene Corp.(3)
 
21,382

 
12,170

DFC Global Facility Borrower II LLC(2)
 
9,765

 
10,425

Boyne USA, Inc.(3)
 
5,961

 

CircusTrix Holdings LLC(2)
 
4,459

 

Foundation Consumer Healthcare, LLC(2)
 
4,211

 
4,211

Discovery DJ Services LLC(2)
 
3,922

 
4,706

Moss Holding Company(2)
 
3,278

 
3,278

LSCS Holdings, Inc.(2)
 
2,727

 

Access CIG, LLC(2)
 
2,701

 

NM GRC Holdco, LLC(2)
 
2,654

 

Elemica, Inc.(2)
 
2,500

 
2,500

Instant Web LLC(2)
 
2,055

 

Studio Movie Grill Holdings, LLC(2)
 
1,608

 
1,608

Phylogeny, LLC / Conversant Biologics, LLC(2)
 
1,299

 

Teladoc, Inc.(2)
 
1,250

 
1,250

Ivy Hill Middle Market Credit Fund VIII, Ltd.(2)
 
1,111

 
1,111

VLS Recovery Services, LLC(2)
 
949

 
1,108

American Media, Inc.(2)
 
830

 
237

Frontline Technologies Group Holding LLC(2)
 
540

 
540

Pathway Partners Vet Management Company LLC(2)
 
343

 
818

Covenant Surgical Partners, Inc.(2)
 
271

 
458

Charming Charlie, LLC
 
210

 
1,048

Accruent, LLC(2)
 
111

 
111

Visual Edge Technology, Inc.
 
65

 

Ministry Brands, LLC(2)
 

 
1,865

PDI TA Holdings, Inc.(2)
 

 
815

Total
 
$
110,181

 
$
48,259

(1)
Unless otherwise noted, the funding criteria for these unfunded commitments had not been met at the date indicated.
(2)
As of May 10, 2018, the Company was committed, upon the satisfaction of certain conditions, to fund an additional $912, $1,007, $111, $1,778, $1,672, $4,459, $226, $9,765, $2,667, $2,500, $4,211, $540, $2,055, $1,111, $5,000, $1,364, $4,858, $3,278, $2,654, $92, $2,629, $1,299, $1,608, $1,250, $40,000, $949 and $1,317 to ABG Intermediate Holdings 2 LLC, Access CIG, LLC, Accruent, LLC, American Media, Inc., Avetta, LLC, CircusTrix Holdings, LLC, Covenant Surgical Partners, Inc., DFC Global Facility Borrower II LLC, Discovery DJ Services LLC, Elemica, Inc., Foundation Consumer Healthcare, LLC, Frontline Technologies Group Holding LLC, Instant Web, LLC, Ivy Hill Middle Market Credit Fund VIII, Ltd., Lift Brands, Inc., LSCS Holdings, Inc., Ministry Brands, LLC, Moss Holding Company, NM GRC Holdco, LLC, Pathway Partners Vet Management Company LLC, PDI TA Holdings, Inc., Phylogeny, LLC / Conversant Biologics, LLC, Studio Movie Grill Holdings, LLC, Teladoc, Inc., TherapeuticsMD, Inc., VLS Recovery Services, LLC and West Dermatology, LLC, respectively. In addition, subsequent to March 31, 2018, the Company entered into unfunded commitments of $28,775 and $44,997 with Citibank and Deutsche Bank AG, respectively.

45

CĪON Investment Corporation
Notes to Consolidated Financial Statements (unaudited)
March 31, 2018
(in thousands, except share and per share amounts)


(3)
As of March 31, 2018, such commitment was subject to the execution of a definitive loan agreement and the consummation of the underlying corporate transaction, and conditional upon receipt of all necessary shareholder, regulatory and other applicable approvals. Prior to May 10, 2018, the unfunded commitment was terminated.
Unfunded commitments to provide funds to companies are not recorded on the Company’s consolidated balance sheets. Since these commitments may expire without being drawn upon, unfunded commitments do not necessarily represent future cash requirements or future earning assets for the Company. The Company intends to use cash on hand, short-term investments, proceeds from borrowings, and other liquid assets to fund these commitments should the need arise. For information on the companies to which the Company is committed to fund additional amounts as of March 31, 2018 and December 31, 2017, refer to the table above and the consolidated schedules of investments.

The Company will fund its unfunded commitments from the same sources it uses to fund its investment commitments that are funded at the time they are made (i.e., advances from its financing arrangements and/or cash flows from operations). The Company will not fund its unfunded commitments from future net proceeds generated by securities offerings. The Company follows a process to manage its liquidity and ensure that it has available capital to fund its unfunded commitments. Specifically, the Company prepares detailed analyses of the level of its unfunded commitments relative to its then available liquidity on a daily basis.  These analyses are reviewed and discussed on a weekly basis by the Company's executive officers and senior members of CIM (including members of the investment committee) and are updated on a “real time” basis in order to ensure that the Company has adequate liquidity to satisfy its unfunded commitments.
Note 12. Fee Income
Fee income consists of commitment fees and amendment fees. The following table summarizes the Company’s fee income for the three months ended March 31, 2018 and 2017:
 
Three Months Ended
March 31,
 
2018
 
2017
Amendment fees
$
155

 
$
255

Commitment fees
59

 
292

Total
$
214

 
$
547

For the three months ended March 31, 2018 and 2017, all fee income was non-recurring.

46

CĪON Investment Corporation
Notes to Consolidated Financial Statements (unaudited)
March 31, 2018
(in thousands, except share and per share amounts)

Note 13. Financial Highlights

The following is a schedule of financial highlights as of and for the three months ended March 31, 2018 and 2017:
 
 
Three Months Ended
March 31,
 
 
2018
 
2017
Per share data:(1)
 
 
 
 
Net asset value at beginning of period
 
$
9.14

 
$
9.11

Results of operations:
 
 
 
 
Net investment income
 
0.17

 
0.15

Net realized gain and net change in unrealized depreciation on investments(2)
 

 
(0.02
)
Net realized gain and net change in unrealized appreciation on total return swap
 

 
0.01

Net increase in net assets resulting from operations(2)
 
0.17

 
0.14

Shareholder distributions:
 
 
 
 
Distributions from net investment income
 
(0.16
)
 
(0.14
)
Distributions from net realized gains
 
(0.02
)
 
(0.04
)
Net decrease in net assets from shareholders' distributions
 
(0.18
)
 
(0.18
)
Capital share transactions:
 
 
 
 
Issuance of common stock above net asset value(3)
 

 

Repurchases of common stock(4)
 

 

Net increase in net assets resulting from capital share transactions
 

 

Net asset value at end of period
 
$
9.13

 
$
9.07

Shares of common stock outstanding at end of period
 
116,108,932

 
111,370,686

Total investment return-net asset value(5)
 
1.90
%
 
1.60
%
Net assets at beginning of period
 
$
1,058,691

 
$
999,763

Net assets at end of period
 
$
1,060,553

 
$
1,010,010

Average net assets
 
$
1,056,223

 
$
1,003,153

Ratio/Supplemental data:
 
 
 
 
Ratio of net investment income to average net assets
 
1.81
%
 
1.65
%
Ratio of gross operating expenses to average net assets(6)
 
1.83
%
 
1.15
%
Ratio of expenses to average net assets(7)
 
1.83
%
 
1.15
%
Portfolio turnover rate(8)
 
16.41
%
 
12.50
%
Asset coverage ratio(9)
 
2.49

 
3.16

(1)
The per share data for the three months ended March 31, 2018 and 2017 was derived by using the weighted average shares of common stock outstanding during each period.
(2)
The amount shown for net realized loss and net change in unrealized depreciation on investments is the balancing figure derived from the other figures in the schedule. The amount shown at this caption for a share outstanding throughout the period may not agree with the change in the aggregate gains and losses in portfolio securities for the period because of the timing of sales and repurchases of the Company’s shares in relation to fluctuating market values for the portfolio. As a result, net increase in net assets resulting from operations in this schedule may vary from the consolidated statements of operations.

47

CĪON Investment Corporation
Notes to Consolidated Financial Statements (unaudited)
March 31, 2018
(in thousands, except share and per share amounts)

(3)
The continuous issuance of shares of common stock may cause an incremental increase in net asset value per share due to the sale of shares at the then prevailing public offering price and the receipt of net proceeds per share by the Company in excess of net asset value per share on each subscription closing date. The per share impact of the continuous issuance of shares of common stock was an increase to net asset value of less than $0.01 per share during the three months ended March 31, 2018 and 2017.
(4)
Repurchases of common stock may cause an incremental decrease in net asset value per share due to the repurchase of shares at a price in excess of net asset value per share on each repurchase date. The per share impact of repurchases of common stock was a decrease to net asset value of less than $0.01 per share during the three months ended March 31, 2018 and 2017.
(5)
Total investment return-net asset value is a measure of the change in total value for shareholders who held the Company’s common stock at the beginning and end of the period, including distributions paid or payable during the period. Total investment return-net asset value is based on (i) the beginning period net asset value per share on the first day of the period, (ii) the net asset value per share on the last day of the period of (A) one share plus (B) any fractional shares issued in connection with the reinvestment of monthly distributions, and (iii) the value of distributions payable, if any, on the last day of the period. The total investment return-net asset value calculation assumes that monthly cash distributions are reinvested in accordance with the Company's distribution reinvestment plan then in effect as described in Note 5. The total investment return-net asset value does not consider the effect of the sales load from the sale of the Company’s common stock. The total investment return-net asset value includes the effect of the issuance of shares at a net offering price that is greater than net asset value per share, which causes an increase in net asset value per share. Total returns covering less than a full year are not annualized.
(6)
Ratio of gross operating expenses to average net assets does not include expense support provided by CIG, AIM and/or CIM, if any.
(7)
In order to record an obligation to reimburse CIM for expense support provided, the ratio of gross operating expenses to average net assets, when considering the recoupment, in the period in which recoupment is sought, cannot exceed the ratio of gross operating expenses to average net assets for the period when the expense support was provided. For purposes of this calculation, gross operating expenses include all expenses borne by the Company, except for offering and organizational costs, base management fees, incentive fees, administrative services expenses, other general and administrative expenses owed to CIM and its affiliates and interest expense. For the three months ended March 31, 2018 and 2017, the ratio of gross operating expenses to average net assets, when considering recoupment of expense support to CIG, was 0.17% and 0.15%, respectively.
(8)
Portfolio turnover rate is calculated using the lesser of year-to-date sales or purchases over the average of the invested assets at fair value, excluding short term investments, and is not annualized.
(9)
Asset coverage ratio is equal to (i) the sum of (a) net assets at the end of the period and (b) total senior securities outstanding at the end of the period (excluding unfunded commitments), divided by (ii) total senior securities outstanding at the end of the period. For purposes of the asset coverage ratio test applicable to the Company as a BDC, the Company treated the outstanding TRS notional amount at the end of the period, less the total amount of cash collateral posted by Flatiron under the TRS, as senior securities. 

48



Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations
As used in this Quarterly Report on Form 10-Q, “we,” “us,” “our” or similar terms include CĪON Investment Corporation and its consolidated subsidiaries.
The following discussion should be read in conjunction with our unaudited consolidated financial statements and related notes appearing elsewhere in this Quarterly Report on Form 10-Q and the audited consolidated financial statements and related notes included in our Annual Report on Form 10-K for the year ended December 31, 2017. In addition to historical information, the following discussion and other parts of this Quarterly Report on Form 10-Q contain forward-looking information that involves risks and uncertainties. Amounts and percentages presented herein may have been rounded for presentation and all dollar amounts, excluding share and per share amounts, are presented in thousands unless otherwise noted.
Forward-Looking Statements
Some of the statements within this Quarterly Report on Form 10-Q constitute forward-looking statements because they relate to future events or our future performance or financial condition. The forward-looking statements contained in this Quarterly Report on Form 10-Q may include statements as to:
our future operating results;
our business prospects and the prospects of our portfolio companies;
the impact of the investments that we expect to make;
the ability of our portfolio companies to achieve their objectives;
our current and expected financings and investments;
the adequacy of our cash resources, financing sources and working capital;
the use of borrowed money to finance a portion of our investments;
the timing of cash flows, if any, from the operations of our portfolio companies;
our contractual arrangements and relationships with third parties;
the actual and potential conflicts of interest with CIM and Apollo and their respective affiliates;
the ability of CIM and AIM to locate suitable investments for us and the ability of CIM to monitor and administer our investments;
the ability of CIM and its affiliates to attract and retain highly talented professionals;
the dependence of our future success on the general economy and its impact on the industries in which we invest;
the effects of a changing interest rate environment;
our ability to source favorable private investments;
our tax status;
the effect of changes to tax legislation and our tax position;
the tax status of the companies in which we invest; and
the timing and amount of distributions and dividends from the companies in which we invest.
In addition, words such as “anticipate,” “believe,” “expect” and “intend” indicate a forward-looking statement, although not all forward-looking statements include these words. The forward-looking statements contained in this Quarterly Report on Form 10-Q involve risks and uncertainties. Our actual results could differ materially from those implied or expressed in the forward-looking statements for any reason, including the factors set forth in “Risk Factors” in Item 1A of Part II of this Quarterly Report on Form 10-Q. Other factors that could cause actual results to differ materially include: 
changes in the economy;
risks associated with possible disruption in our operations or the economy generally due to terrorism or natural disasters; and
future changes in laws or regulations and conditions in our operating areas.
We have based the forward-looking statements on information available to us on the date of this Quarterly Report on Form 10-Q. Except as required by the federal securities laws, we undertake no obligation to revise or update any forward-looking statements, whether as a result of new information, future events or otherwise. You are advised to review any additional disclosures that we may make directly to you or through reports that we in the future may file with the SEC, including annual reports on Form 10-K, quarterly reports on Form 10-Q and current reports on Form 8-K. The forward-looking statements contained in this Quarterly Report on Form 10-Q are excluded from the safe harbor protection provided by Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended.

49



Overview
We were incorporated under the general corporation laws of the State of Maryland on August 9, 2011 and commenced operations on December 17, 2012 upon raising proceeds of $2,500 from persons not affiliated with us, CIM or Apollo. We are an externally managed, non-diversified closed-end management investment company that has elected to be regulated as a BDC under the 1940 Act. We elected to be treated for federal income tax purposes as a RIC, as defined under Subchapter M of the Code.
Our investment objective is to generate current income and, to a lesser extent, capital appreciation for investors. Our portfolio is comprised primarily of investments in senior secured debt, including first lien loans, second lien loans and unitranche loans, and, to a lesser extent, collateralized securities, structured products and other similar securities, unsecured debt, including corporate bonds and long-term subordinated loans, referred to as mezzanine loans, and equity, of private and thinly traded U.S. middle-market companies. In connection with our debt investments, we may receive equity interests such as warrants or options as additional consideration. We may also purchase minority interests in the form of common or preferred equity in our target companies, either in conjunction with one of our debt investments or through a co-investment with a financial sponsor.
We are managed by CIM, our affiliate and a registered investment adviser. Pursuant to an investment advisory agreement with us, CIM oversees the management of our activities and is responsible for making investment decisions for our portfolio. On November 1, 2017, our board of directors, including a majority of directors who are not interested persons, approved the renewal of the investment advisory agreement with CIM for a period of twelve months commencing December 17, 2017. We and CIM previously engaged AIM to act as our investment sub-adviser.
On July 11, 2017, the members of CIM entered into the Third CIM LLC Agreement for the purpose of creating a joint venture between AIM and CIG. Under the Third CIM LLC Agreement, AIM became a member of CIM and was issued a newly-created class of membership interests in CIM pursuant to which AIM will, among other things, share in the profits, losses, distributions and expenses of CIM with the other members in accordance with the terms of the Third CIM LLC Agreement, which will ultimately result in CIG and AIM each owning a 50% economic interest in CIM.
On July 10, 2017, our independent directors unanimously approved the termination of the investment sub-advisory agreement with AIM, effective as of July 11, 2017, as part of the new and ongoing relationship among us, CIM and AIM. Although the investment sub-advisory agreement and AIM's engagement as our investment sub-adviser were terminated, AIM continues to perform certain non-advisory services for CIM and us, including, without limitation, identifying investment opportunities for approval by CIM's investment committee. AIM is not paid a separate fee in exchange for such services, but is entitled to receive distributions as a member of CIM as described above.
On December 4, 2017, the members of CIM entered into the Fourth CIM LLC Agreement. Under the Fourth CIM LLC Agreement, AIM performs sourcing services for CIM, which include, among other services, (i) identifying and providing information about potential investment opportunities for approval by CIM’s investment committee; (ii) providing (a) trade and settlement support; (b) portfolio and cash reconciliation; (c) market pipeline information regarding syndicated deals, in each case, as reasonably requested by CIM; and (d) monthly valuation reports and support for all broker-quoted investments. AIM has a limited role as a member of CIM and does not provide advice, evaluation, or recommendation with respect to our investments. All of our investment decisions are the sole responsibility of, and are made at the sole discretion of, CIM.
We seek to meet our investment objective by utilizing the experienced management team of CIM, which includes its access to the relationships and human capital of its affiliates in sourcing, evaluating and structuring transactions, as well as monitoring and servicing our investments. We focus primarily on the senior secured debt of private and thinly-traded U.S. middle-market companies, which we define as companies that generally possess annual EBITDA of $50 million or less, with experienced management teams, significant free cash flow, strong competitive positions and potential for growth.
Revenue
We primarily generate revenue in the form of interest income on the debt securities that we hold and capital gains on debt or other equity interests that we acquire in portfolio companies. The majority of our senior debt investments bear interest at a floating rate. Interest on debt securities is generally payable quarterly or monthly. In some cases, some of our investments may provide for deferred interest payments or PIK interest. The principal amount of the debt securities and any accrued, but unpaid, interest generally will become due at the maturity date. In addition, we may generate revenue in the form of commitment, structuring or diligence fees, monitoring fees, fees for providing managerial assistance and possibly consulting fees and performance-based fees. Any such fees generated in connection with our investments will be recognized when earned.
Operating Expenses
Our primary operating expenses are the payment of advisory fees under the investment advisory agreement and interest expense on our financing arrangements. Our investment advisory fees compensate CIM for its work in identifying, evaluating, negotiating, executing, monitoring and servicing our investments. We bear all other expenses of our operations and transactions.

50



Portfolio Investment Activity for the Three Months Ended March 31, 2018 and 2017
The following table summarizes our investment activity, excluding short term investments and PIK securities, for the three months ended March 31, 2018 and 2017:
 
 
Three Months Ended
March 31,
 
 
2018
 
2017
Net Investment Activity
 
Investment Portfolio
 
Total Return Swap
 
Total
 
Investment Portfolio
 
Total Return Swap
 
Total
Purchases and drawdowns
 
 
 
 
 
 
 
 
 
 
 
 
    Senior secured first lien debt
 
$
245,212

 
$

 
$
245,212

 
$
445,074

 
$
49,590

 
$
494,664

    Senior secured second lien debt
 
75,008

 

 
75,008

 
62,176

 

 
62,176

    Unsecured debt
 

 

 

 
1,089

 

 
1,089

    Equity
 
1,936

 

 
1,936

 

 

 

Sales and principal repayments
 
(252,787
)
 

 
(252,787
)
 
(140,346
)
 
(428,106
)
 
(568,452
)
Net portfolio activity
 
$
69,369

 
$

 
$
69,369

 
$
367,993

 
$
(378,516
)
 
$
(10,523
)
The following table summarizes the composition of our investment portfolio at amortized cost and fair value as of March 31, 2018 and December 31, 2017:
 
 
March 31, 2018
 
 
Investments Cost(1)
 
Investments Fair
Value
 
Percentage of
Investment
Portfolio
Senior secured first lien debt
 
$
1,153,204

 
$
1,160,746

 
73.4
%
Senior secured second lien debt
 
361,671

 
354,061

 
22.4
%
Collateralized securities and structured products - debt
 
22,052

 
22,380

 
1.4
%
Collateralized securities and structured products - equity
 
19,675

 
18,731

 
1.2
%
Equity
 
23,474

 
24,503

 
1.6
%
Subtotal/total percentage
 
1,580,076

 
1,580,421

 
100.0
%
Short term investments(2)
 
181,095

 
181,095

 
 
Total investments
 
$
1,761,171

 
$
1,761,516

 
 
Number of portfolio companies
 
 
 
148

Average annual EBITDA of portfolio companies
 
$75.3 million
 
Median annual EBITDA of portfolio companies
 
$54.1 million
 
Purchased at a weighted average price of par
 
95.94
%
Gross annual portfolio yield based upon the purchase price(3)
 
10.21
%
(1)
Represents amortized cost for debt investments and cost for equity investments. Amortized cost represents the original cost adjusted for the amortization of premiums and/or accretion of discounts, as applicable, on our investments.
(2)
Short term investments represent an investment in a fund that invests in highly liquid investments with average original maturity dates of three months or less.
(3)
The gross annual portfolio yield does not represent and may be higher than an actual investment return to shareholders because it excludes our expenses and all sales commissions and dealer manager fees and does not consider the cost of leverage.

51



 
December 31, 2017
 
Investments Cost(1)
 
Investments Fair
Value
 
Percentage of
Investment
Portfolio
Senior secured first lien debt
$
1,088,512

 
$
1,100,336

 
73.0
%
Senior secured second lien debt
342,906

 
333,944

 
22.1
%
Collateralized securities and structured products - debt
25,411

 
25,289

 
1.7
%
Collateralized securities and structured products - equity
19,833

 
18,525

 
1.2
%
Unsecured debt
7,653

 
7,639

 
0.5
%
Equity
21,538

 
21,915

 
1.5
%
Subtotal/total percentage
1,505,853

 
1,507,648

 
100.0
%
Short term investments(2)
206,547

 
206,547

 
 

Total investments
$
1,712,400

 
$
1,714,195

 
 
Number of portfolio companies
 
 

 
150

Average annual EBITDA of portfolio companies
 
$70.1 million
 
Median annual EBITDA of portfolio companies
 
$50.2 million
 
Purchased at a weighted average price of par
 
95.83
%
Gross annual portfolio yield based upon the purchase price(3)
 
9.24
%
(1)
Represents amortized cost for debt investments and cost for equity investments. Amortized cost represents the original cost adjusted for the amortization of premiums and/or accretion of discounts, as applicable, on our investments.
(2)
Short term investments represent an investment in a fund that invests in highly liquid investments with average original maturity dates of three months or less.
(3)
The gross annual portfolio yield does not represent and may be higher than an actual investment return to shareholders because it excludes our expenses and all sales commissions and dealer manager fees and does not consider the cost of leverage.
The following table summarizes the composition of our investment portfolio by the type of interest rate as of March 31, 2018 and December 31, 2017, excluding short term investments of $181,095 and $206,547, respectively:
 
 
March 31, 2018
Interest Rate Allocation
 
Investments Cost
 
Investments Fair
Value
 
Percentage of
Investment
Portfolio
Floating interest rate investments
 
$
1,451,177

 
$
1,452,822

 
91.9
%
Other income producing investments
 
59,974

 
60,107

 
3.8
%
Fixed interest rate investments
 
54,651

 
52,089

 
3.3
%
Non-income producing equity
 
14,274

 
15,403

 
1.0
%
Total investments
 
$
1,580,076

 
$
1,580,421

 
100.0
%
 
 
December 31, 2017
Interest Rate Allocation
 
Investments Cost
 
Investments Fair
Value
 
Percentage of
Investment
Portfolio
Floating interest rate investments
 
$
1,390,234

 
$
1,389,395

 
92.2
%
Fixed interest rate investments
 
83,448

 
87,113

 
5.8
%
Other income producing investments
 
19,833

 
18,525

 
1.2
%
Non-income producing equity
 
12,338

 
12,615

 
0.8
%
Total investments
 
$
1,505,853

 
$
1,507,648

 
100.0
%

52



The following tables show the composition of our investment portfolio by industry classification and the percentage, by fair value, of the total assets in such industries as of March 31, 2018 and December 31, 2017:
 
 
March 31, 2018
Industry Classification
 
Investments Fair Value
 
Percentage of
Investment Portfolio
Healthcare & Pharmaceuticals
 
$
269,418

 
17.0
%
High Tech Industries
 
171,458

 
10.8
%
Services: Business
 
149,753

 
9.5
%
Media: Advertising, Printing & Publishing
 
131,460

 
8.3
%
Media: Diversified & Production
 
118,845

 
7.5
%
Consumer Goods: Durable
 
77,821

 
4.9
%
Chemicals, Plastics & Rubber
 
74,979

 
4.7
%
Telecommunications
 
60,229

 
3.8
%
Capital Equipment
 
57,661

 
3.6
%
Aerospace & Defense
 
52,337

 
3.3
%
Services: Consumer
 
47,229

 
3.0
%
Banking, Finance, Insurance & Real Estate
 
43,724

 
2.8
%
Hotel, Gaming & Leisure
 
43,626

 
2.8
%
Diversified Financials
 
41,111

 
2.6
%
Automotive
 
40,659

 
2.6
%
Retail
 
35,933

 
2.3
%
Energy: Oil & Gas
 
34,725

 
2.2
%
Transportation: Cargo
 
32,694

 
2.1
%
Beverage, Food & Tobacco
 
32,264

 
2.0
%
Construction & Building
 
30,879

 
2.0
%
Metals & Mining
 
11,659

 
0.7
%
Consumer Goods: Non-Durable
 
7,210

 
0.5
%
Media: Broadcasting & Subscription
 
6,241

 
0.4
%
Forest Products & Paper
 
5,566

 
0.4
%
Environmental Industries
 
2,940

 
0.2
%
Subtotal/total percentage
 
1,580,421

 
100.0
%
Short term investments
 
181,095

 
 

Total investments
 
$
1,761,516

 
 

53



 
 
December 31, 2017
Industry Classification
 
Investments Fair Value
 
Percentage of
Investment Portfolio
Healthcare & Pharmaceuticals
 
$
255,608

 
17.0
%
Services: Business
 
195,251

 
13.0
%
High Tech Industries
 
194,902

 
12.9
%
Media: Diversified & Production
 
117,896

 
7.8
%
Chemicals, Plastics & Rubber
 
82,981

 
5.5
%
Media: Advertising, Printing & Publishing
 
65,795

 
4.4
%
Consumer Goods: Durable
 
60,863

 
4.0
%
Telecommunications
 
58,891

 
3.9
%
Capital Equipment
 
53,276

 
3.5
%
Aerospace & Defense
 
52,312

 
3.5
%
Services: Consumer
 
46,702

 
3.1
%
Diversified Financials
 
43,814

 
2.9
%
Automotive
 
40,565

 
2.7
%
Energy: Oil & Gas
 
38,397

 
2.5
%
Retail
 
33,319

 
2.2
%
Transportation: Cargo
 
32,877

 
2.2
%
Hotel, Gaming & Leisure
 
29,550

 
2.0
%
Beverage, Food & Tobacco
 
25,631

 
1.7
%
Construction & Building
 
24,633

 
1.6
%
Banking, Finance, Insurance & Real Estate
 
19,857

 
1.3
%
Metals & Mining
 
12,785

 
0.8
%
Consumer Goods: Non-Durable
 
7,055

 
0.5
%
Media: Broadcasting & Subscription
 
6,224

 
0.4
%
Forest Products & Paper
 
5,599

 
0.4
%
Environmental Industries
 
2,865

 
0.2
%
Subtotal/total percentage
 
1,507,648

 
100.0
%
Short term investments
 
206,547

 
 
Total investments
 
$
1,714,195

 
 
Our investment portfolio may contain senior secured investments that are in the form of lines of credit, delayed draw term loans, revolving credit facilities, or unfunded commitments, which may require us to provide funding when requested in accordance with the terms of the underlying agreements. As of March 31, 2018 and December 31, 2017, our unfunded commitments amounted to $110,181 and $48,259, respectively. As of May 10, 2018, our unfunded commitments amounted to $173,081. Since these commitments may expire without being drawn upon, unfunded commitments do not necessarily represent future cash requirements or future earning assets for us. For additional information on our unfunded commitments, refer to Note 11 to our consolidated financial statements included in this report.
Investment Portfolio Asset Quality
CIM uses an investment rating system to characterize and monitor our expected level of returns on each investment in our portfolio. These ratings are just one of several factors that CIM uses to monitor our portfolio, are not in and of themselves determinative of fair value or revenue recognition and are presented for indicative purposes. CIM rates the credit risk of all investments on a scale of 1 to 5 no less frequently than quarterly. This system is intended primarily to reflect the underlying risk of a portfolio investment relative to our initial cost basis in respect of such portfolio investment (i.e., at the time of acquisition), although it may also take into account under certain circumstances the performance of the portfolio company’s business, the collateral coverage of the investment and other relevant factors.

54



The following is a description of the conditions associated with each investment rating used in this ratings system:
Investment Rating
 
Description
1
 
Indicates the least amount of risk to our initial cost basis. The trends and risk factors for this investment since origination or acquisition are generally favorable, which may include the performance of the portfolio company or a potential exit.
2
 
Indicates a level of risk to our initial cost basis that is similar to the risk to our initial cost basis at the time of origination or acquisition. This portfolio company is generally performing in accordance with our analysis of its business and the full return of principal and interest or dividend is expected.
3
 
Indicates that the risk to our ability to recoup the cost of such investment has increased since origination or acquisition, but full return of principal and interest or dividend is expected. A portfolio company with an investment rating of 3 requires closer monitoring.
4
 
Indicates that the risk to our ability to recoup the cost of such investment has increased significantly since origination or acquisition, including as a result of factors such as declining performance and noncompliance with debt covenants, and we expect some loss of interest, dividend or capital appreciation, but still expect an overall positive internal rate of return on the investment.
5
 
Indicates that the risk to our ability to recoup the cost of such investment has increased materially since origination or acquisition and the portfolio company likely has materially declining performance. Loss of interest or dividend and some loss of principal investment is expected, which would result in an overall negative internal rate of return on the investment.
For investments rated 3, 4, or 5, CIM enhances its level of scrutiny over the monitoring of such portfolio company.
The following table summarizes the composition of our investment portfolio based on the 1 to 5 investment rating scale at fair value as of March 31, 2018 and December 31, 2017, excluding short term investments of $181,095 and $206,547, respectively:    
 
 
 
March 31, 2018
 
December 31, 2017
 
 
Investment Rating
 
Investments
Fair Value
 
Percentage of
Investment Portfolio
 
Investments
Fair Value
 
Percentage of
Investment Portfolio
 
 
1
 
$

 

 
$

 

 
 
2
 
1,308,088

 
82.8
%
 
1,274,569

 
84.5
%
 
 
3
 
242,330

 
15.3
%
 
202,950

 
13.5
%
 
 
4
 
28,644

 
1.8
%
 
21,311

 
1.4
%
 
 
5
 
1,359

 
0.1
%
 
8,818

 
0.6
%
 
 
 
 
$
1,580,421

 
100.0
%
 
$
1,507,648

 
100.0
%
 
The amount of the investment portfolio in each rating category may vary substantially from period to period resulting primarily from changes in the composition of such portfolio as a result of new investment, repayment and exit activities. In addition, changes in the rating of investments may be made to reflect our expectation of performance and changes in investment values.

55



Current Investment Portfolio

As of May 10, 2018, our investment portfolio, excluding our short term investments, consisted of interests in 148 portfolio companies (74% in senior secured first lien debt, 22% in senior secured second lien debt, 2% in collateralized securities and structured products (comprised of 1% invested in non-rated debt and 1% invested in non-rated equity of such securities and products), and 2% in equity) with a total fair value of $1,448,954 with an average and median portfolio company annual EBITDA of $70.2 million and $50.0 million, respectively, at initial investment. As of May 10, 2018, investments in our portfolio, excluding our short term investments, were purchased at a weighted average price of 96.56% of par value. Our estimated gross annual portfolio yield was 9.74% based upon the purchase price of such investments. The estimated gross portfolio yield does not represent and may be higher than an actual investment return to shareholders because it excludes our expenses and all sales commissions and dealer manager fees. For the quarter ended March 31, 2018, our total investment return-net asset value was 1.90%. Total investment return-net asset value does not represent and may be higher than an actual investment return to shareholders because it excludes all sales commissions and dealer manager fees. Total investment return-net asset value is a measure of the change in total value for shareholders who held our common stock at the beginning and end of the period, including distributions paid or payable during the period, and is described further in Note 13 of our consolidated financial statements.
As of May 10, 2018, our only short term investment was an investment in a U.S. Treasury Obligations Fund of $144,990.
Results of Operations for the Three Months Ended March 31, 2018 and 2017
Our results of operations for the three months ended March 31, 2018 and 2017 were as follows:
 
Three Months Ended
March 31,
 
2018
 
2017
Investment income
$
38,386

 
$
28,045

Net operating expenses
19,300

 
11,500

Net investment income
19,086

 
16,545

Net realized gain on investments and foreign currency
2,097

 
884

Net change in unrealized depreciation on investments
(1,450
)
 
(2,817
)
Net realized loss on total return swap

 
(14,269
)
Net change in unrealized appreciation on total return swap

 
15,536

Net increase in net assets resulting from operations
$
19,733

 
$
15,879

Investment Income
For the three months ended March 31, 2018 and 2017, we generated investment income of $38,386 and $28,045, respectively, consisting primarily of interest income on investments in senior secured debt, collateralized securities, structured products, and unsecured debt of 159 and 153 portfolio companies held during each respective period. Our average investment portfolio size, excluding our short term investments, increased $340,801, from $1,203,234 for the three months ended March 31, 2017 to $1,544,035 for the three months ended March 31, 2018, as we deployed the net proceeds from our financing arrangements and the net proceeds from our follow-on continuous public offering, which commenced on January 25, 2016. We expect our investment portfolio to continue to grow due to the anticipated capital available to us for investment from our follow-on continuous public offering and available under our financing arrangements. As a result, we believe that reported investment income for the three months ended March 31, 2018 and 2017 is not representative of our stabilized or future performance. Interest income earned by loans underlying the TRS was not included in investment income in the consolidated statements of operations, but rather it was recorded as part of net realized loss on total return swap. In lieu of extending the expiration date of the TRS beyond April 18, 2017, we entered into a traditional credit facility with Citibank on March 29, 2017.

56



Operating Expenses
The composition of our operating expenses for the three months ended March 31, 2018 and 2017 was as follows:
 
Three Months Ended
March 31,
 
2018
 
2017
Management fees
$
7,939

 
$
6,482

Administrative services expense
461

 
346

General and administrative
1,982

 
1,746

Interest expense
8,918

 
2,926

Total operating expenses
$
19,300

 
$
11,500

During the three months ended March 31, 2018, the increase in management fees was a direct result of the increase in our gross assets, less cash and cash equivalents, while the increase in interest expense was primarily the result of entering into new financing arrangements during and subsequent to the three months ended March 31, 2017.
The composition of our general and administrative expenses for the three months ended March 31, 2018 and 2017 was as follows:
 
Three Months Ended
March 31,
 
2018
 
2017
Professional fees
$
629

 
$
568

Transfer agent expense
329

 
314

Dues and subscriptions
244

 
170

Valuation expense
164

 
199

Director fees and expenses
121

 
86

Insurance expense
100

 
103

Due diligence fees
82

 
55

Accounting costs
77

 
55

Printing and marketing expense
72

 
106

Other expenses
164

 
90

Total general and administrative expense
$
1,982

 
$
1,746


Expense Support and Recoupment of Expense Support

Our affiliate, CIG, agreed to provide expense support to us commencing with the quarter ended December 31, 2012 for certain expenses pursuant to the expense support and conditional reimbursement agreement. We further amended and restated the expense support and conditional reimbursement agreement on December 16, 2015 and December 14, 2016 for purposes of including AIM as a party to the expense support and conditional reimbursement agreement and extending the termination date from December 31, 2016 to December 31, 2017, respectively. On January 2, 2018, we entered into an expense support and conditional reimbursement agreement with CIM for purposes of (i) replacing CIG and AIM with CIM as the expense support provider pursuant to the terms of the expense support and conditional reimbursement agreement; and (ii) extending the termination date to December 31, 2018. Refer to the discussion under “Related Party Transactions” below for further details about the expense support and conditional reimbursement agreement. Also, see Note 4 to our consolidated financial statements for additional disclosure regarding expense support from CIM, CIG and/or AIM.

For the three months ended March 31, 2018 and 2017, CIM, CIG and AIM did not provide any expense support or recoup any previously provided expense support. All expense support previously provided to us has been recouped.

Recoupment of expense support will be determined as appropriate to meet the objectives of the expense support and conditional reimbursement agreement. As a result, we may or may not be requested to reimburse CIM for any expense support that may be received from CIM in the future.

57



Net Investment Income

Our net investment income totaled $19,086 and $16,545 for the three months ended March 31, 2018 and 2017, respectively. The increase in net investment income was primarily due to an increase in the size of our investment portfolio relative to our expenses as we continued to achieve economies of scale due to proceeds received from our follow-on continuous public offering and our financing arrangements.
Net Realized Gain on Investments and Foreign Currency
Our net realized gain on investments and foreign currency totaled $2,097 and $884 for the three months ended March 31, 2018 and 2017, respectively. This change was primarily due to an increase in sales and principal repayment activity during the three months ended March 31, 2018 compared to the three months ended March 31, 2017. During the three months ended March 31, 2018, we received sale proceeds of $60,369 and principal repayments of $192,418, resulting in net realized gains of $2,095. During the three months ended March 31, 2017, we received sale proceeds of $30,903 and principal repayments of $109,443, resulting in net realized gains of $740.
Net Change in Unrealized Depreciation on Investments
The net change in unrealized depreciation on our investments totaled ($1,450) and ($2,817) for the three months ended March 31, 2018 and 2017, respectively. This change was driven primarily by unrealized losses on certain underperforming investments during the three months ended March 31, 2018, partially offset by a greater tightening of credit spreads during the three months ended March 31, 2018 compared to the three months ended March 31, 2017 that positively impacted the fair value of certain investments.
Net Realized Loss on TRS
Our net realized loss on the TRS totaled $0 and ($14,269) for the three months ended March 31, 2018 and 2017, respectively. The components of net realized loss on the TRS are summarized below:
 
Three Months Ended
March 31,
 
2018
 
2017
Interest and other income from TRS portfolio
$

 
$
6,082

Interest and other expense from TRS portfolio

 
(2,767
)
Net loss on TRS loan sales

 
(17,584
)
   Total
$

 
$
(14,269
)
The net realized loss on TRS for the three months ended March 31, 2017 was primarily due to the sale of a majority of loans underlying the TRS to Flatiron Funding II on March 29, 2017.
Net Change in Unrealized Appreciation on TRS
The net change in unrealized appreciation on the TRS totaled $0 and $15,536 for the three months ended March 31, 2018 and 2017, respectively. This change was driven primarily by a reversal of previous unrealized depreciation on the loans underlying the TRS upon the purchase of the loans by Flatiron Funding II on March 29, 2017.
Net Increase in Net Assets Resulting from Operations
For the three months ended March 31, 2018 and 2017, we recorded a net increase in net assets resulting from operations of $19,733 and $15,879, respectively, as a result of our operating activity for the respective periods.
Net Asset Value per Share, Annual Investment Return and Total Return Since Inception 

Our net asset value per share was $9.13 and $9.14 on March 31, 2018 and December 31, 2017, respectively. After considering (i) the overall changes in net asset value per share, (ii) paid distributions of approximately $0.1829 per share during the three months ended March 31, 2018, and (iii) the assumed reinvestment of those distributions in accordance with our distribution reinvestment plan then in effect, the total investment return-net asset value was 1.90% for the three month period ended March 31, 2018. Total investment return-net asset value does not represent and may be higher than an actual return to shareholders because it excludes all sales commissions and dealer manager fees. Total investment return-net asset value is a measure of the change in total value for shareholders who held our common stock at the beginning and end of the period, including distributions paid or payable during the period, and is described further in Note 13 to our consolidated financial statements included in this report.

58



Initial shareholders who subscribed to the offering in December 2012 with an initial investment of $10,000 and an initial purchase price equal to $9.00 per share (public offering price net of sales load) have seen an annualized return of 8.41% and a cumulative total return of 53.31% through March 31, 2018 (see chart below). Initial shareholders who subscribed to the offering in December 2012 with an initial investment of $10,000 and an initial purchase price equal to $10.00 per share (the initial public offering price including sales load) have seen an annualized return of 6.27% and a cumulative total return of 37.98% through March 31, 2018. Over the same time period, the S&P/LSTA Leveraged Loan Index, a primary measure of senior debt covering the U.S. leveraged loan market, which currently consists of approximately 1,000 credit facilities throughout numerous industries, recorded an annualized return of 4.24% and a cumulative total return of 24.57%. In addition, the BofA Merrill Lynch US High Yield Index, a primary measure of short-term US dollar denominated below investment grade corporate debt publicly issued in the US domestic market, recorded an annualized return of 5.32% and a cumulative total return of 31.58% over the same period.
a10000charta03.jpg
(1) Cumulative performance: December 17, 2012 to March 31, 2018
The calculations for the Growth of $10,000 Initial Investment are based upon (i) an initial investment of $10,000 in our common stock at the beginning of the period, at a share price of $10.00 per share (including sales load) and $9.00 per share (excluding sales load), (ii) assumes reinvestment of monthly distributions in accordance with our distribution reinvestment plan then in effect, (iii) the sale of the entire investment position at the net asset value per share on the last day of the period, and (iv) the distributions declared and payable to shareholders, if any, on the last day of the period.

59



Financial Condition, Liquidity and Capital Resources

We generate cash primarily from the net proceeds from our follow-on continuous public offering and from cash flows from interest, fees and dividends earned from our investments as well as principal repayments and proceeds from sales of our investments. We also employ leverage to seek to enhance our returns as market conditions permit and at the discretion of CIM. On March 23, 2018, an amendment to Section 61(a) of the 1940 Act was signed into law to permit BDCs to reduce the minimum “asset coverage” ratio from 200% to 150% and, as a result, to potentially increase the ratio of a BDC’s debt to equity to a maximum 2 to 1 from a maximum of 1 to 1, so long as certain approval and disclosure requirements are satisfied. We currently have not determined whether to seek to utilize such additional leverage. We are engaged in a follow-on continuous public offering of shares of our common stock. Our initial continuous public offering commenced on July 2, 2012 and ended on December 31, 2015. Our follow-on continuous public offering commenced on January 25, 2016 and will continue until no later than January 25, 2019. We accept subscriptions on a continuous basis and issue shares at weekly closings at prices that, after deducting selling commissions and dealer manager fees, are at or above our net asset value per share.

We have temporarily suspended the sale of shares of our common stock while we engage with the SEC to have declared effective a post-effective amendment to our registration statement. We are currently working with the SEC to have our registration statement declared effective as promptly as practicable. We will file a Form 8-K to announce the resumption of the sale of shares of our common stock. 
We will sell our shares on a continuous basis at our latest public offering price of $9.70 per share; however, to the extent that our net asset value fluctuates, we will sell at a price necessary to ensure that shares are sold at a price, after deduction of selling commissions and dealer manager fees, that is above and within 2.5% of net asset value per share.
Since commencing our initial continuous public offering on July 2, 2012 and through March 31, 2018, we sold 116,108,932 shares of common stock for net proceeds of $1,178,452 at an average price per share of $10.15. The net proceeds include gross proceeds received from reinvested shareholder distributions of $133,976, for which we issued 14,699,524 shares of common stock, and gross proceeds paid for shares of common stock tendered for repurchase of $84,200, for which we repurchased 9,276,383 shares of common stock. Since commencing our initial continuous public offering on July 2, 2012 and through March 31, 2018, sales commissions and dealer manager fees related to the sale of our common stock were $64,714 and $32,200, respectively.
As of May 10, 2018, we sold 114,822,990 shares of common stock for net proceeds of $1,166,968 at an average price per share of $10.16. The net proceeds include gross proceeds received from reinvested shareholder distributions of $136,984, for which we issued 15,028,599 shares of common stock, and gross proceeds paid for shares of common stock tendered for repurchase of $105,725, for which we repurchased 11,628,963 shares of common stock. Since commencing our initial continuous public offering on July 2, 2012 and through May 10, 2018, sales commissions and dealer manager fees related to the sale of our common stock were $64,845 and $32,305, respectively.
The net proceeds from our follow-on continuous public offering will be invested primarily in cash, cash equivalents, U.S. government securities, repurchase agreements and high-quality debt instruments maturing in one year or less prior to being invested in debt securities of private U.S. middle-market companies.
As of March 31, 2018 and December 31, 2017, we had $181,095 and $206,547 in short term investments, respectively, invested in a fund that primarily invests in U.S. government securities.

Citibank Credit Facility

As of March 31, 2018 and May 10, 2018, our outstanding borrowings under the Amended Citibank Credit Facility were $324,542 and the aggregate unfunded principal amount in connection with the Amended Citibank Credit Facility was $458. For a detailed discussion of our Amended Citibank Credit Facility, refer to Note 8 to our consolidated financial statements included in this report.

JPM Credit Facility
As of March 31, 2018 and May 10, 2018, our outstanding borrowings under the Amended JPM Credit Facility were $224,423 and the aggregate unfunded principal amount in connection with the Amended JPM Credit Facility was $577. For a detailed discussion of our Amended JPM Credit Facility, refer to Note 8 to our consolidated financial statements included in this report.
UBS Facility
As of March 31, 2018 and May 10, 2018, our outstanding borrowings under the UBS Facility were $162,500 and $200,000, respectively, and the aggregate unfunded principal amount in connection with the UBS Facility was $37,500 and $0, respectively. For a detailed discussion of our UBS Facility, refer to Note 8 to our consolidated financial statements included in this report.

60



MS Credit Facility
As of March 31, 2018 and May 10, 2018, we had no outstanding borrowings under the MS Credit Facility and the aggregate unfunded principal amount in connection with the MS Credit Facility was $200,000. For a detailed discussion of our MS Credit Facility, refer to Note 8 to our consolidated financial statements included in this report.
Unfunded Commitments
As of March 31, 2018 and May 10, 2018, our unfunded commitments amounted to $110,181 and $173,081, respectively. For a detailed discussion of our unfunded commitments, refer to Note 11 to our consolidated financial statements included in this report.
Recent Accounting Pronouncements

See Note 2 to our consolidated financial statements included in this report for a discussion of certain recent accounting pronouncements that are applicable to us.
Critical Accounting Policies
Our consolidated financial statements are prepared in conformity with GAAP, which requires us to make estimates and assumptions that affect the reported amounts of assets and liabilities at the date of the consolidated financial statements and the reported amounts of revenues and expenses during the reporting periods. Critical accounting policies are those that require the application of management’s most difficult, subjective or complex judgments, often because of the need to make estimates about the effect of matters that are inherently uncertain and that may change in subsequent periods. In preparing the consolidated financial statements, we also utilize available information, including our past history, industry standards and the current economic environment, among other factors, in forming our estimates and judgments, giving due consideration to materiality. Actual results may differ from these estimates. In addition, other companies may utilize different estimates, which may impact the comparability of our results of operations to those of companies in similar businesses.
Valuation of Portfolio Investments
The value of our assets is determined quarterly and at such other times that an event occurs that materially affects the valuation. The valuation is made pursuant to Section 2(a)(41) of the 1940 Act, which requires that we value our assets as follows: (i) the market price for those securities for which a market quotation is readily available, and (ii) for all other securities and assets, at fair value, as determined in good faith by our board of directors. As a BDC, Section 2(a)(41) of the 1940 Act requires the board of directors to determine in good faith the fair value of portfolio securities for which a market price is not readily available, and it does so in conjunction with the application of our valuation procedures by CIM.
There is no single standard for determining fair value in good faith. As a result, determining fair value requires that judgment be applied to the specific facts and circumstances of each asset while employing a valuation process that is consistently followed. Determinations of fair value involve subjective judgments and estimates. Accordingly, the notes to our consolidated financial statements refer to the uncertainty with respect to the possible effect of such valuations, and any change in such valuations in our consolidated financial statements.
Valuation Methods
With respect to investments for which market quotations are not readily available, we undertake a multi-step valuation process each quarter, as described below:
our quarterly valuation process begins with each portfolio company or investment being initially valued by certain of CIM’s investment professionals and certain members of its management team, with such valuation taking into account information received from various sources, including independent valuation firms, if applicable;
preliminary valuation conclusions are then documented and discussed with CIM’s valuation committee;
CIM’s valuation committee reviews the preliminary valuation, and, if applicable, delivers such preliminary valuation to an independent valuation firm for its review;
CIM’s valuation committee, or its designee, and, if appropriate, the relevant investment professionals meet with the independent valuation firm to discuss the preliminary valuation;
designated members of CIM’s management team respond and supplement the preliminary valuation to reflect any comments provided by the independent valuation firm;
our audit committee meets with members of CIM’s management team and the independent valuation firm to discuss the assistance provided and the results of the independent valuation firm’s review; and
our board of directors discusses the valuation and determines the fair value of each investment in our portfolio in good faith based on various statistical and other factors, including the input and recommendation of CIM, the audit committee and any third-party valuation firm, if applicable.

61



In addition to the foregoing, certain investments for which a market price is not readily available are evaluated on a quarterly basis by an independent valuation firm and certain other investments are on a rotational basis reviewed once over a twelve-month period by an independent valuation firm. Finally, certain investments are not evaluated by an independent valuation firm unless the net asset value and other aspects of such investments in the aggregate exceed certain thresholds.
Given the expected types of investments, excluding short term investments that are classified as Level 1, management expects our portfolio holdings to be classified as Level 3. Due to the uncertainty inherent in the valuation process, particularly for Level 3 investments, such fair value estimates may differ significantly from the values that would have been used had an active market for the investments existed. In addition, changes in the market environment and other events that may occur over the life of the investments may cause the gains or losses that we ultimately realize on these investments to materially differ from the valuations currently assigned. Inputs used in the valuation process are subject to variability in the future and can result in materially different fair values.
For an additional discussion of our investment valuation process, refer to Note 2 to our consolidated financial statements included in this report.
Related Party Transactions

For a discussion of our relationship with related parties including CION Securities, CIM, ICON Capital, and CIG and amounts incurred under agreements with such related parties, refer to Note 4 to our consolidated financial statements included in this report.
Contractual Obligations

On August 26, 2016, 34th Street entered into the JPM Credit Facility with JPM, as amended and restated on September 30, 2016, July 11, 2017 and November 28, 2017. See Note 8 to our consolidated financial statements for a more detailed description of the JPM Credit Facility.

On March 29, 2017, Flatiron Funding II entered into the Citibank Credit Facility with Citibank, as amended on July 11, 2017. See Note 8 to our consolidated financial statements for a more detailed description of the Citibank Credit Facility.
    
On May 19, 2017, Murray Hill Funding II entered into the UBS Facility with UBS, as amended on December 1, 2017. See Note 8 to our consolidated financial statements for a more detailed description of the UBS Facility.

On December 19, 2017, 33rd Street entered into the MS Credit Facility with MS. See Note 8 to our consolidated financial statements for a more detailed description of the MS Credit Facility.
Commitments and Contingencies and Off-Balance Sheet Arrangements
Commitments and Contingencies
We have entered into certain contracts with other parties that contain a variety of indemnifications. Our maximum exposure under these arrangements is unknown. However, we have not experienced claims or losses pursuant to these contracts and believe the risk of loss related to such indemnifications to be remote.
Our investment portfolio may contain debt investments that are in the form of lines of credit, delayed draw term loans, revolving credit facilities, or other unfunded commitments, which may require us to provide funding when requested in accordance with the terms of the underlying agreements. For further details on such debt investments, refer to Note 11 to our consolidated financial statements included in this report.
Off-Balance Sheet Arrangements
    
We currently have no off-balance sheet arrangements, except for those discussed in Note 11 to our consolidated financial statements included in this report.

62



Item 3. Quantitative and Qualitative Disclosures About Market Risk
We are subject to financial market risks, including changes in interest rates. As of March 31, 2018, 91.9% of our investments paid variable interest rates. A rise in the general level of interest rates can be expected to lead to higher interest rates applicable to our debt investments, especially to the extent that we hold variable rate investments, and to declines in the value of any fixed rate investments we may hold. To the extent that a majority of our investments may be in variable rate investments, an increase in interest rates could make it easier for us to meet or exceed our incentive fee hurdle rate, as defined in our investment advisory agreement, and may result in a substantial increase in our net investment income, and also to the amount of incentive fees payable to CIM with respect to our pre-incentive fee net investment income.
    
Under the terms of the Amended JPM Credit Facility, advances currently bear interest at a floating rate equal to the three-month LIBOR, plus a spread of 3.50% per year. Under the terms of the Amended Citibank Credit Facility, advances currently bear interest at a floating rate equal to the three-month LIBOR plus 2.0%. Pursuant to the terms of the amended UBS Facility, we currently pay a financing fee equal to the three-month LIBOR plus a spread of 3.50%. In addition, we may seek to further borrow funds in order to make additional investments. Our net investment income will be impacted, in part, by the difference between the rate at which we borrow funds and the rate at which we invest those funds. As a result, we would be subject to risks relating to changes in market interest rates. In periods of rising interest rates when we have debt outstanding, our cost of funds would increase, which could reduce our net investment income, especially to the extent we hold fixed rate investments. We expect that our long-term investments will be financed primarily with equity and long-term debt. Our interest rate risk management techniques may include various interest rate hedging activities to the extent permitted by the 1940 Act. Adverse developments resulting from changes in interest rates could have a material adverse effect on our business, financial condition and results of operations.
    
The following table shows the effect over a twelve month period of changes in interest rates on our net interest income, excluding short term investments, assuming no changes in our investment portfolio, the Amended Citibank Credit Facility, the Amended JPM Credit Facility, the amended UBS Facility or the MS Credit Facility in effect as of March 31, 2018:
Change in Interest Rates
 
Increase (Decrease) in Net Interest Income(1)
 
Percentage Change in Net Interest Income
Down 100 basis points
 
$
(6,611
)
 
(6.3
)%
Down 50 basis points
 
(3,756
)
 
(3.6
)%
Current base interest rate
 

 

Up 50 basis points
 
3,757

 
3.6
 %
Up 100 basis points
 
7,514

 
7.2
 %
Up 200 basis points
 
15,027

 
14.3
 %
Up 300 basis points
 
22,541

 
21.5
 %
(1)
This table assumes no change in defaults or prepayments by portfolio companies over the next twelve months.

The interest rate sensitivity analysis presented above does not consider the potential impact of the changes in fair value of our fixed rate debt investments and the net asset value of our common stock in the event of sudden changes in interest rates. Approximately 3.3% of our investments paid fixed interest rates as of March 31, 2018. Rising market interest rates will most likely lead to fair value declines for fixed interest rate investments and a decline in the net asset value of our common stock, while declining market interest rates will most likely lead to an increase in the fair value of fixed interest rate investments and an increase in the net asset value of our common stock.
In addition, we may have risk regarding portfolio valuation as discussed in Note 2 to our consolidated financial statements included in this report.
Item 4. Controls and Procedures
Evaluation of disclosure controls and procedures 
In connection with the preparation of this Quarterly Report on Form 10-Q for the three months ended March 31, 2018, we carried out an evaluation, under the supervision and with the participation of our management, including our Co-Chief Executive Officers and our Chief Financial Officer, of the effectiveness of the design and operation of our disclosure controls and procedures as of the end of the period covered by this report pursuant to Rule 13a-15(b) and Rule 15d-15(b) of the Securities Exchange Act of 1934, as amended. Based on the foregoing evaluation, the Co-Chief Executive Officers and the Chief Financial Officer concluded that our disclosure controls and procedures were effective.

63



In designing and evaluating our disclosure controls and procedures, we recognized that disclosure controls and procedures, no matter how well conceived and operated, can provide only reasonable, not absolute, assurance that the objectives of the disclosure controls and procedures are met.  Our disclosure controls and procedures have been designed to meet reasonable assurance standards. Disclosure controls and procedures cannot detect or prevent all error and fraud. Some inherent limitations in disclosure controls and procedures include costs of implementation, faulty decision-making, simple error and mistake. Additionally, controls can be circumvented by the individual acts of some persons, by collusion of two or more people, or by management override of the controls. The design of any system of controls is based, in part, upon certain assumptions about the likelihood of future events, and there can be no assurance that any design will succeed in achieving its stated goals under all anticipated and unanticipated future conditions. Over time, controls may become inadequate because of changes in conditions, or the degree of compliance with established policies or procedures.
Evaluation of internal control over financial reporting
There have been no changes in our internal control over financial reporting during the three months ended March 31, 2018 that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.

64



PART II - OTHER INFORMATION
Item 1. Legal Proceedings
We are not currently subject to any material legal proceedings, nor, to our knowledge, is any material legal proceeding threatened against us. From time to time, we may be party to certain legal proceedings in the ordinary course of business, including proceedings relating to the enforcement of our rights under contracts with our portfolio companies and other third parties. While the outcome of these legal proceedings cannot be predicted with certainty, we do not expect that any such proceedings will have a material effect upon our financial condition or results of operations.
Item 1A. Risk Factors
Except as set forth below, there have been no material changes from the risk factors disclosed in “Item 1A. Risk Factors” of our Annual Report on Form 10-K for the year ended December 31, 2017.
Recent legislation may allow us to incur additional leverage.

As a BDC, we are generally not permitted to incur indebtedness unless immediately after such borrowing we have an asset coverage for total borrowings of at least 200% (i.e., the amount of debt may not exceed 50% of the value of our assets). On March 23, 2018, an amendment to Section 61(a) of the 1940 Act was signed into law to permit BDCs to reduce the minimum “asset coverage” ratio from 200% to 150% and, as a result, to potentially increase the ratio of a BDC’s debt to equity to a maximum 2 to 1 from a maximum of 1 to 1, so long as certain approval and disclosure requirements are satisfied. Specifically, a BDC is permitted to apply a lower minimum asset coverage ratio of 150% if: (1) the BDC complies with certain additional asset coverage disclosure requirements; and (2)(A) a “required majority” of the BDC’s directors, as defined in Section 57(o) of the 1940 Act, approves the application of such a lower minimum asset coverage ratio to the BDC, in which case the 150% minimum asset coverage ratio will become effective on the date that is one year after the date of such independent director approval; or (B) the BDC obtains, at a special or annual meeting of its shareholders at which a quorum is present, the approval of more than 50% of the votes cast for the application of such a lower minimum asset coverage ratio to the BDC, in which case the 150% minimum asset coverage ratio will become effective on the first day after the date of such shareholder approval. As a result, we may be able to incur additional indebtedness in the future, and, therefore, your risk of an investment in us may increase. We currently have not determined whether to seek to utilize such additional leverage. If we choose to take advantage of such leverage, we will act in accordance with the requirements set forth in the amended legislation.
Item 2. Unregistered Sales of Equity Securities and Use of Proceeds
Our registration statement on Form N-2, as amended, in connection with our follow-on continuous public offering was declared effective by the SEC on January 25, 2016 (SEC File No. 333-203683). Our follow-on continuous public offering commenced on January 25, 2016.
We did not engage in any unregistered sales of equity securities during the three months ended March 31, 2018.
The table below provides information concerning our repurchases of shares of our common stock during the three months ended March 31, 2018 pursuant to our share repurchase program.
Period
 
Total Number of Shares Purchased
 
Average Price Paid per Share
 
Total Number of Shares Purchased as Part of Publicly Announced Plans or Programs
 
Maximum Number of Shares That May Yet Be Purchased Under the Plans or Programs
January 1 to January 31, 2018
 
2,014,536

 
$
9.12

 
2,014,536

 
(1
)
February 1 to February 28, 2018
 

 

 

 

March 1 to March 31, 2018
 

 

 

 

Total
 
2,014,536

 
$
9.12

 
2,014,536

 
(1
)
(1)
A description of the maximum number of shares of our common stock that may be repurchased is set forth in a detailed discussion of the terms of our share repurchase program in Note 3 to our unaudited consolidated financial statements contained in this Quarterly Report on Form 10-Q.
Item 3. Defaults Upon Senior Securities
Not applicable.
Item 4. Mine Safety Disclosures
Not applicable.
Item 5. Other Information
Not applicable.

65



Item 6. Exhibits
Exhibit
Number
 
Description of Document
2.1
 
3.1
 
3.2
 
3.3
 
4.1
 
4.2
 
10.1
 
10.2
 
10.3
 
10.4
 
10.5
 
10.6
 
10.7
 
10.8
 
10.9
 
10.10
 
10.11
 
10.12
 


66



Exhibit
Number
 
Description of Document
10.13
 
10.14
 
10.15
 
10.16
 
10.17
 
10.18
 
10.19
 
10.20
 
10.21
 
10.22
 
10.23
 
10.24
 
10.25
 
10.26
 
10.27
 
10.28
 
10.29
 


67



Exhibit
Number
 
Description of Document
10.30
 
10.31
 
10.32
 
10.33
 
10.34
 
10.35
 
10.36
 
10.37
 
10.38
 
10.39
 
10.40
 
10.41
 
31.1
 
31.2
 
31.3
 
32.1
 
32.2
 
32.3
 


68



SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
Date: May 15, 2018
CĪON Investment Corporation
(Registrant)
By: /s/ Michael A. Reisner
Michael A. Reisner
Co-Chief Executive Officer
(Principal Executive Officer)
By: /s/ Mark Gatto
Mark Gatto
Co-Chief Executive Officer
(Principal Executive Officer)
By: /s/ Keith S. Franz
Keith S. Franz
Chief Financial Officer
(Principal Financial and Accounting Officer)


69